data_1l2z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l2z _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.824 0.345 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtt -78.12 160.79 27.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.4 ' CD1' ' OG ' ' A' ' 22' ' ' SER . 59.4 m95 -144.23 116.63 8.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.572 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.9 mt-10 -68.21 165.34 18.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.07 132.8 12.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.098 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.7 125.84 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -56.49 -46.62 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 6.7 mt-10 . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.0 0.428 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.91 107.84 17.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 55.3 m-85 -130.84 -163.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.581 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.43 28.74 18.79 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.011 -0.614 . . . . 0.0 114.356 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 93.4 Cg_endo -82.16 25.76 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.907 1.738 . . . . 0.0 111.924 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -99.34 166.26 11.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.894 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.3 p -69.15 150.01 48.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.819 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.4 ' OG ' ' CD1' ' A' ' 4' ' ' TRP . 0.3 OUTLIER -46.7 -30.28 2.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.134 0.493 . . . . 0.0 110.148 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.14 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.541 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 31.2 tp60 -65.99 -36.64 83.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 mmm -67.1 -44.29 80.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.536 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.84 -38.61 75.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLU . 84.9 m -60.65 -57.77 11.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.2 m0 -62.2 -45.26 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.73 -34.83 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.285 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -88.61 -35.05 17.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' THR . 3.4 mm-40 -55.67 -30.09 60.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.099 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.3 2.6 24.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.437 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 0.3 OUTLIER -55.09 -34.56 63.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.847 0.356 . . . . 0.0 110.819 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -108.51 81.06 1.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.42 -17.16 49.04 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.701 2.268 . . . . 0.0 112.514 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.26 -8.76 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.294 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 158.94 35.14 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.005 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.97 160.95 42.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.993 0.425 . . . . 0.0 111.452 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 85.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.413 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.7 m -83.32 143.88 30.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.469 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -170.4 137.41 1.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -59.55 132.54 54.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.588 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.392 -179.505 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 4.0 m-85 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.54 137.6 19.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.05 136.85 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.802 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -54.88 -30.78 58.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -8.34 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -107.81 2.73 23.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 56' ' ' ILE . 36.7 mt -109.06 153.11 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -118.45 87.02 2.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -60.4 -24.04 64.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -62.61 -21.85 65.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 37.1 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.607 0.169 . . . . 0.01 111.848 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.451 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.1 Cg_endo -61.42 -179.44 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.355 2.037 . . . . 0.01 112.171 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 C-N-CA 120.707 -0.759 . . . . 0.65000000000000002 112.453 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.832 0.349 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.419 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.7 mtt -78.75 153.33 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.408 ' CD1' ' OG ' ' A' ' 22' ' ' SER . 68.7 m95 -140.73 115.13 9.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.956 0.407 . . . . 0.0 111.691 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -66.4 170.81 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.487 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -161.87 135.09 6.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -129.68 129.0 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.055 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -62.87 -57.39 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.17 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.4 mp0 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.948 0.404 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 94.91 5.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.089 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 67.0 m-85 -114.3 -166.1 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.459 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 93.32 27.59 13.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.993 -0.622 . . . . 0.0 114.466 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.1 Cg_endo -82.56 27.46 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.719 1.76 . . . . 0.0 111.753 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -98.7 167.52 10.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.98 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.7 p -70.15 149.81 47.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.408 ' OG ' ' CD1' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -46.91 -30.54 2.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.21 0.528 . . . . 0.0 110.148 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.65 86.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.76 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.445 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.5 tp60 -71.44 -31.7 67.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.839 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.6 mmm -75.16 -49.85 18.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.35 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.52 -33.08 69.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.399 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLU . 92.4 m -68.53 -51.5 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.476 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.445 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.4 m0 -63.2 -40.69 98.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.81 -30.98 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.253 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 p -95.11 -31.37 13.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.589 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.2 mm-40 -56.21 -46.16 79.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 110.982 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.63 -25.55 0.44 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -54.88 160.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.796 0.331 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 62.9 62.38 1.86 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.574 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.89 -23.79 17.2 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.582 2.188 . . . . 0.0 112.596 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.69 -4.51 10.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.468 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.65 160.31 34.1 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.883 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.96 160.36 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.964 0.412 . . . . 0.0 111.419 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.27 83.97 0.55 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.512 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -84.33 155.27 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.908 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 5.3 ptm180 -178.28 138.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -62.13 125.39 23.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.983 0.42 . . . . 0.0 110.547 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 14.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.683 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 134.91 19.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.779 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -55.25 133.07 49.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.6 p -53.3 -31.48 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.33 -7.82 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.029 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 1.83 22.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.677 0.275 . . . . 0.0 111.362 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.8 mt -108.08 152.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.793 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -117.96 84.75 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -58.88 -22.18 58.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -62.05 -25.9 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.162 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.464 -0.249 0 CA-C-O 120.673 0.197 . . . . 0.01 112.408 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.424 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.3 Cg_endo -59.69 -178.06 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.595 2.197 . . . . 0.01 112.363 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.507 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 112.618 179.7 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.762 0.315 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.402 ' HB3' HD12 ' A' ' 43' ' ' LEU . 3.4 mtt -81.52 158.15 24.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.528 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -145.13 117.0 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 111.787 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 1.8 mt-10 -66.46 171.94 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.316 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -168.56 130.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HE2' ' CD2' ' A' ' 39' ' ' TYR . 11.1 pttt -128.87 127.51 41.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.367 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.25 -55.14 38.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.07 89.69 3.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.243 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' B' ' 69' ' ' PRO . 75.6 m-85 -111.31 -164.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.083 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.629 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.83 23.99 34.02 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.813 -0.708 . . . . 0.0 114.29 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 85.5 Cg_endo -80.01 28.72 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 119.788 1.794 . . . . 0.0 112.031 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -102.93 169.19 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.8 p -72.27 150.86 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.834 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -48.12 -28.99 3.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 110.098 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.67 84.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.448 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 39.8 tp60 -74.79 -33.58 62.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 41.9 mmm -73.04 -44.48 60.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 51.9 tp60 -59.91 -40.51 89.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 31' ' ' GLU . 18.5 m -60.92 -52.2 66.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.8 m0 -62.83 -43.64 98.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.61 -33.25 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.5 t -89.06 -40.06 13.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.059 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 27' ' ' THR . 11.3 tm-20 -51.48 -28.93 14.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.08 4.31 29.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.832 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -35.82 65.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.327 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -105.35 78.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.535 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.06 -16.82 57.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.641 2.227 . . . . 0.0 112.401 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -113.97 -12.15 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.337 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.52 160.73 36.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -136.84 160.99 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -79.65 87.56 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.184 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 20.5 m -93.08 159.84 15.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.349 0.595 . . . . 0.0 112.134 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -178.85 141.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.305 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -51.69 134.24 30.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 111.338 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 3' ' ' MET . 16.7 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.148 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.0 m-85 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.691 0.281 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.45 129.64 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.028 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.12 124.53 15.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.41 -34.54 35.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -11.2 60.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.65 2.86 20.49 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.655 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.8 mt -101.41 153.41 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 110.771 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -115.99 83.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.785 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 81.0 m-85 -56.81 -22.82 39.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -21.26 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.287 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 -179.956 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.558 0.149 . . . . 0.01 112.188 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 Cg_endo -65.14 -179.21 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.475 2.116 . . . . 0.01 112.264 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 C-N-CA 120.793 -0.718 . . . . 0.65000000000000002 112.387 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.844 0.354 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 mtt -80.89 160.0 24.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -144.79 115.41 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.683 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 3.4 pt-20 -71.39 149.8 45.63 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 3.6 p90 -137.13 140.78 42.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.453 . . . . 0.0 111.564 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -131.21 123.41 28.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.832 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -62.48 -57.73 10.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.234 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.2 -179.474 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 89.01 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 54.3 m-85 -107.73 -161.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.95 25.4 29.44 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.224 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 96.8 Cg_endo -77.97 15.0 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 CA-C-N 119.635 1.718 . . . . 0.0 111.647 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.446 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -88.18 165.71 14.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.776 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 p -70.85 148.55 47.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -30.14 2.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.38 88.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.458 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.405 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.0 tp60 -73.37 -34.0 65.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.566 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 36.3 mmm -71.61 -42.68 67.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.43 -43.95 92.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 31.7 m -58.0 -53.52 57.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.405 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.87 -42.85 99.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.948 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.68 -33.99 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.444 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -30.63 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.3 mm-40 -56.34 -23.06 34.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.21 6.04 42.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.595 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -61.81 -28.65 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.626 0.251 . . . . 0.0 111.229 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -114.1 80.75 5.76 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.836 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.85 -27.98 37.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.495 2.13 . . . . 0.0 112.427 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.13 15.13 15.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.074 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 -164.38 53.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.048 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -162.03 161.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.908 0.385 . . . . 0.0 111.091 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.446 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -71.09 85.66 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.773 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -93.72 152.22 19.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.808 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -178.75 150.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -58.98 136.05 57.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 21.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CE1' ' HD2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -159.68 134.02 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -58.13 133.82 55.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 p -54.14 -28.89 42.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 0.8 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 2.11 10.63 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.326 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 mt -99.58 153.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -107.63 79.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -58.25 -24.29 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.05 -26.85 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.048 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 CA-C-O 120.746 0.227 . . . . 0.01 112.436 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.418 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.0 Cg_endo -62.1 -179.57 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.606 2.204 . . . . 0.01 112.312 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 120.843 -0.694 . . . . 0.65000000000000002 112.59 179.773 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.8 mtt -79.74 160.54 26.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.489 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 63.1 m95 -144.92 115.65 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 111.853 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -71.24 165.95 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -157.05 133.39 9.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.199 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' CZ ' ' A' ' 50' ' ' PHE . 10.8 pttt -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.376 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -60.58 -56.74 17.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.774 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.83 96.89 4.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.343 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.2 m-85 -111.02 -163.49 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.082 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.637 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.82 24.2 33.39 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.23 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 91.1 Cg_endo -79.02 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 CA-C-N 119.714 1.757 . . . . 0.0 111.859 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -101.85 166.33 10.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.4 p -66.44 147.97 52.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -46.75 -30.67 2.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.82 88.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -70.93 -34.17 71.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.613 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.96 -43.87 56.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.363 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.23 -36.36 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 55.7 m -66.34 -50.04 64.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.448 ' CD2' ' HG3' ' B' ' 68' ' ' PRO . 11.8 m0 -65.74 -44.22 86.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.71 -31.26 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.3 t -91.89 -33.45 14.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.051 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 4.1 mm-40 -57.19 -29.48 63.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.06 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.69 2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -55.29 -27.38 46.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -116.3 81.66 10.95 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.785 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.09 -27.0 53.14 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.548 2.165 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.54 12.19 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.102 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.03 -169.54 52.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.034 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -159.33 160.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CD2' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -73.3 90.9 1.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.888 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -90.44 156.37 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.216 0.531 . . . . 0.0 111.95 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HG3' ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -175.2 142.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.752 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -64.17 127.79 32.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.623 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CD2' ' HG3' ' A' ' 41' ' ' ARG . 2.7 m-85 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -156.1 134.87 11.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.25 138.01 57.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.9 p -53.88 -30.86 47.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -77.97 -3.86 44.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -115.3 2.89 14.11 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 56' ' ' ILE . 46.7 mt -106.91 152.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.837 0.351 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -113.3 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -65.14 -24.3 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.15 -9.34 58.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.448 ' HG3' ' CD2' ' A' ' 28' ' ' TRP . 35.8 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.684 0.202 . . . . 0.01 112.118 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.415 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 14.2 Cg_endo -59.36 -178.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 0.01 112.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 C-N-CA 120.873 -0.68 . . . . 0.65000000000000002 112.513 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.873 0.368 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.411 ' HB3' HD13 ' A' ' 43' ' ' LEU . 45.0 mtt -126.32 162.59 25.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.573 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.404 ' O ' ' O ' ' A' ' 18' ' ' GLY . 60.4 m95 -145.61 114.35 6.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.848 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -71.94 158.82 35.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.082 179.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -145.87 136.58 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.51 122.88 36.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.15 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -53.65 -47.03 70.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.918 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.907 0.384 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.25 98.66 3.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.013 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.465 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 67.1 m-85 -115.77 -163.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.555 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.598 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 87.43 28.35 24.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.049 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.4 Cg_endo -81.24 22.12 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 CA-C-N 119.595 1.698 . . . . 0.0 111.64 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -94.18 165.41 12.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.567 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.1 p -68.51 146.87 52.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.51 -31.29 1.72 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.182 0.515 . . . . 0.0 110.237 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.58 70.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.474 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 36.2 tp60 -66.83 -36.8 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.7 mmm -68.27 -51.49 44.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 35.8 tp60 -54.19 -32.82 56.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.471 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 31' ' ' GLU . 37.1 m -64.4 -52.36 58.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.568 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.2 m0 -64.55 -42.43 95.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.57 -31.86 55.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.183 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 p -96.85 -31.27 12.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.454 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' THR . 16.6 mm-40 -54.37 -33.37 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.262 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.91 -26.25 1.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.484 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -56.09 164.2 1.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 60.4 61.86 3.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.518 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.72 -32.49 36.63 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.674 2.25 . . . . 0.0 112.531 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -115.2 12.63 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.251 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.74 159.81 24.85 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.111 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.83 161.97 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.125 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.81 80.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.27 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.6 m -82.77 145.14 29.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.717 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -169.27 135.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.082 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -60.39 136.23 57.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 10.7 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.774 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.708 0.289 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.92 132.08 9.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.15 134.54 56.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 p -55.14 -25.96 35.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 4.82 29.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.36 5.34 5.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.563 0.22 . . . . 0.0 111.554 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 56' ' ' ILE . 24.1 mt -103.13 153.21 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -109.4 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 66.7 m-85 -70.21 -12.95 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.07 -14.58 46.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.869 0.366 . . . . 0.0 111.196 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 CA-C-O 120.575 0.156 . . . . 0.01 112.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.465 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.3 Cg_endo -58.69 -174.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.447 2.098 . . . . 0.01 112.391 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 115.627 -0.715 . . . . 0.65000000000000002 112.58 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.778 0.323 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mtt -76.49 157.52 32.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -142.76 117.08 9.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.968 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -69.64 166.66 18.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.232 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -159.75 130.56 5.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.081 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -120.17 120.91 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.16 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 34' ' ' PHE . 85.1 m95 -56.94 -52.62 64.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 2.8 pm0 . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 121.002 0.43 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.59 107.87 16.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.419 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.4 m-85 -133.97 -164.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.553 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 95.52 18.25 33.57 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.872 -0.68 . . . . 0.0 114.337 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 78.3 Cg_endo -77.02 51.59 3.5 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.958 1.879 . . . . 0.0 111.544 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -127.08 166.67 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.52 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -70.55 148.35 48.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -46.57 -30.1 2.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.087 0.47 . . . . 0.0 110.181 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.03 30.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.398 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 42.3 tp60 -61.29 -34.67 75.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 39.4 mmm -70.06 -41.25 74.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.182 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -58.07 -40.17 80.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.561 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 31' ' ' GLU . 99.2 m -62.55 -60.71 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 12.4 m0 -55.99 -46.33 78.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 81.4 t -60.56 -29.61 45.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 m -99.05 -25.65 14.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.356 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.0 tp10 -56.82 -33.36 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.47 -5.39 13.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.735 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.15 -34.8 66.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 110.794 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -107.48 73.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.477 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.18 -19.94 62.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.596 2.197 . . . . 0.0 112.42 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.29 -12.44 11.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.193 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.79 159.4 28.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.809 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.87 160.98 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 79.15 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -78.22 150.34 33.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.542 -179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.6 ttm-85 -179.57 126.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.41 137.85 10.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.285 -179.544 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 4.3 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.72 0.295 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.59 131.46 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -55.26 128.33 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.024 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -54.65 -32.23 58.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.82 -4.74 45.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -114.71 3.64 14.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.576 0.227 . . . . 0.0 111.569 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -103.3 153.89 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.298 . . . . 0.0 110.97 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -100.71 111.95 24.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CB ' ' HG2' ' A' ' 26' ' ' GLN . 88.6 m-85 -95.7 20.36 9.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.984 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -108.45 -23.46 11.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.95 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.642 0.184 . . . . 0.01 112.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.419 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 28.9 Cg_endo -65.26 -178.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.451 2.1 . . . . 0.01 112.482 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 C-N-CA 120.866 -0.683 . . . . 0.65000000000000002 112.536 179.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.3 mtt -79.67 163.41 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.435 ' CZ2' ' HE2' ' A' ' 42' ' ' LYS . 54.4 m95 -148.02 117.13 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.712 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -70.14 163.81 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.0 p90 -152.22 137.23 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 0.0 110.997 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -126.05 128.13 46.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.33 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -58.92 -51.72 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.773 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.981 0.42 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.85 113.03 24.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.455 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 72.4 m-85 -133.22 -162.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.419 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.66 28.67 18.36 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.999 -0.62 . . . . 0.0 114.293 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.9 Cg_endo -80.77 23.62 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 119.668 1.734 . . . . 0.0 111.624 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -94.28 165.15 12.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.746 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 p -70.32 148.07 48.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -45.56 -30.88 1.6 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.212 0.529 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.11 -48.29 80.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.531 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 41.3 tp60 -68.89 -34.28 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.628 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.2 mmm -69.07 -46.29 68.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.279 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.675 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.1 m -59.02 -54.88 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.625 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.455 ' CD1' ' HG3' ' B' ' 68' ' ' PRO . 7.0 m0 -59.81 -40.96 90.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.19 -30.57 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.796 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 p -95.43 -31.58 13.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.8 tp10 -57.76 -47.99 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.24 -26.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.773 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -53.37 162.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER 63.48 55.6 1.87 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.31 -22.85 28.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.196 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -114.56 -14.04 12.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.32 158.34 23.99 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.948 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.56 159.93 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.298 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -74.49 88.08 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.22 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.2 m -80.94 158.03 25.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.178 0.513 . . . . 0.0 111.754 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG3' ' CG ' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -179.72 145.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.714 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 18.2 mtmt -73.14 123.12 22.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.253 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.419 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.503 ' CD2' ' CD2' ' A' ' 39' ' ' TYR . 1.5 m-85 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -156.36 136.17 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -59.16 136.2 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.5 t -53.27 -31.22 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -6.35 53.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.112 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -1.4 19.7 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -104.96 150.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.634 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -117.89 83.99 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -59.4 -25.56 64.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.5 -22.42 43.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' A' ' 28' ' ' TRP . 32.5 Cg_exo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.618 0.174 . . . . 0.01 112.3 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.455 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.6 Cg_endo -59.33 -177.71 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.507 2.138 . . . . 0.01 112.399 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.65000000000000002 112.6 179.671 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.638 0.256 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.5 mtt -81.83 156.66 24.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.52 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -143.6 115.93 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.352 . . . . 0.0 111.845 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 5.4 pt-20 -71.87 162.79 28.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 6.0 p90 -152.63 135.43 15.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.42 128.7 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.05 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -62.04 -54.91 34.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.69 147.61 35.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.212 0.529 . . . . 0.0 111.54 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 70.3 m-85 -155.38 -160.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.77 29.66 17.68 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.864 -0.684 . . . . 0.0 114.284 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 90.4 Cg_endo -79.05 17.79 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 119.588 1.694 . . . . 0.0 111.464 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -91.19 166.24 13.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.716 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.9 p -68.46 148.52 50.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.991 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.4 p -47.26 -30.08 2.83 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.206 0.526 . . . . 0.0 110.284 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.37 80.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.437 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.2 tp60 -71.11 -33.05 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.9 mmm -72.77 -46.13 54.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.183 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.64 -38.0 71.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.395 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLU . 38.8 m -63.36 -60.52 3.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.49 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.437 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.1 m0 -53.8 -40.75 66.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.973 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.4 -33.53 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.243 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -89.68 -32.15 17.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.2 tp10 -56.46 -44.12 80.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -0.97 6.93 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.825 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -53.95 -33.4 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -105.39 82.15 0.73 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.54 -29.16 83.95 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.589 2.193 . . . . 0.0 112.243 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -115.53 14.75 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.52 -166.8 54.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.114 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -160.83 161.78 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 0.0 111.054 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.3 82.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.0 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.5 m -87.01 150.84 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.904 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -179.85 143.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.262 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -55.86 131.59 47.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.068 -179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.451 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 2.5 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -151.03 130.4 12.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.69 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -54.95 129.59 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.926 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.4 p -53.45 -32.27 49.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -78.71 -3.35 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -117.56 4.24 12.4 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.518 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.15 153.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -109.48 80.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.001 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -58.14 -22.41 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -75.77 -6.74 52.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 111.062 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.596 0.165 . . . . 0.01 111.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.2 Cg_endo -60.52 -176.59 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.378 2.052 . . . . 0.01 112.271 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 CA-C-N 115.63 -0.714 . . . . 0.65000000000000002 112.504 179.792 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.779 0.323 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.434 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . 5.6 mmm -79.64 152.11 30.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 73.9 m95 -144.65 114.84 7.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 111.736 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -70.3 170.58 11.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.353 179.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.87 135.38 8.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.28 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -127.4 129.43 47.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.037 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -58.43 -48.49 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.165 -179.696 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.73 92.34 2.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.717 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 53.9 m-85 -113.47 -166.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 92.38 28.55 12.75 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.527 -0.596 . . . . 0.0 114.317 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.3 Cg_endo -83.49 25.93 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 CA-C-N 119.788 1.794 . . . . 0.0 111.788 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -99.42 171.03 8.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -71.93 147.47 46.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.929 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -46.66 -30.64 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.285 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.04 -46.9 85.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.559 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.2 tp60 -70.33 -32.72 70.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.623 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.9 mmm -73.75 -47.98 35.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.305 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -56.92 -34.1 67.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.567 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 31' ' ' GLU . 8.4 m -71.05 -53.21 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.425 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.84 -42.05 98.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.38 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.9 m -95.6 -31.33 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.7 mm-40 -55.14 -32.09 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.133 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.16 -0.03 20.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -56.44 -34.47 66.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -109.39 76.38 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.5 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.2 -19.03 65.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.634 2.223 . . . . 0.0 112.408 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -115.85 2.23 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.66 159.33 13.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.982 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.23 160.64 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.957 0.408 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 87.53 3.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.353 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.69 156.33 19.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 0.0 111.807 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -175.29 127.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.082 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 12.6 mtmt -50.27 135.26 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.281 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' CD1' ' CB ' ' A' ' 3' ' ' MET . 12.9 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 3.3 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.764 0.316 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.27 129.4 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.76 133.6 56.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -34.97 64.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -68.18 -12.12 60.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.186 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.26 11.98 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.463 HG21 HD12 ' A' ' 56' ' ' ILE . 47.2 mt -109.2 155.34 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.933 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 56' ' ' ILE . 6.7 t0 -113.37 82.24 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -57.51 -22.49 44.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.96 -10.57 59.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.326 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 111.012 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.704 0.21 . . . . 0.01 112.232 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.3 Cg_endo -61.32 -177.65 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.482 2.121 . . . . 0.01 112.273 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 C-N-CA 120.752 -0.737 . . . . 0.65000000000000002 112.322 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.74 0.305 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.8 mtt -80.09 156.04 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.592 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -139.67 117.69 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 111.732 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mt-10 -67.34 169.41 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.707 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -160.8 136.19 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.072 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -127.7 122.36 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.291 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -55.98 -48.91 74.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.9 mt-10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 107.99 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 74.2 m-85 -126.45 -163.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 91.48 29.89 11.55 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.351 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 75.8 Cg_endo -83.37 26.08 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.882 1.721 . . . . 0.0 111.812 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -96.34 167.51 11.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.842 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 p -69.13 147.02 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -44.16 -34.04 1.71 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.216 0.532 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -56.51 20.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.8 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.427 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.0 tp60 -58.08 -32.37 68.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.46 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.6 mmm -72.71 -43.09 63.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -57.58 -38.31 74.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 65.5 m -64.81 -60.03 3.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.7 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.427 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.7 m0 -55.23 -43.23 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 111.016 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.85 -29.44 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -94.89 -29.71 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.34 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.0 tm-20 -57.61 -44.43 85.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.995 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.39 -3.05 5.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD ' ' B' ' 68' ' ' PRO . 16.1 m-85 -54.43 -32.04 56.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -111.04 78.82 1.76 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -20.15 47.62 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.176 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -116.95 -6.81 11.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.448 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.17 160.23 34.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.28 161.12 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 111.231 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -71.79 81.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.048 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.74 149.12 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 111.93 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HB3' ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -173.71 140.5 0.77 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.804 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -57.06 128.17 35.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.404 -179.445 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 6.2 m-85 . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -140.85 127.6 20.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -57.72 131.72 51.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 p -53.03 -29.11 27.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -79.4 -2.5 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -118.05 3.92 12.08 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.516 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mt -101.31 151.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.814 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.48 89.56 3.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.23 -16.28 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.502 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -71.92 -19.98 61.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.512 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 111.172 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.426 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 Cg_exo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.677 0.199 . . . . 0.01 112.092 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.473 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 20.7 Cg_endo -64.87 179.54 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.267 1.978 . . . . 0.01 112.29 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.779 -0.724 . . . . 0.65000000000000002 112.468 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 mtp -87.34 145.78 26.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.795 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 42.4 m95 -132.53 -172.07 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -147.45 163.16 37.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.022 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -151.98 136.89 17.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.976 0.417 . . . . 0.0 111.176 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.69 128.83 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.435 ' CE3' HG11 ' A' ' 38' ' ' VAL . 31.7 m95 -62.9 -57.38 10.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.866 0.365 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.61 84.44 1.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.201 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 45.0 m-85 -106.85 -175.24 2.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.961 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.26 -16.87 41.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.895 -0.947 . . . . 0.0 115.297 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.5 Cg_exo -40.29 -26.19 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 120.428 2.114 . . . . 0.0 112.985 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.2 m-85 -43.14 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.366 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -66.91 146.57 54.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 5.5 p -47.75 -30.53 3.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.14 0.495 . . . . 0.0 110.221 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.65 92.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.537 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.0 tp60 -71.23 -30.45 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.5 mmm -73.23 -47.06 46.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.201 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -57.08 -39.63 75.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -62.07 -59.76 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.684 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.458 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.1 m0 -57.2 -44.54 83.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.802 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.947 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -83.94 -41.65 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.26 -27.84 49.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.77 6.93 30.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -54.09 -25.95 24.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.283 . . . . 0.0 111.081 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -117.56 80.85 13.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.793 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.69 -19.47 65.28 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.663 2.242 . . . . 0.0 112.531 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.51 -3.76 14.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.43 162.45 29.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.972 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 HG11 ' CE3' ' A' ' 8' ' ' TRP . 7.4 m -137.34 161.53 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.955 0.407 . . . . 0.0 111.458 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.01 90.21 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.421 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.8 m -88.04 142.23 27.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.81 139.79 11.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.416 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 1.5 mtmt -73.42 142.64 46.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.848 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 5.6 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.797 0.332 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.05 126.59 11.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -63.04 130.71 45.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -52.06 -28.2 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -7.8 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.97 7.29 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.479 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.9 mt -104.28 153.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 111.141 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -118.11 117.53 29.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.667 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -94.46 30.35 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.63 -26.01 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.972 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 0 N--CA 1.464 -0.206 0 CA-C-O 120.635 0.181 . . . . 0.01 112.199 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.89 179.35 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.485 2.123 . . . . 0.01 112.179 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 C-N-CA 120.681 -0.771 . . . . 0.65000000000000002 112.388 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.76 0.314 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mtt -85.21 142.88 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 42' ' ' LYS . 49.6 m95 -129.78 -170.92 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 2.0 mt-10 -145.37 170.13 16.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.58 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' TYR . 1.3 p90 -168.22 130.54 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -126.09 128.7 47.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.424 ' CE3' HG12 ' A' ' 38' ' ' VAL . 72.4 m95 -63.82 -58.09 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.119 -179.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 5.1 mm-40 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.12 102.7 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.451 . . . . 0.0 111.439 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 6' ' ' TYR . 46.4 m-85 -131.11 179.74 5.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.963 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 107.35 -17.01 37.64 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.341 -0.933 . . . . 0.0 115.326 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.3 Cg_exo -40.38 -25.56 0.18 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 CA-C-N 120.235 2.018 . . . . 0.0 113.099 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.0 m-85 -43.01 166.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.328 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -66.89 145.9 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 12.1 t -47.04 -30.2 2.55 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.157 0.503 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.48 88.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.647 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.457 ' CG ' ' CZ3' ' A' ' 28' ' ' TRP . 30.0 tp60 -69.72 -30.71 68.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.581 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.8 mmm -72.96 -46.81 50.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.303 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -59.39 -35.31 73.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.368 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -65.49 -61.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.457 ' CZ3' ' CG ' ' A' ' 24' ' ' GLN . 8.8 m0 -54.7 -42.83 71.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.52 -33.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.928 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.9 p -84.62 -38.68 19.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.107 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -27.24 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 7.04 32.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.776 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.9 m-85 -54.87 -39.47 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -102.51 94.81 5.34 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 -24.73 30.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.553 2.169 . . . . 0.0 112.555 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.34 15.28 14.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.138 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.54 -176.23 35.67 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.018 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.424 HG12 ' CE3' ' A' ' 8' ' ' TRP . 2.6 m -152.11 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.875 0.369 . . . . 0.0 111.116 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -77.99 87.06 4.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.227 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 57.5 m -91.89 152.57 20.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 111.945 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 9.3 ttp85 -160.72 142.8 12.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.113 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 4.8 mtmt -68.41 146.4 53.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 2.0 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.64 126.86 21.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.927 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.3 134.54 45.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t -57.98 -37.12 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.26 -12.52 56.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.281 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 7.24 27.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 56' ' ' ILE . 51.4 mt -108.97 153.83 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.055 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.35 84.97 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -60.08 -20.98 60.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.256 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.22 -10.11 59.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.574 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 111.194 -179.863 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.424 ' HD3' ' CD1' ' A' ' 28' ' ' TRP . 81.0 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 CA-C-O 120.703 0.209 . . . . 0.01 112.099 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.16 178.13 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.504 2.136 . . . . 0.01 112.199 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.685 -0.769 . . . . 0.65000000000000002 112.417 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.834 0.349 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.418 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.1 mmm -81.12 159.43 24.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.577 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -147.61 116.8 6.89 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 5.1 pt-20 -80.8 136.08 36.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.561 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -127.38 137.33 52.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -126.05 128.49 47.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.412 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -59.1 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.065 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 9.5 mm-40 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 85.07 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 30.2 m-85 -109.29 -171.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.668 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.63 -9.87 41.39 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.057 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.8 Cg_exo -42.18 -26.48 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.431 2.116 . . . . 0.0 112.314 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.05 167.44 0.05 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.851 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -77.9 153.73 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -47.71 -29.58 3.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.073 0.463 . . . . 0.0 110.052 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.89 -57.56 11.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.625 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.3 tp60 -62.37 -37.47 85.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.4 mmm -64.51 -49.85 69.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -54.12 -36.68 63.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' GLU . 88.2 m -61.11 -59.75 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.632 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.468 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -58.13 -46.08 86.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 94.0 t -57.86 -30.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 t -96.81 -29.29 13.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 14.1 tp10 -55.21 -30.22 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -0.66 26.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -58.83 -32.4 69.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -106.88 75.29 0.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.78 -21.69 69.44 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.86 6.51 15.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.207 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 159.81 10.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.094 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.88 161.5 41.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.836 0.35 . . . . 0.0 111.225 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -75.62 82.11 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.106 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 2.1 m -87.9 151.04 23.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.787 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 8.5 ptm180 179.02 151.76 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.434 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -59.32 135.9 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.872 0.367 . . . . 0.0 110.512 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 11.6 mt . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.27 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.7 m-85 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -142.66 127.3 18.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.712 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -55.84 130.01 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -53.85 -28.3 35.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -2.06 46.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.229 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 4.87 11.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.532 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.1 mt -107.19 153.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -104.92 107.85 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -89.54 52.58 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.664 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -145.69 -37.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.299 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.464 -0.213 0 CA-C-O 120.617 0.174 . . . . 0.01 112.246 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . 0.418 ' HG2' ' CG ' ' A' ' 17' ' ' TYR . 33.5 Cg_endo -65.85 178.38 2.35 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.383 2.055 . . . . 0.01 112.357 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.616 179.853 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 mtt -74.65 163.86 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.423 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 64.8 m95 -145.49 115.8 7.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.697 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.549 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 8.6 pt-20 -76.2 146.17 39.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 1.5 p90 -133.99 134.82 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -127.47 126.96 43.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.332 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -56.7 -49.58 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.871 0.367 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.13 82.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 28.3 m-85 -113.88 -165.91 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.825 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 105.92 -9.45 43.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.357 -0.925 . . . . 0.0 115.036 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 99.7 Cg_exo -42.17 -26.68 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 120.408 2.104 . . . . 0.0 112.362 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.72 161.07 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 p -73.05 152.37 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 15.5 t -47.27 -29.68 2.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.209 0.528 . . . . 0.0 110.259 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.0 64.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.747 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.442 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -67.2 -35.4 79.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.634 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.9 mmm -70.72 -46.87 62.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.277 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -54.42 -37.3 64.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.497 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.0 m -63.8 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.442 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -51.31 -41.81 60.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.893 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.6 t -71.08 -31.07 43.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.832 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.75 23.73 13.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.8 tp10 -112.42 -33.87 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.61 -26.57 0.75 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CE2' ' HD2' ' B' ' 68' ' ' PRO . 32.8 m-85 -64.15 168.04 5.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 55.0 68.02 2.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.753 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -24.36 76.5 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.637 2.225 . . . . 0.0 112.29 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -116.9 -5.93 11.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.45 158.13 30.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.021 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.55 161.25 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 0.0 111.217 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -68.51 83.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.151 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 3.4 m -91.66 146.38 23.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.724 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -179.06 147.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.538 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.62 131.11 49.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.412 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 12.9 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.086 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.804 0.335 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -162.15 134.12 5.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.966 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.64 137.92 57.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.5 p -53.79 -30.68 45.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.976 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -78.81 -3.91 46.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.33 4.07 13.41 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.626 0.251 . . . . 0.0 111.459 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 56' ' ' ILE . 30.1 mt -106.46 153.25 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -116.49 82.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -57.5 -24.04 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -74.91 -14.72 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.99 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.412 ' HD2' ' CE2' ' A' ' 33' ' ' TYR . 43.9 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.769 0.237 . . . . 0.01 112.35 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.76 -179.37 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.222 . . . . 0.01 112.385 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.867 -0.682 . . . . 0.65000000000000002 112.476 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.1 p30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.849 0.357 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -154.77 108.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtt -78.12 160.79 27.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.4 ' CD1' ' OG ' ' A' ' 22' ' ' SER . 59.4 m95 -144.23 116.63 8.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.572 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.9 mt-10 -68.21 165.34 18.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.07 132.8 12.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.098 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.7 125.84 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -56.49 -46.62 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.79 -177.15 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.43 38.77 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -109.41 165.96 11.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.79 -3.77 90.35 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.183 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.26 -25.51 10.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.549 0.214 . . . . 0.0 111.012 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.01 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.732 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 6.7 mt-10 -67.05 136.95 56.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.91 107.84 17.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 55.3 m-85 -130.84 -163.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.581 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.43 28.74 18.79 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.011 -0.614 . . . . 0.0 114.356 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 93.4 Cg_endo -82.16 25.76 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.907 1.738 . . . . 0.0 111.924 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -99.34 166.26 11.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.894 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.3 p -69.15 150.01 48.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.819 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.4 ' OG ' ' CD1' ' A' ' 4' ' ' TRP . 0.3 OUTLIER -46.7 -30.28 2.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.134 0.493 . . . . 0.0 110.148 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.14 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.541 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 31.2 tp60 -65.99 -36.64 83.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 mmm -67.1 -44.29 80.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.536 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.84 -38.61 75.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLU . 84.9 m -60.65 -57.77 11.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.2 m0 -62.2 -45.26 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.73 -34.83 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.285 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -88.61 -35.05 17.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' THR . 3.4 mm-40 -55.67 -30.09 60.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.099 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.3 2.6 24.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.437 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 0.3 OUTLIER -55.09 -34.56 63.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.847 0.356 . . . . 0.0 110.819 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -108.51 81.06 1.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.42 -17.16 49.04 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.701 2.268 . . . . 0.0 112.514 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.26 -8.76 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.294 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 158.94 35.14 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.005 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.97 160.95 42.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.993 0.425 . . . . 0.0 111.452 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 85.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.413 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.7 m -83.32 143.88 30.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.469 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -170.4 137.41 1.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -59.55 132.54 54.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.588 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.58 -53.83 27.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.392 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.13 126.07 36.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.1 161.46 90.75 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.629 -1.404 . . . . 0.0 112.428 0.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.62 117.74 3.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.68 2.253 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.9 99.43 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.652 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.29 -175.23 27.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.742 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.7 mt-30 -67.0 75.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.939 0.4 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 4.0 m-85 -42.15 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.65 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.54 137.6 19.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.05 136.85 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.802 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -54.88 -30.78 58.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -8.34 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -107.81 2.73 23.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.415 HG21 HD12 ' A' ' 56' ' ' ILE . 36.7 mt -109.06 153.11 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -118.45 87.02 2.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -60.4 -24.04 64.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -62.61 -21.85 65.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.2 mt -97.1 29.33 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -142.78 -46.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.9 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.338 . . . . 3.6400000000000001 111.244 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -62.43 177.44 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 3.9399999999999999 110.861 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 155.47 21.32 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.955 0.407 . . . . 6.8899999999999997 111.079 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.64 167.37 24.23 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.881 2.387 . . . . 0.01 112.417 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.44 132.79 28.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.714 2.276 . . . . 0.66000000000000003 112.015 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 37.1 Cg_endo -65.69 155.66 67.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.234 1.956 . . . . 0.01 111.848 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.451 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.1 Cg_endo -61.42 -179.44 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.355 2.037 . . . . 0.01 112.171 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 76.79 -80.08 1.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.707 -0.759 . . . . 0.65000000000000002 112.453 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 41.98 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.916 0.389 . . . . 4.1699999999999999 111.831 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 176.05 106.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.03 -0.532 . . . . 6.9500000000000002 110.87 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.209 -0.9 . . . . 5.7400000000000002 111.151 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.84 108.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.419 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.7 mtt -78.75 153.33 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.417 ' CZ2' ' CE2' ' A' ' 61' ' ' TYR . 68.7 m95 -140.73 115.13 9.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.956 0.407 . . . . 0.0 111.691 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -66.4 170.81 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.487 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -161.87 135.09 6.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' HD2' ' CB ' ' A' ' 14' ' ' ALA . 30.4 ttpt -129.68 129.0 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.055 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -62.87 -57.39 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.17 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.98 -176.16 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.98 39.0 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -105.57 171.92 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.82 -9.38 71.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.148 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.65 -19.92 13.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.491 0.186 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . . . -42.21 159.11 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 111.491 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.4 mp0 -62.0 135.88 57.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.495 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 94.91 5.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.089 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 67.0 m-85 -114.3 -166.1 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.459 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 93.32 27.59 13.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.993 -0.622 . . . . 0.0 114.466 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.1 Cg_endo -82.56 27.46 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.719 1.76 . . . . 0.0 111.753 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -98.7 167.52 10.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.98 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.7 p -70.15 149.81 47.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.408 ' OG ' ' CD1' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -46.91 -30.54 2.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.21 0.528 . . . . 0.0 110.148 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.65 86.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.76 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.445 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.5 tp60 -71.44 -31.7 67.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.839 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 47.6 mmm -75.16 -49.85 18.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.35 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.52 -33.08 69.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.399 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLU . 92.4 m -68.53 -51.5 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.476 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.445 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.4 m0 -63.2 -40.69 98.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.1 t -70.81 -30.98 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.253 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 p -95.11 -31.37 13.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.589 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.2 mm-40 -56.21 -46.16 79.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 110.982 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.63 -25.55 0.44 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -54.88 160.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.796 0.331 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 62.9 62.38 1.86 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.574 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.89 -23.79 17.2 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.582 2.188 . . . . 0.0 112.596 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.69 -4.51 10.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.468 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.65 160.31 34.1 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.883 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.96 160.36 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.964 0.412 . . . . 0.0 111.419 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.27 83.97 0.55 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.512 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -84.33 155.27 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.908 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 5.3 ptm180 -178.28 138.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -62.13 125.39 23.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.983 0.42 . . . . 0.0 110.547 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 14.2 mt -46.25 -61.48 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.289 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.21 137.29 19.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.45 153.34 88.1 Favored 'Cis proline' 0 C--N 1.348 0.528 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.411 0.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.15 156.28 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.65 85.46 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.312 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.51 159.12 20.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.813 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.38 77.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.7 0.286 . . . . 0.0 110.642 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -31.87 144.43 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.683 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 134.91 19.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.779 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -55.25 133.07 49.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.6 p -53.3 -31.48 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.33 -7.82 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.029 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 1.83 22.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.677 0.275 . . . . 0.0 111.362 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.8 mt -108.08 152.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.793 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -117.96 84.75 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -58.88 -22.18 58.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -62.05 -25.9 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.22 29.36 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 20.0 m-85 -138.27 -46.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.904 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.865 0.364 . . . . 3.6400000000000001 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -62.4 -58.18 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.9399999999999999 110.919 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.83 157.63 88.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 6.8899999999999997 110.91 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.65 174.82 10.45 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.736 2.291 . . . . 0.01 112.608 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -87.95 151.73 7.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.987 2.458 . . . . 0.66000000000000003 112.452 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.06 154.36 37.55 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.614 2.209 . . . . 0.01 112.408 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.424 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.3 Cg_endo -59.69 -178.06 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.595 2.197 . . . . 0.01 112.363 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 77.96 -73.22 2.16 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 112.618 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 45.02 -167.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 4.1699999999999999 111.7 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.09 135.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 6.9500000000000002 110.823 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.205 -0.902 . . . . 5.7400000000000002 111.172 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.786 0.327 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 123.71 20.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.402 ' HB3' HD12 ' A' ' 43' ' ' LEU . 3.4 mtt -81.52 158.15 24.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.528 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -145.13 117.0 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 111.787 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 1.8 mt-10 -66.46 171.94 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.316 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -168.56 130.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HE2' ' CD2' ' A' ' 39' ' ' TYR . 11.1 pttt -128.87 127.51 41.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.367 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.25 -55.14 38.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.44 146.01 52.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -97.88 40.12 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 p -100.83 -171.61 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.29 41.19 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.634 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -128.79 -3.5 5.25 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.18 178.09 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.848 0.356 . . . . 0.0 111.357 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -55.14 140.9 36.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.769 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.07 89.69 3.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.243 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' B' ' 69' ' ' PRO . 75.6 m-85 -111.31 -164.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.083 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.629 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.83 23.99 34.02 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.813 -0.708 . . . . 0.0 114.29 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 85.5 Cg_endo -80.01 28.72 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 119.788 1.794 . . . . 0.0 112.031 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -102.93 169.19 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.8 p -72.27 150.86 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.834 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -48.12 -28.99 3.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 110.098 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.67 84.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.448 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 39.8 tp60 -74.79 -33.58 62.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 41.9 mmm -73.04 -44.48 60.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.475 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 51.9 tp60 -59.91 -40.51 89.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 31' ' ' GLU . 18.5 m -60.92 -52.2 66.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.448 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.8 m0 -62.83 -43.64 98.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.61 -33.25 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.5 t -89.06 -40.06 13.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.059 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 27' ' ' THR . 11.3 tm-20 -51.48 -28.93 14.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.08 4.31 29.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.832 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -35.82 65.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.327 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -105.35 78.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.535 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.06 -16.82 57.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.641 2.227 . . . . 0.0 112.401 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -113.97 -12.15 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.337 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.52 160.73 36.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -136.84 160.99 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.425 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -79.65 87.56 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.184 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 20.5 m -93.08 159.84 15.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.349 0.595 . . . . 0.0 112.134 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -178.85 141.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.305 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -51.69 134.24 30.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 111.338 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 3' ' ' MET . 16.7 mt -59.92 -32.81 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.148 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -117.06 114.2 39.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.965 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.19 149.48 94.22 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.594 -1.419 . . . . 0.0 112.42 -0.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.23 123.04 3.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.674 2.249 . . . . 0.0 112.565 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.36 96.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.505 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.45 -147.8 5.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.845 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.11 74.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.045 0.45 . . . . 0.0 110.791 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.0 m-85 -44.27 159.88 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.153 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.45 129.64 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.028 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.12 124.53 15.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.41 -34.54 35.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -11.2 60.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.65 2.86 20.49 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.655 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.8 mt -101.41 153.41 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 110.771 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -115.99 83.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.785 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 81.0 m-85 -56.81 -22.82 39.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -21.26 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.287 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.92 29.24 3.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.09 -62.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.949 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.913 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.831 0.348 . . . . 3.6400000000000001 111.107 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -135.13 62.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 3.9399999999999999 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.36 151.99 63.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 6.8899999999999997 110.972 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.73 174.48 12.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.794 2.33 . . . . 0.01 112.442 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.59 135.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.959 2.439 . . . . 0.66000000000000003 112.408 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.11 156.6 55.5 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.466 2.111 . . . . 0.01 112.188 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 Cg_endo -65.14 -179.21 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.475 2.116 . . . . 0.01 112.264 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 70.45 -77.38 0.48 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.793 -0.718 . . . . 0.65000000000000002 112.387 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.34 -165.26 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.955 0.407 . . . . 4.1699999999999999 111.916 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 174.73 92.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 6.9500000000000002 110.842 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.301 -0.857 . . . . 5.7400000000000002 111.17 -179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.88 0.371 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.35 118.68 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.2 mtt -80.89 160.0 24.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -144.79 115.41 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.683 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 3.4 pt-20 -71.39 149.8 45.63 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 3.6 p90 -137.13 140.78 42.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.453 . . . . 0.0 111.564 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -131.21 123.41 28.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.832 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -62.48 -57.73 10.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.234 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -100.16 126.07 46.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.2 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -77.56 60.34 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.709 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -111.55 -178.58 3.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.907 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.68 -11.67 61.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -112.27 -18.59 12.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.544 0.211 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.23 145.59 1.08 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.786 0.327 . . . . 0.0 111.252 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -58.4 179.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.695 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 89.01 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 54.3 m-85 -107.73 -161.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.95 25.4 29.44 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.224 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 96.8 Cg_endo -77.97 15.0 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 CA-C-N 119.635 1.718 . . . . 0.0 111.647 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.446 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -88.18 165.71 14.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.776 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 p -70.85 148.55 47.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -30.14 2.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.38 88.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.458 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.405 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.0 tp60 -73.37 -34.0 65.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.566 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 36.3 mmm -71.61 -42.68 67.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.43 -43.95 92.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 31.7 m -58.0 -53.52 57.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.405 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.87 -42.85 99.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.948 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.68 -33.99 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.444 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -30.63 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.3 mm-40 -56.34 -23.06 34.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.21 6.04 42.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.595 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -61.81 -28.65 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.626 0.251 . . . . 0.0 111.229 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -114.1 80.75 5.76 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.836 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.85 -27.98 37.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.495 2.13 . . . . 0.0 112.427 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.13 15.13 15.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.074 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.36 -164.38 53.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.048 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m -162.03 161.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.908 0.385 . . . . 0.0 111.091 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.446 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -71.09 85.66 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.773 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -93.72 152.22 19.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.808 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -178.75 150.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -58.98 136.05 57.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 21.7 mt -57.39 -47.67 81.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -118.42 120.61 31.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.69 136.95 47.12 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.208 -0.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.41 141.12 19.88 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.501 2.134 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 91.53 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -138.76 2.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.577 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.71 72.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.973 0.416 . . . . 0.0 110.892 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CE1' ' HD2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -47.45 160.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.108 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -159.68 134.02 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -58.13 133.82 55.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.0 p -54.14 -28.89 42.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 0.8 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 2.11 10.63 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.326 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 mt -99.58 153.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -107.63 79.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -58.25 -24.29 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.05 -26.85 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.6 28.76 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.048 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.28 -52.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.901 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.829 0.347 . . . . 3.6400000000000001 111.24 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -137.6 112.21 8.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 3.9399999999999999 110.905 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.07 156.17 72.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.423 . . . . 6.8899999999999997 110.85 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.02 174.94 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.861 2.374 . . . . 0.01 112.631 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.74 140.75 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.858 2.372 . . . . 0.66000000000000003 112.244 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.88 162.67 41.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.484 2.123 . . . . 0.01 112.436 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.418 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.0 Cg_endo -62.1 -179.57 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.606 2.204 . . . . 0.01 112.312 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.2 -118.94 5.06 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.843 -0.694 . . . . 0.65000000000000002 112.59 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.502 ' C ' ' CD2' ' B' ' 71' ' ' HIS . 0.0 OUTLIER 66.31 120.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 4.1699999999999999 110.258 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.04 146.29 52.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 6.9500000000000002 110.797 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.252 -0.88 . . . . 5.7400000000000002 111.089 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.749 0.309 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -68.63 116.12 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.8 mtt -79.74 160.54 26.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.489 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 63.1 m95 -144.92 115.65 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 111.853 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -71.24 165.95 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -157.05 133.39 9.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.199 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' CZ ' ' A' ' 50' ' ' PHE . 10.8 pttt -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.376 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -60.58 -56.74 17.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.774 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.48 154.89 41.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -98.12 39.74 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -112.7 160.42 17.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.73 -3.04 86.36 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.317 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.86 -25.62 8.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.65 0.262 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.76 163.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.38 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -49.24 145.08 4.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.83 96.89 4.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.343 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.2 m-85 -111.02 -163.49 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.082 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.637 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.82 24.2 33.39 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.23 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 91.1 Cg_endo -79.02 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 CA-C-N 119.714 1.757 . . . . 0.0 111.859 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -101.85 166.33 10.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.4 p -66.44 147.97 52.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -46.75 -30.67 2.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.82 88.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -70.93 -34.17 71.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.613 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.6 mmm -73.96 -43.87 56.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.363 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.23 -36.36 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 55.7 m -66.34 -50.04 64.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.448 ' CD2' ' HG3' ' B' ' 68' ' ' PRO . 11.8 m0 -65.74 -44.22 86.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.71 -31.26 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.3 t -91.89 -33.45 14.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.051 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 4.1 mm-40 -57.19 -29.48 63.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.06 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.69 2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' B' ' 67' ' ' PRO . 10.5 m-85 -55.29 -27.38 46.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -116.3 81.66 10.95 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.785 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.09 -27.0 53.14 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.548 2.165 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.54 12.19 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.102 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.03 -169.54 52.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.034 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 m -159.33 160.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CD2' ' HE3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -73.3 90.9 1.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.888 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -90.44 156.37 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.216 0.531 . . . . 0.0 111.95 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HG3' ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -175.2 142.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.752 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -64.17 127.79 32.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -47.35 -48.86 25.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -123.2 120.31 27.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.59 143.34 71.84 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.076 -0.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -85.72 130.14 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.604 2.203 . . . . 0.0 112.601 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.75 99.84 1.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.26 -155.31 9.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 1.2 mt-30 -66.42 75.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.68 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CD2' ' HG3' ' A' ' 41' ' ' ARG . 2.7 m-85 -42.8 158.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.585 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 49' ' ' GLN . 25.4 m-85 -156.1 134.87 11.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.25 138.01 57.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.9 p -53.88 -30.86 47.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -77.97 -3.86 44.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -115.3 2.89 14.11 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 56' ' ' ILE . 46.7 mt -106.91 152.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.837 0.351 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -113.3 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -65.14 -24.3 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.15 -9.34 58.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.5 mt -97.14 29.34 3.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -140.19 -51.71 0.49 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.936 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.822 0.344 . . . . 3.6400000000000001 111.181 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -166.28 -41.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 3.9399999999999999 111.051 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.458 ' HG3' ' HD2' ' B' ' 66' ' ' PRO . 0.0 OUTLIER -50.83 140.09 20.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 6.8899999999999997 110.829 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.458 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.6 Cg_endo -76.87 173.03 15.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.538 2.159 . . . . 0.01 112.694 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . 0.429 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 91.7 Cg_endo -89.85 128.24 1.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.178 2.585 . . . . 0.66000000000000003 112.569 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.448 ' HG3' ' CD2' ' A' ' 28' ' ' TRP . 35.8 Cg_exo -59.43 166.71 7.32 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.412 2.075 . . . . 0.01 112.118 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.415 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 14.2 Cg_endo -59.36 -178.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 0.01 112.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 78.31 -80.42 1.41 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.873 -0.68 . . . . 0.65000000000000002 112.513 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.81 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 4.1699999999999999 111.76 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.81 88.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 6.9500000000000002 110.862 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.279 -0.867 . . . . 5.7400000000000002 111.144 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.81 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.411 ' HB3' HD13 ' A' ' 43' ' ' LEU . 45.0 mtt -126.32 162.59 25.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.573 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.404 ' O ' ' O ' ' A' ' 18' ' ' GLY . 60.4 m95 -145.61 114.35 6.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.848 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -71.94 158.82 35.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.082 179.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -145.87 136.58 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.51 122.88 36.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.15 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -53.65 -47.03 70.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -104.45 -176.63 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 39' ' ' TYR . 8.3 m-20 -129.36 38.81 3.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.673 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -103.84 174.11 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.55 6.02 81.6 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.088 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -117.59 -31.73 5.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.572 0.225 . . . . 0.0 111.005 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.66 142.94 1.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.9 -176.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.25 98.66 3.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.013 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.465 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 67.1 m-85 -115.77 -163.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.555 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.598 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 87.43 28.35 24.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.049 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.4 Cg_endo -81.24 22.12 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 CA-C-N 119.595 1.698 . . . . 0.0 111.64 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -94.18 165.41 12.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.567 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.1 p -68.51 146.87 52.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.51 -31.29 1.72 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.182 0.515 . . . . 0.0 110.237 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.58 70.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.474 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 36.2 tp60 -66.83 -36.8 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.7 mmm -68.27 -51.49 44.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 35.8 tp60 -54.19 -32.82 56.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.471 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 31' ' ' GLU . 37.1 m -64.4 -52.36 58.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.568 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.2 m0 -64.55 -42.43 95.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.57 -31.86 55.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.183 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 p -96.85 -31.27 12.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.454 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' THR . 16.6 mm-40 -54.37 -33.37 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.262 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.91 -26.25 1.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.484 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -56.09 164.2 1.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 60.4 61.86 3.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.518 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.72 -32.49 36.63 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.674 2.25 . . . . 0.0 112.531 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -115.2 12.63 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.251 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.74 159.81 24.85 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.111 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.83 161.97 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.125 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.407 ' CD1' ' OD1' ' A' ' 10' ' ' ASN . 0.1 OUTLIER -70.81 80.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.27 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.6 m -82.77 145.14 29.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.717 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -169.27 135.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.082 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -60.39 136.23 57.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 10.7 mt -60.24 -67.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.774 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -120.42 138.71 27.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.746 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.89 149.28 87.38 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.478 -0.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.61 153.99 34.74 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.626 2.218 . . . . 0.0 112.352 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.5 -92.9 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.541 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.05 -155.96 22.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.21 67.89 0.81 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.402 0.62 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.57 179.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.24 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.92 132.08 9.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.15 134.54 56.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 p -55.14 -25.96 35.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 4.82 29.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.36 5.34 5.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.563 0.22 . . . . 0.0 111.554 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 56' ' ' ILE . 24.1 mt -103.13 153.21 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -109.4 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 66.7 m-85 -70.21 -12.95 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.07 -14.58 46.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.0 mt -96.09 28.75 3.04 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.869 0.366 . . . . 0.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -140.88 -47.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.912 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.74 0.305 . . . . 3.6400000000000001 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -127.06 -169.33 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 3.9399999999999999 110.971 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' B' ' 65' ' ' ARG . 0.0 OUTLIER 63.38 137.37 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 6.8899999999999997 110.905 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -86.58 173.25 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.854 2.369 . . . . 0.01 112.674 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.83 150.66 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.266 2.644 . . . . 0.66000000000000003 112.324 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.27 156.87 46.23 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.497 2.131 . . . . 0.01 112.218 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.465 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.3 Cg_endo -58.69 -174.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.447 2.098 . . . . 0.01 112.391 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 70.96 -65.31 0.89 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.627 -0.715 . . . . 0.65000000000000002 112.58 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.2 -164.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 4.1699999999999999 111.813 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.73 119.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 6.9500000000000002 110.849 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.268 -0.872 . . . . 5.7400000000000002 111.086 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.733 0.302 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.05 108.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mtt -76.49 157.52 32.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -142.76 117.08 9.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.968 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -69.64 166.66 18.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.232 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -159.75 130.56 5.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.081 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HD2' ' CB ' ' A' ' 14' ' ' ALA . 18.4 ttpt -120.17 120.91 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.16 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 34' ' ' PHE . 85.1 m95 -56.94 -52.62 64.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.03 -177.54 6.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.431 ' ND2' ' CD1' ' A' ' 39' ' ' TYR . 14.2 m120 -129.61 37.48 3.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.499 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -91.21 -167.01 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.69 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.49 -12.9 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.43 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -139.43 11.06 2.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . . . -47.76 167.51 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.654 0.264 . . . . 0.0 111.19 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 2.8 pm0 -49.75 134.41 20.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.912 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.59 107.87 16.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.419 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.4 m-85 -133.97 -164.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.553 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 95.52 18.25 33.57 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.872 -0.68 . . . . 0.0 114.337 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 78.3 Cg_endo -77.02 51.59 3.5 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.958 1.879 . . . . 0.0 111.544 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.465 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -127.08 166.67 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.52 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -70.55 148.35 48.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -46.57 -30.1 2.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.087 0.47 . . . . 0.0 110.181 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.03 30.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.398 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 42.3 tp60 -61.29 -34.67 75.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 39.4 mmm -70.06 -41.25 74.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.182 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.42 ' HG2' ' CB ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -58.07 -40.17 80.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.561 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 31' ' ' GLU . 99.2 m -62.55 -60.71 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 12.4 m0 -55.99 -46.33 78.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 81.4 t -60.56 -29.61 45.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 m -99.05 -25.65 14.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.356 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.0 tp10 -56.82 -33.36 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.47 -5.39 13.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.735 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.15 -34.8 66.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 110.794 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -107.48 73.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.477 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.18 -19.94 62.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.596 2.197 . . . . 0.0 112.42 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.29 -12.44 11.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.193 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.79 159.4 28.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.809 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.87 160.98 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CD1' ' ND2' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -70.87 79.15 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -78.22 150.34 33.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.542 -179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.6 ttm-85 -179.57 126.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.41 137.85 10.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -57.46 -36.93 72.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.285 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -118.46 116.38 35.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.17 144.9 80.93 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.22 -0.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.58 115.07 2.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.536 2.157 . . . . 0.0 112.49 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.32 100.42 1.91 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.691 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.07 -153.67 8.53 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -67.76 74.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 4.3 m-85 -41.73 160.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.417 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.59 131.46 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -55.26 128.33 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.024 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -54.65 -32.23 58.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.82 -4.74 45.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -114.71 3.64 14.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.576 0.227 . . . . 0.0 111.569 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -103.3 153.89 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.298 . . . . 0.0 110.97 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 7.0 t0 -100.71 111.95 24.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.42 ' CB ' ' HG2' ' A' ' 26' ' ' GLN . 88.6 m-85 -95.7 20.36 9.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.984 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -108.45 -23.46 11.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.29 29.35 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 25.8 m-85 -135.2 -48.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.884 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.749 0.309 . . . . 3.6400000000000001 111.157 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -94.26 51.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 3.9399999999999999 110.827 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -90.81 136.77 27.39 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 6.8899999999999997 110.82 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.25 174.83 8.84 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.748 2.299 . . . . 0.01 112.523 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.82 123.1 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.079 2.519 . . . . 0.66000000000000003 112.271 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.91 168.57 20.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.412 2.075 . . . . 0.01 112.296 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.419 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 28.9 Cg_endo -65.26 -178.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.451 2.1 . . . . 0.01 112.482 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 72.37 -67.17 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.866 -0.683 . . . . 0.65000000000000002 112.536 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 42.65 -163.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.932 0.396 . . . . 4.1699999999999999 111.763 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.18 98.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 6.9500000000000002 110.964 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.236 -0.888 . . . . 5.7400000000000002 111.121 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.887 0.375 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.06 110.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.3 mtt -79.67 163.41 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.435 ' CZ2' ' HE2' ' A' ' 42' ' ' LYS . 54.4 m95 -148.02 117.13 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.712 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -70.14 163.81 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.0 p90 -152.22 137.23 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 0.0 110.997 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -126.05 128.13 46.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.33 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -58.92 -51.72 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -90.48 162.08 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -101.05 38.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -104.44 -173.08 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.27 -6.72 36.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.252 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -112.09 -20.89 11.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.49 0.186 . . . . 0.0 111.224 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.2 163.05 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.733 0.301 . . . . 0.0 111.608 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -60.82 139.05 58.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.669 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.85 113.03 24.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.455 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 72.4 m-85 -133.22 -162.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.419 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.66 28.67 18.36 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.999 -0.62 . . . . 0.0 114.293 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.9 Cg_endo -80.77 23.62 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 119.668 1.734 . . . . 0.0 111.624 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -94.28 165.15 12.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.746 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 p -70.32 148.07 48.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -45.56 -30.88 1.6 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.212 0.529 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.11 -48.29 80.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.531 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 41.3 tp60 -68.89 -34.28 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.628 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.2 mmm -69.07 -46.29 68.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.279 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.675 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.1 m -59.02 -54.88 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.625 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.455 ' CD1' ' HG3' ' B' ' 68' ' ' PRO . 7.0 m0 -59.81 -40.96 90.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.19 -30.57 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.796 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 p -95.43 -31.58 13.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.8 tp10 -57.76 -47.99 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.24 -26.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.773 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -53.37 162.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER 63.48 55.6 1.87 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.31 -22.85 28.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.196 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -114.56 -14.04 12.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.32 158.34 23.99 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.948 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.56 159.93 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.298 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -74.49 88.08 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.22 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.2 m -80.94 158.03 25.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.178 0.513 . . . . 0.0 111.754 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG3' ' CG ' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -179.72 145.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.714 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 18.2 mtmt -73.14 123.12 22.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.253 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -42.64 -52.06 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -118.84 125.75 27.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.72 152.47 82.22 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 123.627 -1.405 . . . . 0.0 112.391 -0.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.37 139.64 13.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.76 2.307 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 97.11 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.518 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' ' NH1' ' A' ' 41' ' ' ARG . . . -158.77 -169.46 22.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.866 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -67.06 75.84 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.503 ' CD2' ' CD2' ' A' ' 39' ' ' TYR . 1.5 m-85 -38.92 156.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -156.36 136.17 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -59.16 136.2 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.5 t -53.27 -31.22 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -6.35 53.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.112 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -1.4 19.7 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 mt -104.96 150.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.634 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -117.89 83.99 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -59.4 -25.56 64.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.5 -22.42 43.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.52 29.09 3.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -139.52 -51.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.907 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.783 0.325 . . . . 3.6400000000000001 111.156 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -100.7 91.11 4.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 3.9399999999999999 110.678 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.429 ' HD2' ' CD1' ' A' ' 28' ' ' TRP . 17.5 ttp-105 -62.93 133.93 95.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 6.8899999999999997 110.934 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.98 175.13 5.12 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.004 2.469 . . . . 0.01 112.889 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.68 123.85 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.12 2.547 . . . . 0.66000000000000003 112.619 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' A' ' 28' ' ' TRP . 32.5 Cg_exo -58.33 142.55 97.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.535 2.157 . . . . 0.01 112.3 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.455 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.6 Cg_endo -59.33 -177.71 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.507 2.138 . . . . 0.01 112.399 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 80.84 -79.29 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.65000000000000002 112.6 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.49 -167.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.861 0.362 . . . . 4.1699999999999999 111.672 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.81 98.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 6.9500000000000002 110.851 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.243 -0.884 . . . . 5.7400000000000002 111.104 179.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.35 117.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.5 mtt -81.83 156.66 24.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.52 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -143.6 115.93 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.352 . . . . 0.0 111.845 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 5.4 pt-20 -71.87 162.79 28.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 6.0 p90 -152.63 135.43 15.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.42 128.7 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.05 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -62.04 -54.91 34.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.32 167.05 17.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.13 38.83 1.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -105.77 -172.59 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.965 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.85 -11.7 27.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.153 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -106.66 -21.09 13.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.75 147.5 0.45 Allowed 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.765 0.317 . . . . 0.0 111.58 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.13 135.6 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.171 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.69 147.61 35.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.212 0.529 . . . . 0.0 111.54 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 70.3 m-85 -155.38 -160.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.77 29.66 17.68 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.864 -0.684 . . . . 0.0 114.284 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 90.4 Cg_endo -79.05 17.79 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 119.588 1.694 . . . . 0.0 111.464 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -91.19 166.24 13.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.716 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.9 p -68.46 148.52 50.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.991 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.4 p -47.26 -30.08 2.83 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.206 0.526 . . . . 0.0 110.284 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.37 80.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.437 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.2 tp60 -71.11 -33.05 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.9 mmm -72.77 -46.13 54.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.183 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.64 -38.0 71.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.395 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLU . 38.8 m -63.36 -60.52 3.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.49 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.437 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.1 m0 -53.8 -40.75 66.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.973 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.4 -33.53 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.243 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -89.68 -32.15 17.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.2 tp10 -56.46 -44.12 80.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -0.97 6.93 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.825 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -53.95 -33.4 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -105.39 82.15 0.73 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.54 -29.16 83.95 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.589 2.193 . . . . 0.0 112.243 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -115.53 14.75 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.52 -166.8 54.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.114 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -160.83 161.78 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 0.0 111.054 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.3 82.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.0 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.5 m -87.01 150.84 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.904 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -179.85 143.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.262 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 61' ' ' TYR . 10.9 mttt -55.86 131.59 47.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -49.21 -31.27 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.068 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -120.45 119.62 30.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.832 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.66 143.03 74.77 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.68 -1.383 . . . . 0.0 112.29 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.21 119.85 5.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.511 2.14 . . . . 0.0 112.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.76 96.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.22 -148.63 5.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.633 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -67.47 73.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.783 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 2.5 m-85 -45.58 166.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.433 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -151.03 130.4 12.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.69 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -54.95 129.59 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.926 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.4 p -53.45 -32.27 49.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -78.71 -3.35 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -117.56 4.24 12.4 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.518 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.3 mt -101.15 153.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -109.48 80.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.001 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -58.14 -22.41 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -75.77 -6.74 52.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.48 28.54 3.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 111.062 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 42' ' ' LYS . 98.9 m-85 -146.89 -47.53 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.941 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.772 0.32 . . . . 3.6400000000000001 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -60.27 -69.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 3.9399999999999999 110.849 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' B' ' 66' ' ' PRO . 16.8 tpp180 -62.41 139.97 96.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 6.8899999999999997 110.64 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.3 Cg_endo -78.41 172.68 14.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.563 2.175 . . . . 0.01 112.64 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -90.97 117.81 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.157 2.571 . . . . 0.66000000000000003 112.48 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.46 164.49 32.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.01 111.916 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.2 Cg_endo -60.52 -176.59 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.378 2.052 . . . . 0.01 112.271 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.521 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 70.51 -70.02 0.69 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.63 -0.714 . . . . 0.65000000000000002 112.504 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.14 -164.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.92 0.391 . . . . 4.1699999999999999 111.811 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.403 ' N ' ' CD2' ' B' ' 71' ' ' HIS . 0.9 OUTLIER -174.4 124.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 6.9500000000000002 110.956 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.201 -0.904 . . . . 5.7400000000000002 111.166 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.869 0.366 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 119.95 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.434 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . 5.6 mmm -79.64 152.11 30.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 73.9 m95 -144.65 114.84 7.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 111.736 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -70.3 170.58 11.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.353 179.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.87 135.38 8.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.28 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -127.4 129.43 47.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.037 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -58.43 -48.49 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -129.04 131.53 47.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.165 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 10.8 t-20 -74.03 62.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 p -117.5 169.72 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.33 -0.87 89.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.221 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -114.41 -30.14 6.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.59 0.233 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.66 151.62 0.4 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.91 0.385 . . . . 0.0 111.53 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.44 -177.73 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.73 92.34 2.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.717 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 53.9 m-85 -113.47 -166.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 92.38 28.55 12.75 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.527 -0.596 . . . . 0.0 114.317 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.3 Cg_endo -83.49 25.93 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 CA-C-N 119.788 1.794 . . . . 0.0 111.788 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -99.42 171.03 8.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -71.93 147.47 46.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.929 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -46.66 -30.64 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.285 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.04 -46.9 85.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.559 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.2 tp60 -70.33 -32.72 70.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.623 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.9 mmm -73.75 -47.98 35.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.305 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -56.92 -34.1 67.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.567 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 31' ' ' GLU . 8.4 m -71.05 -53.21 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.425 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.84 -42.05 98.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.38 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.9 m -95.6 -31.33 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.7 mm-40 -55.14 -32.09 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.133 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.16 -0.03 20.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -56.44 -34.47 66.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -109.39 76.38 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.5 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.2 -19.03 65.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.634 2.223 . . . . 0.0 112.408 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -115.85 2.23 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.66 159.33 13.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.982 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.23 160.64 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.957 0.408 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -76.51 87.53 3.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.353 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.69 156.33 19.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 0.0 111.807 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -175.29 127.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.082 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 12.6 mtmt -50.27 135.26 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.281 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' CD1' ' CB ' ' A' ' 3' ' ' MET . 12.9 mt -59.4 -63.16 1.4 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -114.28 137.46 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.43 132.6 27.79 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.857 -1.309 . . . . 0.0 112.18 0.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.74 102.42 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.489 2.126 . . . . 0.0 112.275 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 -81.25 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.533 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 -145.71 7.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.14 69.0 0.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.17 0.51 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 3.3 m-85 -58.62 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.27 129.4 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.76 133.6 56.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -34.97 64.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -68.18 -12.12 60.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.186 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.26 11.98 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.463 HG21 HD12 ' A' ' 56' ' ' ILE . 47.2 mt -109.2 155.34 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.933 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 56' ' ' ILE . 6.7 t0 -113.37 82.24 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -57.51 -22.49 44.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.96 -10.57 59.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.326 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.6 mt -96.04 28.69 3.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 111.012 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -144.67 -47.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.825 0.345 . . . . 3.6400000000000001 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.06 8.45 29.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 3.9399999999999999 111.265 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.429 ' NE ' ' CG2' ' A' ' 27' ' ' THR . 2.2 ttm-85 63.09 138.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.764 0.316 . . . . 6.8899999999999997 111.051 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' B' ' 67' ' ' PRO . 87.2 Cg_endo -83.94 175.75 7.38 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.633 2.222 . . . . 0.01 112.531 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 92.5 Cg_endo -86.83 137.58 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.833 2.355 . . . . 0.66000000000000003 112.227 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.99 162.81 36.42 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.442 2.095 . . . . 0.01 112.232 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.3 Cg_endo -61.32 -177.65 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.482 2.121 . . . . 0.01 112.273 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 72.98 -64.85 1.55 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.752 -0.737 . . . . 0.65000000000000002 112.322 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.482 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.31 -167.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.067 0.461 . . . . 4.1699999999999999 111.788 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.84 73.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.785 -0.643 . . . . 6.9500000000000002 110.732 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.156 -0.926 . . . . 5.7400000000000002 111.181 -179.899 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.799 0.333 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.58 102.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.8 mtt -80.09 156.04 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.592 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.448 ' CZ2' ' CE2' ' A' ' 61' ' ' TYR . 53.2 m95 -139.67 117.69 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 111.732 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mt-10 -67.34 169.41 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.707 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -160.8 136.19 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.072 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -127.7 122.36 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.291 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -55.98 -48.91 74.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.62 -177.08 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.892 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.01 38.27 4.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -110.19 167.92 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.985 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.07 0.44 89.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.138 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.48 -26.16 8.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.645 0.259 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.67 150.85 0.22 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.9 mt-10 -59.12 139.93 56.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 107.99 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 74.2 m-85 -126.45 -163.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 91.48 29.89 11.55 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.351 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 75.8 Cg_endo -83.37 26.08 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.882 1.721 . . . . 0.0 111.812 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.473 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -96.34 167.51 11.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.842 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 p -69.13 147.02 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -44.16 -34.04 1.71 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.216 0.532 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -56.51 20.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.8 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.427 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.0 tp60 -58.08 -32.37 68.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.46 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.6 mmm -72.71 -43.09 63.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -57.58 -38.31 74.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 65.5 m -64.81 -60.03 3.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.7 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.427 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.7 m0 -55.23 -43.23 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 111.016 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.85 -29.44 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -94.89 -29.71 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.34 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.0 tm-20 -57.61 -44.43 85.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.995 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.39 -3.05 5.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD ' ' B' ' 68' ' ' PRO . 16.1 m-85 -54.43 -32.04 56.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -111.04 78.82 1.76 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -20.15 47.62 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.176 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -116.95 -6.81 11.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.448 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.17 160.23 34.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.28 161.12 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 111.231 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -71.79 81.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.048 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.74 149.12 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 111.93 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HB3' ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -173.71 140.5 0.77 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.804 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -57.06 128.17 35.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.8 mt -45.73 -35.76 4.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.404 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -120.0 119.11 31.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.778 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.64 140.18 63.94 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.941 -1.275 . . . . 0.0 112.193 -0.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.73 123.45 4.23 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 0.0 112.422 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.31 99.3 1.25 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.612 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.49 18.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -66.36 74.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.681 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 6.2 m-85 -44.19 166.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.437 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -140.85 127.6 20.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -57.72 131.72 51.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 p -53.03 -29.11 27.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -79.4 -2.5 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -118.05 3.92 12.08 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.516 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mt -101.31 151.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.814 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.48 89.56 3.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.23 -16.28 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.502 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -71.92 -19.98 61.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.512 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.58 29.68 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 111.172 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.448 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 49.9 m-85 -139.59 -46.33 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.077 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.804 0.335 . . . . 3.6400000000000001 111.161 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.18 134.37 31.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 3.9399999999999999 111.006 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.453 ' HG3' ' HD2' ' B' ' 66' ' ' PRO . 3.7 tpp180 -163.07 141.57 6.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 6.8899999999999997 110.718 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.453 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.2 Cg_endo -78.22 174.36 12.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.543 2.162 . . . . 0.01 112.578 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -88.72 111.01 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.064 2.509 . . . . 0.66000000000000003 112.57 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.426 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 Cg_exo -56.94 167.51 3.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.41 2.073 . . . . 0.01 112.092 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.473 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 20.7 Cg_endo -64.87 179.54 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.267 1.978 . . . . 0.01 112.29 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 82.01 -78.08 2.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.779 -0.724 . . . . 0.65000000000000002 112.468 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.3 OUTLIER 45.91 -166.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.951 0.405 . . . . 4.1699999999999999 111.594 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.444 ' N ' ' CD2' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -163.84 73.48 0.29 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 6.9500000000000002 110.609 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.202 -0.904 . . . . 5.7400000000000002 111.049 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.3 t0 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 t -67.46 110.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.214 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.7 mtp -87.34 145.78 26.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.795 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 22' ' ' SER . 42.4 m95 -132.53 -172.07 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -147.45 163.16 37.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.022 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -151.98 136.89 17.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.976 0.417 . . . . 0.0 111.176 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.69 128.83 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.435 ' CE3' HG11 ' A' ' 38' ' ' VAL . 31.7 m95 -62.9 -57.38 10.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.74 134.3 50.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' CE1' ' A' ' 39' ' ' TYR . 6.7 m-20 -80.28 58.35 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -116.54 -177.67 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.98 1.83 71.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.16 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -116.8 -28.33 6.37 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.576 0.227 . . . . 0.0 111.146 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.12 144.18 1.37 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 111.44 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.01 -177.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.607 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.61 84.44 1.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.201 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 45.0 m-85 -106.85 -175.24 2.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.961 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.26 -16.87 41.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.895 -0.947 . . . . 0.0 115.297 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.5 Cg_exo -40.29 -26.19 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 120.428 2.114 . . . . 0.0 112.985 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.2 m-85 -43.14 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.366 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -66.91 146.57 54.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 5.5 p -47.75 -30.53 3.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.14 0.495 . . . . 0.0 110.221 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.65 92.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.537 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.0 tp60 -71.23 -30.45 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.5 mmm -73.23 -47.06 46.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.201 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -57.08 -39.63 75.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -62.07 -59.76 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.684 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.458 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.1 m0 -57.2 -44.54 83.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.802 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.99 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.947 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -83.94 -41.65 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.26 -27.84 49.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.77 6.93 30.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -54.09 -25.95 24.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.283 . . . . 0.0 111.081 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -117.56 80.85 13.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.793 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.69 -19.47 65.28 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.663 2.242 . . . . 0.0 112.531 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.51 -3.76 14.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.43 162.45 29.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.972 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 HG11 ' CE3' ' A' ' 8' ' ' TRP . 7.4 m -137.34 161.53 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.955 0.407 . . . . 0.0 111.458 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.01 90.21 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.421 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.8 m -88.04 142.23 27.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.81 139.79 11.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.416 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 1.5 mtmt -73.42 142.64 46.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.848 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 5.6 mt -73.0 -65.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.98 131.25 24.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.4 143.64 76.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.274 0.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.89 137.18 19.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.519 2.146 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.31 -101.1 0.3 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.517 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 179.2 -145.79 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 42.07 70.94 0.24 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.218 0.532 . . . . 0.0 111.593 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -45.06 167.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.24 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.05 126.59 11.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -63.04 130.71 45.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -52.06 -28.2 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -7.8 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.97 7.29 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.479 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.9 mt -104.28 153.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 111.141 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 16.1 t70 -118.11 117.53 29.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.667 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -94.46 30.35 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.63 -26.01 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -97.67 29.39 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.415 ' CE1' ' HE2' ' A' ' 42' ' ' LYS . 49.4 m-85 -133.49 -48.23 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.842 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.877 0.37 . . . . 3.6400000000000001 111.16 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -127.76 100.07 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 3.9399999999999999 110.909 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.99 157.75 73.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 6.8899999999999997 110.907 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 174.23 12.04 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 0.01 112.499 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -88.98 136.17 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.016 2.477 . . . . 0.66000000000000003 112.374 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.4 169.21 21.55 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.42 2.08 . . . . 0.01 112.199 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.89 179.35 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.485 2.123 . . . . 0.01 112.179 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.496 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 73.91 -65.09 1.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.681 -0.771 . . . . 0.65000000000000002 112.388 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.33 -165.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.98 0.419 . . . . 4.1699999999999999 111.863 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 177.5 96.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.92 -0.582 . . . . 6.9500000000000002 110.788 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.275 -0.869 . . . . 5.7400000000000002 111.197 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.334 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.07 114.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mtt -85.21 142.88 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 42' ' ' LYS . 49.6 m95 -129.78 -170.92 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 2.0 mt-10 -145.37 170.13 16.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.58 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' TYR . 1.3 p90 -168.22 130.54 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -126.09 128.7 47.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.205 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.424 ' CE3' HG12 ' A' ' 38' ' ' VAL . 72.4 m95 -63.82 -58.09 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -86.68 139.25 30.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.119 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -103.05 37.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.681 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 p -76.37 -164.25 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.679 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.0 3.66 75.09 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 -62.6 0.14 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.694 0.283 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.74 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.027 0.441 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 5.1 mm-40 -89.25 136.31 33.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.151 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.12 102.7 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.451 . . . . 0.0 111.439 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 6' ' ' TYR . 46.4 m-85 -131.11 179.74 5.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.963 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 107.35 -17.01 37.64 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.341 -0.933 . . . . 0.0 115.326 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.3 Cg_exo -40.38 -25.56 0.18 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 CA-C-N 120.235 2.018 . . . . 0.0 113.099 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.0 m-85 -43.01 166.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.328 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -66.89 145.9 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.416 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 12.1 t -47.04 -30.2 2.55 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.157 0.503 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.48 88.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.647 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.457 ' CG ' ' CZ3' ' A' ' 28' ' ' TRP . 30.0 tp60 -69.72 -30.71 68.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.581 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.8 mmm -72.96 -46.81 50.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.303 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -59.39 -35.31 73.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.368 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -65.49 -61.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.457 ' CZ3' ' CG ' ' A' ' 24' ' ' GLN . 8.8 m0 -54.7 -42.83 71.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.52 -33.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.928 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.9 p -84.62 -38.68 19.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.107 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -27.24 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 7.04 32.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.776 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.9 m-85 -54.87 -39.47 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -102.51 94.81 5.34 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 -24.73 30.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.553 2.169 . . . . 0.0 112.555 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.34 15.28 14.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.138 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.54 -176.23 35.67 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.018 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.424 HG12 ' CE3' ' A' ' 8' ' ' TRP . 2.6 m -152.11 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.875 0.369 . . . . 0.0 111.116 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -77.99 87.06 4.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.227 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 57.5 m -91.89 152.57 20.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 111.945 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 9.3 ttp85 -160.72 142.8 12.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.113 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 4.8 mtmt -68.41 146.4 53.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.09 -63.47 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -113.72 127.71 26.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.801 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.58 142.25 74.2 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.274 -0.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.71 131.49 15.99 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.536 2.158 . . . . 0.0 112.362 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.14 -102.0 0.41 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.559 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.57 -152.62 12.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 47.41 69.33 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.324 0.583 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 2.0 m-85 -44.87 161.65 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.133 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.64 126.86 21.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.927 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.3 134.54 45.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t -57.98 -37.12 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.26 -12.52 56.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.281 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 7.24 27.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 56' ' ' ILE . 51.4 mt -108.97 153.83 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.055 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -113.35 84.97 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -60.08 -20.98 60.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.256 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.22 -10.11 59.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.574 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 mt -96.41 28.7 3.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 111.194 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 39.9 m-85 -137.71 -47.42 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.978 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.95 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.794 0.33 . . . . 3.6400000000000001 111.143 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -63.45 -78.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 3.9399999999999999 110.977 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -142.97 140.13 17.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 6.8899999999999997 110.937 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.92 172.6 8.67 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.826 2.351 . . . . 0.01 112.802 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -91.03 153.15 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.104 2.536 . . . . 0.66000000000000003 112.308 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.424 ' HD3' ' CD1' ' A' ' 28' ' ' TRP . 81.0 Cg_endo -78.31 155.02 28.66 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.56 2.173 . . . . 0.01 112.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.16 178.13 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.504 2.136 . . . . 0.01 112.199 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.51 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 81.37 -70.99 2.99 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.685 -0.769 . . . . 0.65000000000000002 112.417 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.51 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.7 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.991 0.424 . . . . 4.1699999999999999 111.752 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 175.24 108.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.954 -0.566 . . . . 6.9500000000000002 110.796 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.277 -0.868 . . . . 5.7400000000000002 111.128 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.96 122.92 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.418 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.1 mmm -81.12 159.43 24.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.577 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -147.61 116.8 6.89 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 5.1 pt-20 -80.8 136.08 36.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.561 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -127.38 137.33 52.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.184 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -126.05 128.49 47.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.412 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -59.1 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.065 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.02 140.57 47.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.96 58.44 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.795 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -81.41 -171.59 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.1 65.84 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.893 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -146.68 -59.82 0.29 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.706 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.85 -176.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.093 0.473 . . . . 0.0 111.563 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 9.5 mm-40 -96.2 135.66 37.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 85.07 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 30.2 m-85 -109.29 -171.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.668 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.63 -9.87 41.39 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.057 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.8 Cg_exo -42.18 -26.48 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.431 2.116 . . . . 0.0 112.314 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.05 167.44 0.05 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.851 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -77.9 153.73 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -47.71 -29.58 3.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.073 0.463 . . . . 0.0 110.052 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.89 -57.56 11.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.625 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.3 tp60 -62.37 -37.47 85.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 34.4 mmm -64.51 -49.85 69.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.659 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -54.12 -36.68 63.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' GLU . 88.2 m -61.11 -59.75 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.632 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.468 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -58.13 -46.08 86.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 94.0 t -57.86 -30.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 t -96.81 -29.29 13.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 14.1 tp10 -55.21 -30.22 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -0.66 26.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -58.83 -32.4 69.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -106.88 75.29 0.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.78 -21.69 69.44 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.86 6.51 15.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.207 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 159.81 10.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.094 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.88 161.5 41.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.836 0.35 . . . . 0.0 111.225 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -75.62 82.11 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.106 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 2.1 m -87.9 151.04 23.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.787 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 8.5 ptm180 179.02 151.76 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.434 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -59.32 135.9 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.872 0.367 . . . . 0.0 110.512 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 11.6 mt -55.53 -39.69 70.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.27 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.6 124.49 34.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.81 156.49 98.94 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.21 0.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.89 113.3 3.72 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.546 2.164 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.56 96.48 0.52 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.5 -155.14 6.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.847 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -66.61 74.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.939 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.7 m-85 -42.69 158.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.425 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -142.66 127.3 18.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.712 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -55.84 130.01 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -53.85 -28.3 35.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -2.06 46.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.229 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 4.87 11.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.532 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.1 mt -107.19 153.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.024 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 36.6 t0 -104.92 107.85 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -89.54 52.58 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.664 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -145.69 -37.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.299 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.24 28.01 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 24.2 m-85 -127.8 -40.48 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.009 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.914 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.787 0.327 . . . . 3.6400000000000001 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -85.35 -60.09 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.9399999999999999 110.905 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.409 ' HG2' ' HD2' ' B' ' 66' ' ' PRO . 0.0 OUTLIER -156.82 137.15 8.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 6.8899999999999997 110.668 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.409 ' HD2' ' HG2' ' B' ' 65' ' ' ARG . 92.6 Cg_endo -81.38 175.63 9.44 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.689 2.259 . . . . 0.01 112.562 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 91.0 Cg_endo -88.11 142.73 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.891 2.394 . . . . 0.66000000000000003 112.443 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.29 158.67 40.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.589 2.193 . . . . 0.01 112.246 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . 0.418 ' HG2' ' CG ' ' A' ' 17' ' ' TYR . 33.5 Cg_endo -65.85 178.38 2.35 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.383 2.055 . . . . 0.01 112.357 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.502 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 77.02 -74.24 1.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.616 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.502 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.84 -166.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.925 0.393 . . . . 4.1699999999999999 111.825 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.32 134.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 6.9500000000000002 110.799 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.202 -0.904 . . . . 5.7400000000000002 111.104 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.23 108.88 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 mtt -74.65 163.86 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.423 ' CD1' ' HB2' ' A' ' 22' ' ' SER . 64.8 m95 -145.49 115.8 7.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.697 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.549 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 8.6 pt-20 -76.2 146.17 39.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 1.5 p90 -133.99 134.82 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -127.47 126.96 43.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.332 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -56.7 -49.58 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.7 -170.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -132.48 38.68 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.681 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -110.2 179.95 3.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.9 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.44 5.35 85.19 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.127 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.18 -31.63 5.6 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.602 0.239 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.85 152.38 0.17 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.397 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -55.67 -176.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.731 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.13 82.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 28.3 m-85 -113.88 -165.91 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.825 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 105.92 -9.45 43.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.357 -0.925 . . . . 0.0 115.036 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 99.7 Cg_exo -42.17 -26.68 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 120.408 2.104 . . . . 0.0 112.362 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.72 161.07 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 p -73.05 152.37 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 15.5 t -47.27 -29.68 2.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.209 0.528 . . . . 0.0 110.259 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.0 64.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.747 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.442 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -67.2 -35.4 79.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.634 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.9 mmm -70.72 -46.87 62.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.277 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -54.42 -37.3 64.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.497 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.0 m -63.8 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.442 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -51.31 -41.81 60.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.893 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.6 t -71.08 -31.07 43.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.832 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.75 23.73 13.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.8 tp10 -112.42 -33.87 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.61 -26.57 0.75 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CE2' ' HD2' ' B' ' 68' ' ' PRO . 32.8 m-85 -64.15 168.04 5.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 55.0 68.02 2.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.753 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -24.36 76.5 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.637 2.225 . . . . 0.0 112.29 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -116.9 -5.93 11.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.45 158.13 30.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.021 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.55 161.25 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 0.0 111.217 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -68.51 83.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.151 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 3.4 m -91.66 146.38 23.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.724 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -179.06 147.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.538 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.62 131.11 49.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.412 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 12.9 mt -49.38 -33.27 13.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.086 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -120.41 127.52 26.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -78.77 139.29 53.45 Favored 'Cis proline' 0 C--N 1.349 0.558 0 C-N-CA 123.596 -1.419 . . . . 0.0 112.328 0.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.37 125.3 17.6 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.465 2.11 . . . . 0.0 112.268 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.65 92.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.585 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.12 -151.43 5.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.643 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -67.77 73.62 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -45.27 166.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.058 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -162.15 134.12 5.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.966 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.64 137.92 57.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.5 p -53.79 -30.68 45.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.976 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -78.81 -3.91 46.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.33 4.07 13.41 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.626 0.251 . . . . 0.0 111.459 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 56' ' ' ILE . 30.1 mt -106.46 153.25 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -116.49 82.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -57.5 -24.04 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -74.91 -14.72 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 mt -96.44 29.02 3.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.99 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -139.39 -47.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.954 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.868 0.366 . . . . 3.6400000000000001 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -113.12 38.93 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 3.9399999999999999 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -156.97 135.78 7.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.399 . . . . 6.8899999999999997 110.927 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' B' ' 67' ' ' PRO . 92.1 Cg_endo -87.18 176.54 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.065 2.51 . . . . 0.01 112.392 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 83.4 Cg_endo -87.02 125.36 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.8 2.333 . . . . 0.66000000000000003 112.256 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.412 ' HD2' ' CE2' ' A' ' 33' ' ' TYR . 43.9 Cg_endo -68.02 165.03 29.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.43 2.087 . . . . 0.01 112.35 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.76 -179.37 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.222 . . . . 0.01 112.385 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 71.56 -65.73 1.06 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.867 -0.682 . . . . 0.65000000000000002 112.476 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.01 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.932 0.396 . . . . 4.1699999999999999 111.81 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 178.46 124.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 6.9500000000000002 110.764 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.259 -0.877 . . . . 5.7400000000000002 111.16 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.824 0.345 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.45 ' HB3' HD11 ' A' ' 43' ' ' LEU . 24.3 mtt -78.12 160.79 27.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.558 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 59.4 m95 -144.23 116.63 8.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.572 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.482 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.9 mt-10 -68.21 165.34 18.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 1.3 p90 -154.07 132.8 12.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.7 125.84 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -56.49 -46.62 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 6.7 mt-10 . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.0 0.428 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -109.91 107.84 17.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.018 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 55.3 m-85 -130.84 -163.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.581 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.43 28.74 18.79 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.011 -0.614 . . . . 0.0 114.356 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 93.4 Cg_endo -82.16 25.76 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.907 1.738 . . . . 0.0 111.924 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -99.34 166.26 11.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.894 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.3 p -69.15 150.01 48.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.819 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.7 -30.28 2.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.134 0.493 . . . . 0.0 110.148 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.14 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.541 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 31.2 tp60 -65.99 -36.64 83.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.705 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.4 mmm -67.1 -44.29 80.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.536 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.84 -38.61 75.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLU . 84.9 m -60.65 -57.77 11.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.2 m0 -62.2 -45.26 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' MET . 58.5 t -65.73 -34.83 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.285 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -88.61 -35.05 17.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' THR . 3.4 mm-40 -55.67 -30.09 60.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.099 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.3 2.6 24.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 0.3 OUTLIER -55.09 -34.56 63.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.847 0.356 . . . . 0.0 110.819 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -108.51 81.06 1.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.42 -17.16 49.04 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.701 2.268 . . . . 0.0 112.514 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.26 -8.76 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.294 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 158.94 35.14 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.005 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.97 160.95 42.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.993 0.425 . . . . 0.0 111.452 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -70.11 85.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.413 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.7 m -83.32 143.88 30.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.469 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -170.4 137.41 1.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -59.55 132.54 54.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.588 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.0 mt . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.392 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 4.0 m-85 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.54 137.6 19.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.05 136.85 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.802 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -54.88 -30.78 58.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -8.34 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -107.81 2.73 23.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.558 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.7 mt -109.06 153.11 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -118.45 87.02 2.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -60.4 -24.04 64.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -62.61 -21.85 65.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 37.1 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.607 0.169 . . . . 0.01 111.848 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.474 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.1 Cg_endo -61.42 -179.44 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.355 2.037 . . . . 0.01 112.171 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 C-N-CA 120.707 -0.759 . . . . 0.65000000000000002 112.453 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.832 0.349 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.7 mtt -78.75 153.33 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.527 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 68.7 m95 -140.73 115.13 9.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.956 0.407 . . . . 0.0 111.691 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -66.4 170.81 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.487 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -161.87 135.09 6.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -129.68 129.0 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.055 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -62.87 -57.39 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.17 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.4 mp0 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.948 0.404 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -110.02 94.91 5.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 67.0 m-85 -114.3 -166.1 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.459 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 93.32 27.59 13.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.993 -0.622 . . . . 0.0 114.466 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.1 Cg_endo -82.56 27.46 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.719 1.76 . . . . 0.0 111.753 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.5 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -98.7 167.52 10.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.98 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.7 p -70.15 149.81 47.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.91 -30.54 2.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.21 0.528 . . . . 0.0 110.148 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.65 86.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.76 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.5 tp60 -71.44 -31.7 67.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.839 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 mmm -75.16 -49.85 18.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.35 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.52 -33.08 69.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.399 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLU . 92.4 m -68.53 -51.5 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.476 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.4 m0 -63.2 -40.69 98.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' MET . 95.1 t -70.81 -30.98 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.253 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 p -95.11 -31.37 13.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.589 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.2 mm-40 -56.21 -46.16 79.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 110.982 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.63 -25.55 0.44 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -54.88 160.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.796 0.331 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 62.9 62.38 1.86 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.574 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.89 -23.79 17.2 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.582 2.188 . . . . 0.0 112.596 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.69 -4.51 10.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.468 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.65 160.31 34.1 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.883 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.96 160.36 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.964 0.412 . . . . 0.0 111.419 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.27 83.97 0.55 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.512 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -84.33 155.27 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.908 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 5.3 ptm180 -178.28 138.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -62.13 125.39 23.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.983 0.42 . . . . 0.0 110.547 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 14.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.683 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 134.91 19.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.779 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -55.25 133.07 49.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.6 p -53.3 -31.48 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.33 -7.82 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.029 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 1.83 22.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.677 0.275 . . . . 0.0 111.362 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.8 mt -108.08 152.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.793 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -117.96 84.75 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -58.88 -22.18 58.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -62.05 -25.9 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.162 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.464 -0.249 0 CA-C-O 120.673 0.197 . . . . 0.01 112.408 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.3 Cg_endo -59.69 -178.06 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.595 2.197 . . . . 0.01 112.363 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.507 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 112.618 179.7 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.762 0.315 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.504 ' HB3' HD11 ' A' ' 43' ' ' LEU . 3.4 mtt -81.52 158.15 24.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.528 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 61.3 m95 -145.13 117.0 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 111.787 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 1.8 mt-10 -66.46 171.94 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.316 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -168.56 130.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HE2' ' CD2' ' A' ' 39' ' ' TYR . 11.1 pttt -128.87 127.51 41.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.367 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.25 -55.14 38.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 8.7 mt-10 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.07 89.69 3.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.243 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' B' ' 69' ' ' PRO . 75.6 m-85 -111.31 -164.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.083 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.629 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.83 23.99 34.02 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.813 -0.708 . . . . 0.0 114.29 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 85.5 Cg_endo -80.01 28.72 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 119.788 1.794 . . . . 0.0 112.031 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -102.93 169.19 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.8 p -72.27 150.86 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.834 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -48.12 -28.99 3.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 110.098 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.67 84.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.469 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 39.8 tp60 -74.79 -33.58 62.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.9 mmm -73.04 -44.48 60.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.475 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 51.9 tp60 -59.91 -40.51 89.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' GLU . 18.5 m -60.92 -52.2 66.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.469 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.8 m0 -62.83 -43.64 98.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' MET . 98.5 t -67.61 -33.25 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.184 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.5 t -89.06 -40.06 13.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.059 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 27' ' ' THR . 11.3 tm-20 -51.48 -28.93 14.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.08 4.31 29.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.832 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -35.82 65.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.327 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -105.35 78.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.535 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.06 -16.82 57.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.641 2.227 . . . . 0.0 112.401 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -113.97 -12.15 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.337 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.52 160.73 36.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -136.84 160.99 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -79.65 87.56 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.184 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 20.5 m -93.08 159.84 15.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.349 0.595 . . . . 0.0 112.134 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -178.85 141.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.305 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -51.69 134.24 30.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 111.338 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.7 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.148 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.473 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.0 m-85 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.691 0.281 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.45 129.64 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.028 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.12 124.53 15.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.41 -34.54 35.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -11.2 60.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.65 2.86 20.49 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.655 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.569 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 20.8 mt -101.41 153.41 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 110.771 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 56' ' ' ILE . 6.1 t0 -115.99 83.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.785 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 81.0 m-85 -56.81 -22.82 39.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -21.26 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.287 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 -179.956 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.558 0.149 . . . . 0.01 112.188 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 Cg_endo -65.14 -179.21 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.475 2.116 . . . . 0.01 112.264 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 C-N-CA 120.793 -0.718 . . . . 0.65000000000000002 112.387 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.844 0.354 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 41.2 mtt -80.89 160.0 24.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.664 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 54.8 m95 -144.79 115.41 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.683 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 3.4 pt-20 -71.39 149.8 45.63 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 3.6 p90 -137.13 140.78 42.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.453 . . . . 0.0 111.564 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -131.21 123.41 28.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.832 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -62.48 -57.73 10.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.234 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.2 -179.474 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 89.01 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 54.3 m-85 -107.73 -161.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.95 25.4 29.44 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.224 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 96.8 Cg_endo -77.97 15.0 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 CA-C-N 119.635 1.718 . . . . 0.0 111.647 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -88.18 165.71 14.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.776 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 p -70.85 148.55 47.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -30.14 2.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.38 88.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.458 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.0 tp60 -73.37 -34.0 65.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.566 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.72 ' O ' HG23 ' A' ' 29' ' ' VAL . 36.3 mmm -71.61 -42.68 67.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.43 -43.95 92.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 31' ' ' GLU . 31.7 m -58.0 -53.52 57.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.87 -42.85 99.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.948 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 25' ' ' MET . 87.5 t -66.68 -33.99 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.444 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -30.63 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.3 mm-40 -56.34 -23.06 34.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.21 6.04 42.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.595 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD2' ' HD3' ' B' ' 68' ' ' PRO . 4.4 m-30 -61.81 -28.65 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.626 0.251 . . . . 0.0 111.229 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -114.1 80.75 5.76 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.836 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 33' ' ' TYR . 50.9 Cg_exo -52.85 -27.98 37.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.495 2.13 . . . . 0.0 112.427 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.13 15.13 15.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.074 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 71.36 -164.38 53.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.048 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 37' ' ' GLY . 2.6 m -162.03 161.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.908 0.385 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.446 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -71.09 85.66 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.773 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -93.72 152.22 19.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.808 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -178.75 150.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -58.98 136.05 57.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 21.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HD2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -159.68 134.02 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -58.13 133.82 55.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 38' ' ' VAL . 18.0 p -54.14 -28.89 42.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 0.8 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 2.11 10.63 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.326 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.664 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 33.1 mt -99.58 153.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -107.63 79.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -58.25 -24.29 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.05 -26.85 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.048 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.401 ' HD3' ' CD2' ' A' ' 33' ' ' TYR . 53.1 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 CA-C-O 120.746 0.227 . . . . 0.01 112.436 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.454 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 18.0 Cg_endo -62.1 -179.57 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.606 2.204 . . . . 0.01 112.312 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 120.843 -0.694 . . . . 0.65000000000000002 112.59 179.773 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 52.8 mtt -79.74 160.54 26.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.489 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.539 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 63.1 m95 -144.92 115.65 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 111.853 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.731 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.24 165.95 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -157.05 133.39 9.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.199 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 50' ' ' PHE . 10.8 pttt -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.376 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -60.58 -56.74 17.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.774 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.731 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -125.83 96.89 4.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.343 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 52.2 m-85 -111.02 -163.49 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.082 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.637 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.82 24.2 33.39 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.23 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 91.1 Cg_endo -79.02 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 CA-C-N 119.714 1.757 . . . . 0.0 111.859 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -101.85 166.33 10.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.4 p -66.44 147.97 52.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.464 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -46.75 -30.67 2.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.82 88.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -70.93 -34.17 71.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.613 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 58.6 mmm -73.96 -43.87 56.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.363 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.23 -36.36 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 55.7 m -66.34 -50.04 64.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.8 m0 -65.74 -44.22 86.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' MET . 87.8 t -65.71 -31.26 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.3 t -91.89 -33.45 14.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.051 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 4.1 mm-40 -57.19 -29.48 63.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.06 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.69 2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -55.29 -27.38 46.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -116.3 81.66 10.95 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.785 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.09 -27.0 53.14 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.548 2.165 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.54 12.19 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.102 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.03 -169.54 52.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.034 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.2 m -159.33 160.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -73.3 90.9 1.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.888 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -90.44 156.37 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.216 0.531 . . . . 0.0 111.95 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -175.2 142.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.752 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -64.17 127.79 32.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 15.5 mt . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 41' ' ' ARG . 2.7 m-85 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -156.1 134.87 11.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.25 138.01 57.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.9 p -53.88 -30.86 47.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -77.97 -3.86 44.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -115.3 2.89 14.11 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.539 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 46.7 mt -106.91 152.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.837 0.351 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.58 ' HB3' HD12 ' A' ' 60' ' ' LEU . 7.9 t0 -113.3 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -65.14 -24.3 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.15 -9.34 58.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 57' ' ' ASP . 40.5 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.46 ' HG3' ' CD2' ' A' ' 28' ' ' TRP . 35.8 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.684 0.202 . . . . 0.01 112.118 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 14.2 Cg_endo -59.36 -178.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 0.01 112.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 C-N-CA 120.873 -0.68 . . . . 0.65000000000000002 112.513 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.873 0.368 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.0 mtt -126.32 162.59 25.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.573 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 60.4 m95 -145.61 114.35 6.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.848 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.57 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.94 158.82 35.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.082 179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -145.87 136.58 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.51 122.88 36.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.15 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -53.65 -47.03 70.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.918 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.907 0.384 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -146.25 98.66 3.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.013 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 67.1 m-85 -115.77 -163.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.555 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.598 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 87.43 28.35 24.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.049 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.4 Cg_endo -81.24 22.12 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 CA-C-N 119.595 1.698 . . . . 0.0 111.64 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -94.18 165.41 12.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.567 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.1 p -68.51 146.87 52.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.51 -31.29 1.72 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.182 0.515 . . . . 0.0 110.237 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.58 70.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.474 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.43 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 36.2 tp60 -66.83 -36.8 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.7 mmm -68.27 -51.49 44.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 35.8 tp60 -54.19 -32.82 56.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.471 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 37.1 m -64.4 -52.36 58.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.568 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.43 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.2 m0 -64.55 -42.43 95.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 34' ' ' PHE . 98.4 t -64.57 -31.86 55.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.183 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 p -96.85 -31.27 12.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.454 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 16.6 mm-40 -54.37 -33.37 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.262 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.91 -26.25 1.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.484 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -56.09 164.2 1.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 60.4 61.86 3.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.518 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.72 -32.49 36.63 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.674 2.25 . . . . 0.0 112.531 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -115.2 12.63 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.251 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.74 159.81 24.85 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.111 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.83 161.97 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.125 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.81 80.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.27 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.6 m -82.77 145.14 29.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.717 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -169.27 135.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.082 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 4' ' ' TRP . 18.5 mtmt -60.39 136.23 57.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 3' ' ' MET . 10.7 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.774 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.708 0.289 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.92 132.08 9.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.15 134.54 56.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 p -55.14 -25.96 35.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 4.82 29.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.36 5.34 5.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.563 0.22 . . . . 0.0 111.554 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 24.1 mt -103.13 153.21 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.9 t0 -109.4 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 66.7 m-85 -70.21 -12.95 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.07 -14.58 46.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.475 HD12 ' CB ' ' A' ' 57' ' ' ASP . 81.0 mt . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.869 0.366 . . . . 0.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 CA-C-O 120.575 0.156 . . . . 0.01 112.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.483 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.3 Cg_endo -58.69 -174.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.447 2.098 . . . . 0.01 112.391 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 115.627 -0.715 . . . . 0.65000000000000002 112.58 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.778 0.323 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.409 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.5 mtt -76.49 157.52 32.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.531 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 67.5 m95 -142.76 117.08 9.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.968 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -69.64 166.66 18.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.232 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -159.75 130.56 5.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.081 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -120.17 120.91 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.16 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 34' ' ' PHE . 85.1 m95 -56.94 -52.62 64.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 2.8 pm0 . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 121.002 0.43 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.59 107.87 16.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.4 m-85 -133.97 -164.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.553 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 95.52 18.25 33.57 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.872 -0.68 . . . . 0.0 114.337 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 78.3 Cg_endo -77.02 51.59 3.5 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.958 1.879 . . . . 0.0 111.544 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -127.08 166.67 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.52 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -70.55 148.35 48.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -46.57 -30.1 2.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.087 0.47 . . . . 0.0 110.181 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.03 30.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.398 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 42.3 tp60 -61.29 -34.67 75.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 29' ' ' VAL . 39.4 mmm -70.06 -41.25 74.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.445 ' HG2' ' CB ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -58.07 -40.17 80.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.561 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 31' ' ' GLU . 99.2 m -62.55 -60.71 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.446 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 12.4 m0 -55.99 -46.33 78.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' MET . 81.4 t -60.56 -29.61 45.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 m -99.05 -25.65 14.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.356 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.0 tp10 -56.82 -33.36 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.47 -5.39 13.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.735 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.15 -34.8 66.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 110.794 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -107.48 73.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.477 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.18 -19.94 62.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.596 2.197 . . . . 0.0 112.42 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.29 -12.44 11.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.193 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.79 159.4 28.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.809 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.87 160.98 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 79.15 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -78.22 150.34 33.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.542 -179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.6 ttm-85 -179.57 126.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.41 137.85 10.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.5 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.285 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 4.3 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.72 0.295 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.59 131.46 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -55.26 128.33 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.024 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -54.65 -32.23 58.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.82 -4.74 45.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -114.71 3.64 14.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.576 0.227 . . . . 0.0 111.569 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.531 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 58.6 mt -103.3 153.89 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.298 . . . . 0.0 110.97 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 56' ' ' ILE . 7.0 t0 -100.71 111.95 24.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CB ' ' HG2' ' A' ' 26' ' ' GLN . 88.6 m-85 -95.7 20.36 9.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.984 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -108.45 -23.46 11.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.95 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.642 0.184 . . . . 0.01 112.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 28.9 Cg_endo -65.26 -178.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.451 2.1 . . . . 0.01 112.482 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 C-N-CA 120.866 -0.683 . . . . 0.65000000000000002 112.536 179.835 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 43' ' ' LEU . 18.3 mtt -79.67 163.41 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.565 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.446 ' CZ2' ' HE2' ' A' ' 42' ' ' LYS . 54.4 m95 -148.02 117.13 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.712 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -70.14 163.81 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.0 p90 -152.22 137.23 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 0.0 110.997 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 10.9 ttmt -126.05 128.13 46.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -58.92 -51.72 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.773 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 17.0 mm-40 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.981 0.42 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.85 113.03 24.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 72.4 m-85 -133.22 -162.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.419 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.66 28.67 18.36 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.999 -0.62 . . . . 0.0 114.293 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.9 Cg_endo -80.77 23.62 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 119.668 1.734 . . . . 0.0 111.624 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -94.28 165.15 12.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.746 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 p -70.32 148.07 48.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -45.56 -30.88 1.6 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.212 0.529 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.11 -48.29 80.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.531 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 41.3 tp60 -68.89 -34.28 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.628 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 mmm -69.07 -46.29 68.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.279 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.675 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.1 m -59.02 -54.88 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.625 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.48 ' CD1' ' HG3' ' B' ' 68' ' ' PRO . 7.0 m0 -59.81 -40.96 90.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' MET . 95.8 t -73.19 -30.57 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.796 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 p -95.43 -31.58 13.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.8 tp10 -57.76 -47.99 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.24 -26.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.773 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -53.37 162.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER 63.48 55.6 1.87 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.31 -22.85 28.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.196 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -114.56 -14.04 12.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.32 158.34 23.99 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.948 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 53' ' ' SER . 13.9 m -130.56 159.93 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -74.49 88.08 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.22 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.2 m -80.94 158.03 25.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.178 0.513 . . . . 0.0 111.754 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HG3' ' CG ' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -179.72 145.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.714 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 18.2 mtmt -73.14 123.12 22.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.253 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.7 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.503 ' CD2' ' CD2' ' A' ' 39' ' ' TYR . 1.5 m-85 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -156.36 136.17 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -59.16 136.2 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 38' ' ' VAL . 6.5 t -53.27 -31.22 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -6.35 53.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.112 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -1.4 19.7 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 40' ' ' CYS . 39.8 mt -104.96 150.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.634 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -117.89 83.99 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -59.4 -25.56 64.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.5 -22.42 43.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 28' ' ' TRP . 32.5 Cg_exo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.618 0.174 . . . . 0.01 112.3 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.6 Cg_endo -59.33 -177.71 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.507 2.138 . . . . 0.01 112.399 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.65000000000000002 112.6 179.671 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.638 0.256 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 33.5 mtt -81.83 156.66 24.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.52 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 52.5 m95 -143.6 115.93 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.352 . . . . 0.0 111.845 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 5.4 pt-20 -71.87 162.79 28.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 6.0 p90 -152.63 135.43 15.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.42 128.7 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.05 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -62.04 -54.91 34.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.69 147.61 35.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.212 0.529 . . . . 0.0 111.54 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 70.3 m-85 -155.38 -160.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.77 29.66 17.68 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.864 -0.684 . . . . 0.0 114.284 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 90.4 Cg_endo -79.05 17.79 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 119.588 1.694 . . . . 0.0 111.464 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -91.19 166.24 13.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.716 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.9 p -68.46 148.52 50.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.991 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.4 p -47.26 -30.08 2.83 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.206 0.526 . . . . 0.0 110.284 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.37 80.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.2 tp60 -71.11 -33.05 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.9 mmm -72.77 -46.13 54.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.64 -38.0 71.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.395 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLU . 38.8 m -63.36 -60.52 3.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.49 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.459 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.1 m0 -53.8 -40.75 66.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.973 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 25' ' ' MET . 77.5 t -69.4 -33.53 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -89.68 -32.15 17.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.2 tp10 -56.46 -44.12 80.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -0.97 6.93 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.825 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -53.95 -33.4 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -105.39 82.15 0.73 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.54 -29.16 83.95 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.589 2.193 . . . . 0.0 112.243 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -115.53 14.75 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.594 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.52 -166.8 54.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.114 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.0 m -160.83 161.78 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 0.0 111.054 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.3 82.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.0 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.5 m -87.01 150.84 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.904 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -179.85 143.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.262 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HG2' ' CZ2' ' A' ' 4' ' ' TRP . 10.9 mttt -55.86 131.59 47.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 24.3 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.068 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.451 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 2.5 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -151.03 130.4 12.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.69 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -54.95 129.59 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.926 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.4 p -53.45 -32.27 49.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -78.71 -3.35 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -117.56 4.24 12.4 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.518 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.546 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 18.3 mt -101.15 153.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.693 ' HB3' HD12 ' A' ' 60' ' ' LEU . 9.0 t0 -109.48 80.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.001 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -58.14 -22.41 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -75.77 -6.74 52.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 57' ' ' ASP . 25.8 mt . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 111.062 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.596 0.165 . . . . 0.01 111.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.504 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.2 Cg_endo -60.52 -176.59 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.378 2.052 . . . . 0.01 112.271 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 CA-C-N 115.63 -0.714 . . . . 0.65000000000000002 112.504 179.792 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.779 0.323 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.434 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . 5.6 mmm -79.64 152.11 30.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 73.9 m95 -144.65 114.84 7.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 111.736 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -70.3 170.58 11.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.353 179.082 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.87 135.38 8.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.28 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -127.4 129.43 47.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.037 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -58.43 -48.49 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.165 -179.696 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -140.73 92.34 2.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.717 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 53.9 m-85 -113.47 -166.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 92.38 28.55 12.75 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.527 -0.596 . . . . 0.0 114.317 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.3 Cg_endo -83.49 25.93 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 CA-C-N 119.788 1.794 . . . . 0.0 111.788 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -99.42 171.03 8.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -71.93 147.47 46.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.929 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -46.66 -30.64 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.285 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.04 -46.9 85.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.559 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.2 tp60 -70.33 -32.72 70.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.623 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.9 mmm -73.75 -47.98 35.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.305 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -56.92 -34.1 67.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.567 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLU . 8.4 m -71.05 -53.21 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.84 -42.05 98.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' MET . 73.8 t -65.38 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.9 m -95.6 -31.33 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.7 mm-40 -55.14 -32.09 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.133 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.16 -0.03 20.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CD2' ' HD2' ' B' ' 68' ' ' PRO . 53.9 m-85 -56.44 -34.47 66.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -109.39 76.38 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.5 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.2 -19.03 65.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.634 2.223 . . . . 0.0 112.408 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -115.85 2.23 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.66 159.33 13.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.982 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.23 160.64 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.957 0.408 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 87.53 3.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.353 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.69 156.33 19.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 0.0 111.807 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -175.29 127.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.082 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 12.6 mtmt -50.27 135.26 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.281 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 3.3 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.764 0.316 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.27 129.4 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.76 133.6 56.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -34.97 64.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -68.18 -12.12 60.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.186 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.26 11.98 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.559 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 47.2 mt -109.2 155.34 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.933 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' HB3' HD12 ' A' ' 60' ' ' LEU . 6.7 t0 -113.37 82.24 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -57.51 -22.49 44.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.96 -10.57 59.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.326 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' ASP . 22.6 mt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 111.012 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 33' ' ' TYR . 40.2 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.704 0.21 . . . . 0.01 112.232 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.452 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.3 Cg_endo -61.32 -177.65 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.482 2.121 . . . . 0.01 112.273 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 C-N-CA 120.752 -0.737 . . . . 0.65000000000000002 112.322 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.74 0.305 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.424 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.8 mtt -80.09 156.04 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.592 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 53.2 m95 -139.67 117.69 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 111.732 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mt-10 -67.34 169.41 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.707 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -160.8 136.19 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.072 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -127.7 122.36 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.291 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -55.98 -48.91 74.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.9 mt-10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 107.99 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 74.2 m-85 -126.45 -163.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 91.48 29.89 11.55 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.351 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 75.8 Cg_endo -83.37 26.08 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.882 1.721 . . . . 0.0 111.812 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -96.34 167.51 11.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.842 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 p -69.13 147.02 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.16 -34.04 1.71 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.216 0.532 . . . . 0.0 110.235 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -56.51 20.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.8 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.0 tp60 -58.08 -32.37 68.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.46 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mmm -72.71 -43.09 63.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -38.31 74.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.597 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 65.5 m -64.81 -60.03 3.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.7 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.7 m0 -55.23 -43.23 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 111.016 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' MET . 77.6 t -65.85 -29.44 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -94.89 -29.71 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.34 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.0 tm-20 -57.61 -44.43 85.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.995 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.39 -3.05 5.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD ' ' B' ' 68' ' ' PRO . 16.1 m-85 -54.43 -32.04 56.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -111.04 78.82 1.76 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -20.15 47.62 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.176 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -116.95 -6.81 11.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.448 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.17 160.23 34.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.28 161.12 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 111.231 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -71.79 81.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.048 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.74 149.12 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 111.93 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -173.71 140.5 0.77 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.804 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 17.9 mttt -57.06 128.17 35.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 3' ' ' MET . 14.8 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.404 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m-85 . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -140.85 127.6 20.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -57.72 131.72 51.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 p -53.03 -29.11 27.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -79.4 -2.5 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -118.05 3.92 12.08 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.516 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 19.8 mt -101.31 151.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.814 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.48 89.56 3.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.23 -16.28 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.502 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -71.92 -19.98 61.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.512 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 111.172 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 Cg_exo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.677 0.199 . . . . 0.01 112.092 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 20.7 Cg_endo -64.87 179.54 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.267 1.978 . . . . 0.01 112.29 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.779 -0.724 . . . . 0.65000000000000002 112.468 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.538 ' CB ' HD12 ' A' ' 43' ' ' LEU . 15.7 mtp -87.34 145.78 26.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.795 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.775 ' O ' HD21 ' A' ' 43' ' ' LEU . 42.4 m95 -132.53 -172.07 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -147.45 163.16 37.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.022 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -151.98 136.89 17.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.976 0.417 . . . . 0.0 111.176 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HE3' HD22 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -129.69 128.83 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 31.7 m95 -62.9 -57.38 10.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.866 0.365 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.404 HD22 ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -143.61 84.44 1.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.201 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 45.0 m-85 -106.85 -175.24 2.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.961 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.26 -16.87 41.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.895 -0.947 . . . . 0.0 115.297 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.5 Cg_exo -40.29 -26.19 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 120.428 2.114 . . . . 0.0 112.985 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.2 m-85 -43.14 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.366 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -66.91 146.57 54.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 5.5 p -47.75 -30.53 3.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.14 0.495 . . . . 0.0 110.221 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.65 92.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.537 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.479 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.0 tp60 -71.23 -30.45 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.5 mmm -73.23 -47.06 46.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.201 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -57.08 -39.63 75.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -62.07 -59.76 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.684 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.479 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.1 m0 -57.2 -44.54 83.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.802 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 25' ' ' MET . 97.0 t -66.99 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.947 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -83.94 -41.65 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.26 -27.84 49.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.77 6.93 30.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.8 m-85 -54.09 -25.95 24.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.283 . . . . 0.0 111.081 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.486 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -117.56 80.85 13.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.793 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.69 -19.47 65.28 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.663 2.242 . . . . 0.0 112.531 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.51 -3.76 14.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.43 162.45 29.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.972 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 7.4 m -137.34 161.53 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.955 0.407 . . . . 0.0 111.458 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.01 90.21 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.421 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.622 ' CB ' HD12 ' A' ' 56' ' ' ILE . 1.8 m -88.04 142.23 27.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.81 139.79 11.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 1.5 mtmt -73.42 142.64 46.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.848 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.775 HD21 ' O ' ' A' ' 4' ' ' TRP . 5.6 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.797 0.332 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -149.05 126.59 11.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -63.04 130.71 45.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -52.06 -28.2 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -7.8 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.97 7.29 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.479 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 51' ' ' TYR . 31.9 mt -104.28 153.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 111.141 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 56' ' ' ILE . 16.1 t70 -118.11 117.53 29.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.667 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -94.46 30.35 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.63 -26.01 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.972 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 75.5 Cg_endo . . . . . 0 N--CA 1.464 -0.206 0 CA-C-O 120.635 0.181 . . . . 0.01 112.199 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.89 179.35 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.485 2.123 . . . . 0.01 112.179 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 C-N-CA 120.681 -0.771 . . . . 0.65000000000000002 112.388 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.76 0.314 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.461 ' HB2' HD12 ' A' ' 43' ' ' LEU . 2.1 mtt -85.21 142.88 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.772 ' O ' HD21 ' A' ' 43' ' ' LEU . 49.6 m95 -129.78 -170.92 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 2.0 mt-10 -145.37 170.13 16.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.58 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' TYR . 1.3 p90 -168.22 130.54 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 3.2 pttt -126.09 128.7 47.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.205 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 72.4 m95 -63.82 -58.09 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.119 -179.678 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 5.1 mm-40 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.12 102.7 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.451 . . . . 0.0 111.439 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 6' ' ' TYR . 46.4 m-85 -131.11 179.74 5.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.963 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 107.35 -17.01 37.64 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.341 -0.933 . . . . 0.0 115.326 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.3 Cg_exo -40.38 -25.56 0.18 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 CA-C-N 120.235 2.018 . . . . 0.0 113.099 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.0 m-85 -43.01 166.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.328 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -66.89 145.9 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 12.1 t -47.04 -30.2 2.55 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.157 0.503 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.48 88.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.647 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 30.0 tp60 -69.72 -30.71 68.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.581 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.8 mmm -72.96 -46.81 50.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.303 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -59.39 -35.31 73.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.368 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -65.49 -61.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.8 m0 -54.7 -42.83 71.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 25' ' ' MET . 96.8 t -68.52 -33.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.928 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.9 p -84.62 -38.68 19.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.107 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -27.24 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 7.04 32.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.776 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.9 m-85 -54.87 -39.47 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -102.51 94.81 5.34 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 -24.73 30.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.553 2.169 . . . . 0.0 112.555 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.34 15.28 14.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.138 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.54 -176.23 35.67 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.018 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 2.6 m -152.11 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.875 0.369 . . . . 0.0 111.116 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -77.99 87.06 4.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.227 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 57.5 m -91.89 152.57 20.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 111.945 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 9.3 ttp85 -160.72 142.8 12.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.113 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 4.8 mtmt -68.41 146.4 53.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD21 ' O ' ' A' ' 4' ' ' TRP . 3.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 2.0 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.64 126.86 21.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.927 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.3 134.54 45.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t -57.98 -37.12 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.26 -12.52 56.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.281 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 7.24 27.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 57' ' ' ASP . 51.4 mt -108.97 153.83 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.055 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' CB ' HD12 ' A' ' 60' ' ' LEU . 12.2 t0 -113.35 84.97 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -60.08 -20.98 60.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.256 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.22 -10.11 59.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.574 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 ' CB ' ' A' ' 57' ' ' ASP . 27.3 mt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 111.194 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 81.0 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 CA-C-O 120.703 0.209 . . . . 0.01 112.099 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 28.0 Cg_endo -62.16 178.13 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.504 2.136 . . . . 0.01 112.199 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 8' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.685 -0.769 . . . . 0.65000000000000002 112.417 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.834 0.349 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.1 mmm -81.12 159.43 24.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.577 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 65.7 m95 -147.61 116.8 6.89 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.489 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 5.1 pt-20 -80.8 136.08 36.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.561 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -127.38 137.33 52.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.184 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -126.05 128.49 47.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.412 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -59.1 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.065 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 9.5 mm-40 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 85.07 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 30.2 m-85 -109.29 -171.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.668 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.63 -9.87 41.39 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.057 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.8 Cg_exo -42.18 -26.48 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.431 2.116 . . . . 0.0 112.314 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.05 167.44 0.05 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.851 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -77.9 153.73 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -47.71 -29.58 3.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.073 0.463 . . . . 0.0 110.052 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.89 -57.56 11.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.625 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.3 tp60 -62.37 -37.47 85.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mmm -64.51 -49.85 69.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.659 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -54.12 -36.68 63.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' GLU . 88.2 m -61.11 -59.75 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.632 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -58.13 -46.08 86.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' MET . 94.0 t -57.86 -30.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 t -96.81 -29.29 13.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 14.1 tp10 -55.21 -30.22 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -0.66 26.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -58.83 -32.4 69.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -106.88 75.29 0.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.78 -21.69 69.44 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.86 6.51 15.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.207 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 159.81 10.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.094 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.88 161.5 41.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.836 0.35 . . . . 0.0 111.225 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -75.62 82.11 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.106 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 2.1 m -87.9 151.04 23.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.787 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 8.5 ptm180 179.02 151.76 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.434 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -59.32 135.9 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.872 0.367 . . . . 0.0 110.512 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.6 mt . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.27 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.7 m-85 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CB ' HD11 ' A' ' 56' ' ' ILE . 3.3 m-85 -142.66 127.3 18.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.712 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -55.84 130.01 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -53.85 -28.3 35.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -2.06 46.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.229 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 4.87 11.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.532 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.466 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 40.1 mt -107.19 153.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -104.92 107.85 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -89.54 52.58 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.664 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -145.69 -37.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.299 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.464 -0.213 0 CA-C-O 120.617 0.174 . . . . 0.01 112.246 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 69' ' ' PRO . . . . . 0.436 ' HG2' ' CG ' ' A' ' 17' ' ' TYR . 33.5 Cg_endo -65.85 178.38 2.35 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.383 2.055 . . . . 0.01 112.357 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.616 179.853 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 mtt -74.65 163.86 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 64.8 m95 -145.49 115.8 7.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.697 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.554 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 8.6 pt-20 -76.2 146.17 39.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 1.5 p90 -133.99 134.82 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HE2' ' CD2' ' A' ' 16' ' ' LEU . 17.9 ttmm -127.47 126.96 43.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.332 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -56.7 -49.58 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.871 0.367 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -159.13 82.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 28.3 m-85 -113.88 -165.91 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.825 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 105.92 -9.45 43.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.357 -0.925 . . . . 0.0 115.036 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 99.7 Cg_exo -42.17 -26.68 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 120.408 2.104 . . . . 0.0 112.362 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.72 161.07 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 p -73.05 152.37 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 15.5 t -47.27 -29.68 2.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.209 0.528 . . . . 0.0 110.259 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.0 64.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.747 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -67.2 -35.4 79.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.634 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.426 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.9 mmm -70.72 -46.87 62.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.277 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -54.42 -37.3 64.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.497 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.0 m -63.8 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -51.31 -41.81 60.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.893 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 25' ' ' MET . 93.6 t -71.08 -31.07 43.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.832 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.75 23.73 13.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.8 tp10 -112.42 -33.87 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.61 -26.57 0.75 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' B' ' 68' ' ' PRO . 32.8 m-85 -64.15 168.04 5.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 55.0 68.02 2.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.753 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -24.36 76.5 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.637 2.225 . . . . 0.0 112.29 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -116.9 -5.93 11.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.45 158.13 30.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.021 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.55 161.25 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 0.0 111.217 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -68.51 83.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.151 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 3.4 m -91.66 146.38 23.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.724 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -179.06 147.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.538 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.62 131.11 49.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.412 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.086 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.804 0.335 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -162.15 134.12 5.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.966 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.64 137.92 57.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.5 p -53.79 -30.68 45.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.976 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -78.81 -3.91 46.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.33 4.07 13.41 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.626 0.251 . . . . 0.0 111.459 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.554 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 30.1 mt -106.46 153.25 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.3 t0 -116.49 82.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -57.5 -24.04 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -74.91 -14.72 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 57' ' ' ASP . 56.8 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.99 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 33' ' ' TYR . 43.9 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.769 0.237 . . . . 0.01 112.35 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.76 -179.37 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.222 . . . . 0.01 112.385 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.867 -0.682 . . . . 0.65000000000000002 112.476 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.1 p30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.849 0.357 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -154.77 108.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.45 ' HB3' HD11 ' A' ' 43' ' ' LEU . 24.3 mtt -78.12 160.79 27.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.558 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 59.4 m95 -144.23 116.63 8.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.572 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.482 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.9 mt-10 -68.21 165.34 18.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 1.3 p90 -154.07 132.8 12.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HE2' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -124.7 125.84 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -56.49 -46.62 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.79 -177.15 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.43 38.77 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -109.41 165.96 11.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.79 -3.77 90.35 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.183 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.26 -25.51 10.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.549 0.214 . . . . 0.0 111.012 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.561 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . . . -43.01 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.732 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 6.7 mt-10 -67.05 136.95 56.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -109.91 107.84 17.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.018 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 55.3 m-85 -130.84 -163.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.581 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.43 28.74 18.79 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.011 -0.614 . . . . 0.0 114.356 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 93.4 Cg_endo -82.16 25.76 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.907 1.738 . . . . 0.0 111.924 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -99.34 166.26 11.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.894 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.3 p -69.15 150.01 48.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.819 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.7 -30.28 2.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.134 0.493 . . . . 0.0 110.148 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.14 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.541 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 31.2 tp60 -65.99 -36.64 83.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.705 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.4 mmm -67.1 -44.29 80.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.536 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.84 -38.61 75.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLU . 84.9 m -60.65 -57.77 11.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.2 m0 -62.2 -45.26 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' MET . 58.5 t -65.73 -34.83 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.285 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -88.61 -35.05 17.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' THR . 3.4 mm-40 -55.67 -30.09 60.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.099 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.3 2.6 24.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 0.3 OUTLIER -55.09 -34.56 63.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.847 0.356 . . . . 0.0 110.819 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -108.51 81.06 1.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.42 -17.16 49.04 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.701 2.268 . . . . 0.0 112.514 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.26 -8.76 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.294 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 158.94 35.14 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.005 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.97 160.95 42.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.993 0.425 . . . . 0.0 111.452 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -70.11 85.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.413 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.7 m -83.32 143.88 30.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.469 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -170.4 137.41 1.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -59.55 132.54 54.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.588 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.0 mt -50.58 -53.83 27.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.392 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.13 126.07 36.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.1 161.46 90.75 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.629 -1.404 . . . . 0.0 112.428 0.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.62 117.74 3.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.68 2.253 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.9 99.43 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.652 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.29 -175.23 27.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.742 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.7 mt-30 -67.0 75.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.939 0.4 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 4.0 m-85 -42.15 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.65 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.54 137.6 19.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.05 136.85 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.802 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -54.88 -30.78 58.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -8.34 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -107.81 2.73 23.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.558 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.7 mt -109.06 153.11 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -118.45 87.02 2.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -60.4 -24.04 64.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -62.61 -21.85 65.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.2 mt -97.1 29.33 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -142.78 -46.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.9 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.338 . . . . 3.6400000000000001 111.244 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -62.43 177.44 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 3.9399999999999999 110.861 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 155.47 21.32 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.955 0.407 . . . . 6.8899999999999997 111.079 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.64 167.37 24.23 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.881 2.387 . . . . 0.01 112.417 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.44 132.79 28.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.714 2.276 . . . . 0.66000000000000003 112.015 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 37.1 Cg_endo -65.69 155.66 67.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.234 1.956 . . . . 0.01 111.848 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.474 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.1 Cg_endo -61.42 -179.44 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.355 2.037 . . . . 0.01 112.171 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.79 -80.08 1.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.707 -0.759 . . . . 0.65000000000000002 112.453 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 41.98 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.916 0.389 . . . . 4.1699999999999999 111.831 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 176.05 106.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.03 -0.532 . . . . 6.9500000000000002 110.87 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.572 HG23 ' OXT' ' B' ' 73' ' ' VAL . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.209 -0.9 . . . . 5.7400000000000002 111.151 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.84 108.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.7 mtt -78.75 153.33 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.527 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 68.7 m95 -140.73 115.13 9.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.956 0.407 . . . . 0.0 111.691 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -66.4 170.81 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.487 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -161.87 135.09 6.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.813 ' HD2' ' HB3' ' A' ' 14' ' ' ALA . 30.4 ttpt -129.68 129.0 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.055 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -62.87 -57.39 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.17 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB3' HG23 ' A' ' 11' ' ' THR . 1.4 mm-40 -81.98 -176.16 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.98 39.0 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.7 p -105.57 171.92 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.82 -9.38 71.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.148 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.65 -19.92 13.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.491 0.186 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.813 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . . . -42.21 159.11 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 111.491 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.4 mp0 -62.0 135.88 57.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.495 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -110.02 94.91 5.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 67.0 m-85 -114.3 -166.1 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.459 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 93.32 27.59 13.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.993 -0.622 . . . . 0.0 114.466 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.1 Cg_endo -82.56 27.46 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.719 1.76 . . . . 0.0 111.753 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.5 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -98.7 167.52 10.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.98 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.7 p -70.15 149.81 47.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.91 -30.54 2.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.21 0.528 . . . . 0.0 110.148 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.65 86.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.76 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.5 tp60 -71.44 -31.7 67.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.839 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 mmm -75.16 -49.85 18.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.35 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.52 -33.08 69.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.399 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLU . 92.4 m -68.53 -51.5 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.476 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.4 m0 -63.2 -40.69 98.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' MET . 95.1 t -70.81 -30.98 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.253 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 p -95.11 -31.37 13.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.589 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.2 mm-40 -56.21 -46.16 79.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 110.982 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.63 -25.55 0.44 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -54.88 160.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.796 0.331 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 62.9 62.38 1.86 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.574 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.89 -23.79 17.2 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.582 2.188 . . . . 0.0 112.596 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.69 -4.51 10.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.468 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.65 160.31 34.1 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.883 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.96 160.36 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.964 0.412 . . . . 0.0 111.419 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.27 83.97 0.55 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.512 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -84.33 155.27 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.908 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 5.3 ptm180 -178.28 138.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -62.13 125.39 23.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.983 0.42 . . . . 0.0 110.547 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 14.2 mt -46.25 -61.48 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.289 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.21 137.29 19.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 97.7 Cg_endo -79.45 153.34 88.1 Favored 'Cis proline' 0 C--N 1.348 0.528 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.411 0.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 51.5 Cg_exo -54.15 156.28 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.65 85.46 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.312 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.51 159.12 20.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.813 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.38 77.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.7 0.286 . . . . 0.0 110.642 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -31.87 144.43 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.683 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 134.91 19.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.779 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -55.25 133.07 49.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.6 p -53.3 -31.48 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.33 -7.82 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.029 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 1.83 22.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.677 0.275 . . . . 0.0 111.362 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.8 mt -108.08 152.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.793 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -117.96 84.75 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -58.88 -22.18 58.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -62.05 -25.9 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.22 29.36 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 20.0 m-85 -138.27 -46.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.904 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.865 0.364 . . . . 3.6400000000000001 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -62.4 -58.18 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.9399999999999999 110.919 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.405 ' HB2' ' HD2' ' B' ' 66' ' ' PRO . 0.1 OUTLIER -68.83 157.63 88.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 6.8899999999999997 110.91 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' B' ' 65' ' ' ARG . 57.6 Cg_endo -71.65 174.82 10.45 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.736 2.291 . . . . 0.01 112.608 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -87.95 151.73 7.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.987 2.458 . . . . 0.66000000000000003 112.452 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.06 154.36 37.55 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.614 2.209 . . . . 0.01 112.408 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.3 Cg_endo -59.69 -178.06 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.595 2.197 . . . . 0.01 112.363 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.96 -73.22 2.16 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.728 -0.669 . . . . 0.65000000000000002 112.618 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 45.02 -167.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 4.1699999999999999 111.7 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.09 135.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 6.9500000000000002 110.823 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.205 -0.902 . . . . 5.7400000000000002 111.172 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.786 0.327 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 123.71 20.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.504 ' HB3' HD11 ' A' ' 43' ' ' LEU . 3.4 mtt -81.52 158.15 24.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.528 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 61.3 m95 -145.13 117.0 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 111.787 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 1.8 mt-10 -66.46 171.94 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.316 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -168.56 130.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HE2' ' CD2' ' A' ' 39' ' ' TYR . 11.1 pttt -128.87 127.51 41.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.367 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.25 -55.14 38.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -69.44 146.01 52.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -97.88 40.12 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.524 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.9 p -100.83 -171.61 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.29 41.19 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.634 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -128.79 -3.5 5.25 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 9' ' ' GLU . . . -51.18 178.09 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.848 0.356 . . . . 0.0 111.357 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 8.7 mt-10 -55.14 140.9 36.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.769 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.07 89.69 3.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.243 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' B' ' 69' ' ' PRO . 75.6 m-85 -111.31 -164.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.083 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.629 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.83 23.99 34.02 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.813 -0.708 . . . . 0.0 114.29 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 85.5 Cg_endo -80.01 28.72 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 119.788 1.794 . . . . 0.0 112.031 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -102.93 169.19 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.8 p -72.27 150.86 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.834 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -48.12 -28.99 3.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 110.098 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.67 84.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.469 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 39.8 tp60 -74.79 -33.58 62.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.9 mmm -73.04 -44.48 60.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.475 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 51.9 tp60 -59.91 -40.51 89.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' GLU . 18.5 m -60.92 -52.2 66.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.469 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.8 m0 -62.83 -43.64 98.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' MET . 98.5 t -67.61 -33.25 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.184 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.5 t -89.06 -40.06 13.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.059 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 27' ' ' THR . 11.3 tm-20 -51.48 -28.93 14.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.08 4.31 29.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.832 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -35.82 65.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.327 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -105.35 78.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.535 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.06 -16.82 57.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.641 2.227 . . . . 0.0 112.401 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -113.97 -12.15 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.337 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.52 160.73 36.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -136.84 160.99 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -79.65 87.56 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.184 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 20.5 m -93.08 159.84 15.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.349 0.595 . . . . 0.0 112.134 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -178.85 141.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.305 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -51.69 134.24 30.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 111.338 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.7 mt -59.92 -32.81 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.148 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 6.7 t70 -117.06 114.2 39.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.965 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 64.5 Cg_endo -73.19 149.48 94.22 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.594 -1.419 . . . . 0.0 112.42 -0.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.23 123.04 3.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.674 2.249 . . . . 0.0 112.565 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.36 96.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.505 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.45 -147.8 5.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.845 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.11 74.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.045 0.45 . . . . 0.0 110.791 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.473 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.0 m-85 -44.27 159.88 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.153 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.45 129.64 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.028 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.12 124.53 15.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.41 -34.54 35.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -11.2 60.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.65 2.86 20.49 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.655 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.569 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 20.8 mt -101.41 153.41 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 110.771 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 56' ' ' ILE . 6.1 t0 -115.99 83.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.785 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 81.0 m-85 -56.81 -22.82 39.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -21.26 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.287 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.92 29.24 3.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.09 -62.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.949 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.913 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.831 0.348 . . . . 3.6400000000000001 111.107 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -135.13 62.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 3.9399999999999999 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.36 151.99 63.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 6.8899999999999997 110.972 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.73 174.48 12.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.794 2.33 . . . . 0.01 112.442 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.59 135.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.959 2.439 . . . . 0.66000000000000003 112.408 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.11 156.6 55.5 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.466 2.111 . . . . 0.01 112.188 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 Cg_endo -65.14 -179.21 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.475 2.116 . . . . 0.01 112.264 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.45 -77.38 0.48 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.793 -0.718 . . . . 0.65000000000000002 112.387 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 43.34 -165.26 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.955 0.407 . . . . 4.1699999999999999 111.916 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 174.73 92.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 6.9500000000000002 110.842 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.301 -0.857 . . . . 5.7400000000000002 111.17 -179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.88 0.371 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.35 118.68 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 41.2 mtt -80.89 160.0 24.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.664 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 54.8 m95 -144.79 115.41 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.683 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 3.4 pt-20 -71.39 149.8 45.63 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 3.6 p90 -137.13 140.78 42.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.453 . . . . 0.0 111.564 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.768 ' HD2' ' HB3' ' A' ' 14' ' ' ALA . 28.0 ttpt -131.21 123.41 28.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.832 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -62.48 -57.73 10.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.234 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -100.16 126.07 46.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.2 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -77.56 60.34 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.709 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -111.55 -178.58 3.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.907 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.68 -11.67 61.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -112.27 -18.59 12.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.544 0.211 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . . . -45.23 145.59 1.08 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.786 0.327 . . . . 0.0 111.252 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -58.4 179.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.695 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 89.01 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 54.3 m-85 -107.73 -161.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.95 25.4 29.44 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.224 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 96.8 Cg_endo -77.97 15.0 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 CA-C-N 119.635 1.718 . . . . 0.0 111.647 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -88.18 165.71 14.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.776 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 p -70.85 148.55 47.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -30.14 2.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.38 88.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.458 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.0 tp60 -73.37 -34.0 65.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.566 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.72 ' O ' HG23 ' A' ' 29' ' ' VAL . 36.3 mmm -71.61 -42.68 67.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.43 -43.95 92.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 31' ' ' GLU . 31.7 m -58.0 -53.52 57.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.87 -42.85 99.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.948 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 25' ' ' MET . 87.5 t -66.68 -33.99 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.444 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -30.63 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.3 mm-40 -56.34 -23.06 34.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.21 6.04 42.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.595 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD2' ' HD3' ' B' ' 68' ' ' PRO . 4.4 m-30 -61.81 -28.65 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.626 0.251 . . . . 0.0 111.229 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -114.1 80.75 5.76 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.836 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 33' ' ' TYR . 50.9 Cg_exo -52.85 -27.98 37.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.495 2.13 . . . . 0.0 112.427 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.13 15.13 15.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.074 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 71.36 -164.38 53.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.048 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 37' ' ' GLY . 2.6 m -162.03 161.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.908 0.385 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.446 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -71.09 85.66 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.773 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -93.72 152.22 19.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.808 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -178.75 150.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -58.98 136.05 57.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 21.7 mt -57.39 -47.67 81.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -118.42 120.61 31.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.69 136.95 47.12 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.208 -0.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.41 141.12 19.88 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.501 2.134 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 91.53 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -138.76 2.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.577 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.71 72.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.973 0.416 . . . . 0.0 110.892 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HD2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -47.45 160.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.108 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -159.68 134.02 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -58.13 133.82 55.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 38' ' ' VAL . 18.0 p -54.14 -28.89 42.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 0.8 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 2.11 10.63 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.326 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.664 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 33.1 mt -99.58 153.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -107.63 79.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 m-85 -58.25 -24.29 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.05 -26.85 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.6 28.76 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.048 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.28 -52.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 58' ' ' PHE . 5.0 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.829 0.347 . . . . 3.6400000000000001 111.24 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -137.6 112.21 8.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 3.9399999999999999 110.905 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.07 156.17 72.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.423 . . . . 6.8899999999999997 110.85 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.02 174.94 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.861 2.374 . . . . 0.01 112.631 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.74 140.75 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.858 2.372 . . . . 0.66000000000000003 112.244 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.401 ' HD3' ' CD2' ' A' ' 33' ' ' TYR . 53.1 Cg_endo -69.88 162.67 41.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.484 2.123 . . . . 0.01 112.436 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.454 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 18.0 Cg_endo -62.1 -179.57 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.606 2.204 . . . . 0.01 112.312 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.2 -118.94 5.06 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.843 -0.694 . . . . 0.65000000000000002 112.59 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.31 120.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 4.1699999999999999 110.258 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.586 ' O ' HG13 ' B' ' 73' ' ' VAL . 0.0 OUTLIER -131.04 146.29 52.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 6.9500000000000002 110.797 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.586 HG13 ' O ' ' B' ' 72' ' ' ARG . 3.2 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.252 -0.88 . . . . 5.7400000000000002 111.089 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.749 0.309 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -68.63 116.12 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 52.8 mtt -79.74 160.54 26.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.489 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.539 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 63.1 m95 -144.92 115.65 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 111.853 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.731 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.24 165.95 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -157.05 133.39 9.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.199 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 50' ' ' PHE . 10.8 pttt -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.376 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -60.58 -56.74 17.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.774 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.48 154.89 41.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -98.12 39.74 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 14' ' ' ALA . 3.0 p -112.7 160.42 17.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.73 -3.04 86.36 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.317 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.86 -25.62 8.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.65 0.262 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB2' ' OG1' ' A' ' 11' ' ' THR . . . -45.76 163.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.38 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -49.24 145.08 4.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.731 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -125.83 96.89 4.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.343 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 52.2 m-85 -111.02 -163.49 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.082 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.637 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.82 24.2 33.39 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.23 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 91.1 Cg_endo -79.02 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 CA-C-N 119.714 1.757 . . . . 0.0 111.859 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -101.85 166.33 10.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.4 p -66.44 147.97 52.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.464 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -46.75 -30.67 2.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.82 88.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -70.93 -34.17 71.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.613 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 58.6 mmm -73.96 -43.87 56.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.363 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.23 -36.36 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 55.7 m -66.34 -50.04 64.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.8 m0 -65.74 -44.22 86.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' MET . 87.8 t -65.71 -31.26 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.3 t -91.89 -33.45 14.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.051 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 4.1 mm-40 -57.19 -29.48 63.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.06 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.69 2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -55.29 -27.38 46.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -116.3 81.66 10.95 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.785 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.09 -27.0 53.14 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.548 2.165 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.54 12.19 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.102 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.03 -169.54 52.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.034 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.2 m -159.33 160.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -73.3 90.9 1.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.888 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -90.44 156.37 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.216 0.531 . . . . 0.0 111.95 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -175.2 142.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.752 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -64.17 127.79 32.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 15.5 mt -47.35 -48.86 25.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 20.7 t0 -123.2 120.31 27.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 6.2 Cg_exo -78.59 143.34 71.84 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.076 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -85.72 130.14 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.604 2.203 . . . . 0.0 112.601 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.75 99.84 1.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.26 -155.31 9.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 1.2 mt-30 -66.42 75.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.68 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 41' ' ' ARG . 2.7 m-85 -42.8 158.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.585 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 49' ' ' GLN . 25.4 m-85 -156.1 134.87 11.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.25 138.01 57.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.9 p -53.88 -30.86 47.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -77.97 -3.86 44.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -115.3 2.89 14.11 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.539 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 46.7 mt -106.91 152.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.837 0.351 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.58 ' HB3' HD12 ' A' ' 60' ' ' LEU . 7.9 t0 -113.3 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -65.14 -24.3 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.15 -9.34 58.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 57' ' ' ASP . 40.5 mt -97.14 29.34 3.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -140.19 -51.71 0.49 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.936 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.822 0.344 . . . . 3.6400000000000001 111.181 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -166.28 -41.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 3.9399999999999999 111.051 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' B' ' 66' ' ' PRO . 0.0 OUTLIER -50.83 140.09 20.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 6.8899999999999997 110.829 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.6 Cg_endo -76.87 173.03 15.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.538 2.159 . . . . 0.01 112.694 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' B' ' 68' ' ' PRO . 91.7 Cg_endo -89.85 128.24 1.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.178 2.585 . . . . 0.66000000000000003 112.569 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.46 ' HG3' ' CD2' ' A' ' 28' ' ' TRP . 35.8 Cg_exo -59.43 166.71 7.32 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.412 2.075 . . . . 0.01 112.118 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 14.2 Cg_endo -59.36 -178.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 0.01 112.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.31 -80.42 1.41 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.873 -0.68 . . . . 0.65000000000000002 112.513 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.81 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 4.1699999999999999 111.76 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.81 88.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 6.9500000000000002 110.862 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 73' ' ' VAL . 6.9 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.279 -0.867 . . . . 5.7400000000000002 111.144 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.81 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.0 mtt -126.32 162.59 25.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.573 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 60.4 m95 -145.61 114.35 6.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.848 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.57 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.94 158.82 35.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.082 179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -145.87 136.58 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.742 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 5.4 ttmt -126.51 122.88 36.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.15 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -53.65 -47.03 70.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' A' ' 11' ' ' THR . 4.5 mt-10 -104.45 -176.63 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 39' ' ' TYR . 8.3 m-20 -129.36 38.81 3.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.673 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.3 p -103.84 174.11 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.55 6.02 81.6 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.088 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -117.59 -31.73 5.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.572 0.225 . . . . 0.0 111.005 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.66 142.94 1.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.9 -176.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -146.25 98.66 3.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.013 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 67.1 m-85 -115.77 -163.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.555 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.598 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 87.43 28.35 24.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.049 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.4 Cg_endo -81.24 22.12 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 CA-C-N 119.595 1.698 . . . . 0.0 111.64 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -94.18 165.41 12.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.567 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.1 p -68.51 146.87 52.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.51 -31.29 1.72 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.182 0.515 . . . . 0.0 110.237 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.58 70.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.474 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.43 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 36.2 tp60 -66.83 -36.8 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.7 mmm -68.27 -51.49 44.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 35.8 tp60 -54.19 -32.82 56.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.471 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 37.1 m -64.4 -52.36 58.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.568 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.43 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.2 m0 -64.55 -42.43 95.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 34' ' ' PHE . 98.4 t -64.57 -31.86 55.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.183 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 p -96.85 -31.27 12.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.454 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 16.6 mm-40 -54.37 -33.37 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.262 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.91 -26.25 1.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.484 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -56.09 164.2 1.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 60.4 61.86 3.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.518 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.72 -32.49 36.63 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.674 2.25 . . . . 0.0 112.531 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -115.2 12.63 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.251 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.74 159.81 24.85 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.111 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.83 161.97 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.125 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.81 80.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.27 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.6 m -82.77 145.14 29.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.717 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -169.27 135.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.082 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 4' ' ' TRP . 18.5 mtmt -60.39 136.23 57.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 3' ' ' MET . 10.7 mt -60.24 -67.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.774 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -120.42 138.71 27.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.746 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.89 149.28 87.38 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.478 -0.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.61 153.99 34.74 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.626 2.218 . . . . 0.0 112.352 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.5 -92.9 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.541 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.05 -155.96 22.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.21 67.89 0.81 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.402 0.62 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.57 179.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.24 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.92 132.08 9.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.15 134.54 56.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 p -55.14 -25.96 35.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 4.82 29.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.36 5.34 5.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.563 0.22 . . . . 0.0 111.554 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 24.1 mt -103.13 153.21 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.9 t0 -109.4 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 66.7 m-85 -70.21 -12.95 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.07 -14.58 46.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.475 HD12 ' CB ' ' A' ' 57' ' ' ASP . 81.0 mt -96.09 28.75 3.04 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.869 0.366 . . . . 0.0 111.196 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -140.88 -47.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.912 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.74 0.305 . . . . 3.6400000000000001 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -127.06 -169.33 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 3.9399999999999999 110.971 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.409 ' HB2' ' NH1' ' B' ' 65' ' ' ARG . 0.0 OUTLIER 63.38 137.37 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 6.8899999999999997 110.905 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -86.58 173.25 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.854 2.369 . . . . 0.01 112.674 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.83 150.66 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.266 2.644 . . . . 0.66000000000000003 112.324 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.27 156.87 46.23 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.497 2.131 . . . . 0.01 112.218 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.483 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.3 Cg_endo -58.69 -174.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.447 2.098 . . . . 0.01 112.391 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.96 -65.31 0.89 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.627 -0.715 . . . . 0.65000000000000002 112.58 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 43.2 -164.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 4.1699999999999999 111.813 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.73 119.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 6.9500000000000002 110.849 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.268 -0.872 . . . . 5.7400000000000002 111.086 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.733 0.302 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.05 108.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.409 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.5 mtt -76.49 157.52 32.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.531 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 67.5 m95 -142.76 117.08 9.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.968 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -69.64 166.66 18.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.232 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -159.75 130.56 5.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.081 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.712 ' CD ' ' HB3' ' A' ' 14' ' ' ALA . 18.4 ttpt -120.17 120.91 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.16 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 34' ' ' PHE . 85.1 m95 -56.94 -52.62 64.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB3' HG23 ' A' ' 11' ' ' THR . 5.7 mm-40 -83.03 -177.54 6.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -129.61 37.48 3.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.499 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.8 p -91.21 -167.01 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.69 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.49 -12.9 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.43 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -139.43 11.06 2.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . . . -47.76 167.51 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.654 0.264 . . . . 0.0 111.19 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 2.8 pm0 -49.75 134.41 20.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.912 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.59 107.87 16.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.4 m-85 -133.97 -164.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.553 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 95.52 18.25 33.57 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.872 -0.68 . . . . 0.0 114.337 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 78.3 Cg_endo -77.02 51.59 3.5 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.958 1.879 . . . . 0.0 111.544 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -127.08 166.67 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.52 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -70.55 148.35 48.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -46.57 -30.1 2.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.087 0.47 . . . . 0.0 110.181 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.03 30.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.398 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 42.3 tp60 -61.29 -34.67 75.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 29' ' ' VAL . 39.4 mmm -70.06 -41.25 74.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.445 ' HG2' ' CB ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -58.07 -40.17 80.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.561 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 31' ' ' GLU . 99.2 m -62.55 -60.71 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.446 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 12.4 m0 -55.99 -46.33 78.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' MET . 81.4 t -60.56 -29.61 45.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 m -99.05 -25.65 14.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.356 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.0 tp10 -56.82 -33.36 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.47 -5.39 13.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.735 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.15 -34.8 66.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 110.794 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -107.48 73.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.477 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.18 -19.94 62.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.596 2.197 . . . . 0.0 112.42 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.29 -12.44 11.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.193 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.79 159.4 28.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.809 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.87 160.98 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 79.15 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -78.22 150.34 33.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.542 -179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.6 ttm-85 -179.57 126.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.41 137.85 10.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.5 mt -57.46 -36.93 72.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.285 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 9.6 t70 -118.46 116.38 35.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 72.8 Cg_endo -76.17 144.9 80.93 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.22 -0.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.58 115.07 2.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.536 2.157 . . . . 0.0 112.49 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.32 100.42 1.91 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.691 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.07 -153.67 8.53 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -67.76 74.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 4.3 m-85 -41.73 160.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.417 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.59 131.46 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -55.26 128.33 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.024 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -54.65 -32.23 58.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.82 -4.74 45.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -114.71 3.64 14.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.576 0.227 . . . . 0.0 111.569 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.531 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 58.6 mt -103.3 153.89 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.298 . . . . 0.0 110.97 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 7.0 t0 -100.71 111.95 24.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CB ' ' HG2' ' A' ' 26' ' ' GLN . 88.6 m-85 -95.7 20.36 9.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.984 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -108.45 -23.46 11.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.29 29.35 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 25.8 m-85 -135.2 -48.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.884 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.749 0.309 . . . . 3.6400000000000001 111.157 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -94.26 51.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 3.9399999999999999 110.827 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -90.81 136.77 27.39 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 6.8899999999999997 110.82 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.25 174.83 8.84 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.748 2.299 . . . . 0.01 112.523 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.82 123.1 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.079 2.519 . . . . 0.66000000000000003 112.271 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.91 168.57 20.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.412 2.075 . . . . 0.01 112.296 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 28.9 Cg_endo -65.26 -178.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.451 2.1 . . . . 0.01 112.482 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.37 -67.17 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.866 -0.683 . . . . 0.65000000000000002 112.536 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 42.65 -163.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.932 0.396 . . . . 4.1699999999999999 111.763 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.18 98.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 6.9500000000000002 110.964 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.236 -0.888 . . . . 5.7400000000000002 111.121 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.887 0.375 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.06 110.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 43' ' ' LEU . 18.3 mtt -79.67 163.41 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.565 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.446 ' CZ2' ' HE2' ' A' ' 42' ' ' LYS . 54.4 m95 -148.02 117.13 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.712 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -70.14 163.81 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.0 p90 -152.22 137.23 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 0.0 110.997 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.738 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 10.9 ttmt -126.05 128.13 46.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -58.92 -51.72 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 5.9 mm-40 -90.48 162.08 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -101.05 38.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -104.44 -173.08 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.27 -6.72 36.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.252 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -112.09 -20.89 11.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.49 0.186 . . . . 0.0 111.224 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -44.2 163.05 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.733 0.301 . . . . 0.0 111.608 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 17.0 mm-40 -60.82 139.05 58.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.85 113.03 24.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 72.4 m-85 -133.22 -162.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.419 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.66 28.67 18.36 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.999 -0.62 . . . . 0.0 114.293 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.9 Cg_endo -80.77 23.62 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 119.668 1.734 . . . . 0.0 111.624 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -94.28 165.15 12.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.746 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 p -70.32 148.07 48.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -45.56 -30.88 1.6 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.212 0.529 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.11 -48.29 80.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.531 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 41.3 tp60 -68.89 -34.28 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.628 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 mmm -69.07 -46.29 68.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.279 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.675 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.559 HG22 ' HD3' ' B' ' 65' ' ' ARG . 91.1 m -59.02 -54.88 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.625 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.48 ' CD1' ' HG3' ' B' ' 68' ' ' PRO . 7.0 m0 -59.81 -40.96 90.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' MET . 95.8 t -73.19 -30.57 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.796 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 p -95.43 -31.58 13.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.8 tp10 -57.76 -47.99 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.24 -26.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.773 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -53.37 162.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER 63.48 55.6 1.87 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.31 -22.85 28.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.196 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -114.56 -14.04 12.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.32 158.34 23.99 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.948 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 53' ' ' SER . 13.9 m -130.56 159.93 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -74.49 88.08 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.22 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.2 m -80.94 158.03 25.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.178 0.513 . . . . 0.0 111.754 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HG3' ' CG ' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -179.72 145.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.714 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 18.2 mtmt -73.14 123.12 22.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.253 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.7 mt -42.64 -52.06 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 7.0 t70 -118.84 125.75 27.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 87.8 Cg_endo -80.72 152.47 82.22 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 123.627 -1.405 . . . . 0.0 112.391 -0.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.37 139.64 13.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.76 2.307 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 97.11 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.518 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' ' NH1' ' A' ' 41' ' ' ARG . . . -158.77 -169.46 22.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.866 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -67.06 75.84 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.503 ' CD2' ' CD2' ' A' ' 39' ' ' TYR . 1.5 m-85 -38.92 156.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -156.36 136.17 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -59.16 136.2 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 38' ' ' VAL . 6.5 t -53.27 -31.22 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -6.35 53.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.112 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -1.4 19.7 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 40' ' ' CYS . 39.8 mt -104.96 150.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.634 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -117.89 83.99 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -59.4 -25.56 64.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.5 -22.42 43.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.52 29.09 3.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -139.52 -51.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.907 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.783 0.325 . . . . 3.6400000000000001 111.156 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -100.7 91.11 4.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 3.9399999999999999 110.678 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.559 ' HD3' HG22 ' A' ' 27' ' ' THR . 17.5 ttp-105 -62.93 133.93 95.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 6.8899999999999997 110.934 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.98 175.13 5.12 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.004 2.469 . . . . 0.01 112.889 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' B' ' 68' ' ' PRO . 91.2 Cg_endo -88.68 123.85 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.12 2.547 . . . . 0.66000000000000003 112.619 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 28' ' ' TRP . 32.5 Cg_exo -58.33 142.55 97.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.535 2.157 . . . . 0.01 112.3 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.6 Cg_endo -59.33 -177.71 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.507 2.138 . . . . 0.01 112.399 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.84 -79.29 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.65000000000000002 112.6 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.49 -167.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.861 0.362 . . . . 4.1699999999999999 111.672 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.81 98.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 6.9500000000000002 110.851 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.243 -0.884 . . . . 5.7400000000000002 111.104 179.876 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.35 117.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 33.5 mtt -81.83 156.66 24.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.52 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 52.5 m95 -143.6 115.93 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.352 . . . . 0.0 111.845 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 5.4 pt-20 -71.87 162.79 28.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 6.0 p90 -152.63 135.43 15.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.688 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -123.42 128.7 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -62.04 -54.91 34.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.32 167.05 17.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.13 38.83 1.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -105.77 -172.59 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.965 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.85 -11.7 27.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.153 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -106.66 -21.09 13.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.75 147.5 0.45 Allowed 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.765 0.317 . . . . 0.0 111.58 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.13 135.6 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.171 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.69 147.61 35.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.212 0.529 . . . . 0.0 111.54 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 70.3 m-85 -155.38 -160.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.77 29.66 17.68 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.864 -0.684 . . . . 0.0 114.284 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 90.4 Cg_endo -79.05 17.79 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 119.588 1.694 . . . . 0.0 111.464 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -91.19 166.24 13.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.716 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.9 p -68.46 148.52 50.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.991 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.4 p -47.26 -30.08 2.83 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.206 0.526 . . . . 0.0 110.284 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.37 80.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.2 tp60 -71.11 -33.05 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.9 mmm -72.77 -46.13 54.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.64 -38.0 71.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.395 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' CZ ' ' B' ' 65' ' ' ARG . 38.8 m -63.36 -60.52 3.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.49 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.459 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.1 m0 -53.8 -40.75 66.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.973 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 25' ' ' MET . 77.5 t -69.4 -33.53 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -89.68 -32.15 17.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.2 tp10 -56.46 -44.12 80.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -0.97 6.93 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.825 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -53.95 -33.4 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -105.39 82.15 0.73 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.54 -29.16 83.95 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.589 2.193 . . . . 0.0 112.243 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -115.53 14.75 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.594 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.52 -166.8 54.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.114 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.0 m -160.83 161.78 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 0.0 111.054 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.3 82.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.0 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.5 m -87.01 150.84 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.904 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -179.85 143.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.262 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HE2' ' CE1' ' A' ' 61' ' ' TYR . 10.9 mttt -55.86 131.59 47.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 24.3 mt -49.21 -31.27 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -120.45 119.62 30.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.832 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.66 143.03 74.77 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.68 -1.383 . . . . 0.0 112.29 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.21 119.85 5.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.511 2.14 . . . . 0.0 112.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.76 96.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.22 -148.63 5.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.633 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -67.47 73.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.783 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 2.5 m-85 -45.58 166.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.433 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -151.03 130.4 12.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.69 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -54.95 129.59 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.926 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.4 p -53.45 -32.27 49.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -78.71 -3.35 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -117.56 4.24 12.4 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.518 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.546 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 18.3 mt -101.15 153.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.693 ' HB3' HD12 ' A' ' 60' ' ' LEU . 9.0 t0 -109.48 80.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.001 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -58.14 -22.41 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -75.77 -6.74 52.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 57' ' ' ASP . 25.8 mt -96.48 28.54 3.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 111.062 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.424 ' CE1' ' HE2' ' A' ' 42' ' ' LYS . 98.9 m-85 -146.89 -47.53 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.941 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.772 0.32 . . . . 3.6400000000000001 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -60.27 -69.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 3.9399999999999999 110.849 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.547 ' CZ ' HG21 ' A' ' 27' ' ' THR . 16.8 tpp180 -62.41 139.97 96.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 6.8899999999999997 110.64 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.3 Cg_endo -78.41 172.68 14.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.563 2.175 . . . . 0.01 112.64 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -90.97 117.81 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.157 2.571 . . . . 0.66000000000000003 112.48 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.46 164.49 32.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.01 111.916 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.504 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.2 Cg_endo -60.52 -176.59 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.378 2.052 . . . . 0.01 112.271 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.51 -70.02 0.69 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.63 -0.714 . . . . 0.65000000000000002 112.504 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 43.14 -164.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.92 0.391 . . . . 4.1699999999999999 111.811 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -174.4 124.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 6.9500000000000002 110.956 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.201 -0.904 . . . . 5.7400000000000002 111.166 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.869 0.366 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 119.95 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.434 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . 5.6 mmm -79.64 152.11 30.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 73.9 m95 -144.65 114.84 7.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 111.736 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -70.3 170.58 11.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.353 179.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.87 135.38 8.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.28 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.798 ' HD2' ' HB3' ' A' ' 14' ' ' ALA . 5.4 ttpm? -127.4 129.43 47.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.037 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -58.43 -48.49 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB3' HG23 ' A' ' 11' ' ' THR . 70.5 mm-40 -129.04 131.53 47.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.165 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 49.3 t30 -74.03 62.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 9' ' ' GLU . 5.1 p -117.5 169.72 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.33 -0.87 89.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.221 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -114.41 -30.14 6.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.59 0.233 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.798 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . . . -45.66 151.62 0.4 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.91 0.385 . . . . 0.0 111.53 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.44 -177.73 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -140.73 92.34 2.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.717 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 53.9 m-85 -113.47 -166.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 92.38 28.55 12.75 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.527 -0.596 . . . . 0.0 114.317 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.3 Cg_endo -83.49 25.93 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 CA-C-N 119.788 1.794 . . . . 0.0 111.788 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -99.42 171.03 8.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -71.93 147.47 46.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.929 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -46.66 -30.64 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.285 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.04 -46.9 85.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.559 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.2 tp60 -70.33 -32.72 70.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.623 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.9 mmm -73.75 -47.98 35.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.305 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -56.92 -34.1 67.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.567 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLU . 8.4 m -71.05 -53.21 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.84 -42.05 98.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' MET . 73.8 t -65.38 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.9 m -95.6 -31.33 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.7 mm-40 -55.14 -32.09 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.133 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.16 -0.03 20.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CD2' ' HD2' ' B' ' 68' ' ' PRO . 53.9 m-85 -56.44 -34.47 66.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -109.39 76.38 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.5 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.2 -19.03 65.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.634 2.223 . . . . 0.0 112.408 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -115.85 2.23 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.66 159.33 13.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.982 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.23 160.64 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.957 0.408 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -76.51 87.53 3.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.353 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.69 156.33 19.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 0.0 111.807 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -175.29 127.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.082 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 12.6 mtmt -50.27 135.26 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.281 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt -59.4 -63.16 1.4 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -114.28 137.46 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.43 132.6 27.79 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.857 -1.309 . . . . 0.0 112.18 0.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.74 102.42 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.489 2.126 . . . . 0.0 112.275 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 -81.25 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.533 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 -145.71 7.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.14 69.0 0.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.17 0.51 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 3.3 m-85 -58.62 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.27 129.4 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.76 133.6 56.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -34.97 64.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -68.18 -12.12 60.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.186 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.26 11.98 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.559 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 47.2 mt -109.2 155.34 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.933 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' HB3' HD12 ' A' ' 60' ' ' LEU . 6.7 t0 -113.37 82.24 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -57.51 -22.49 44.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.96 -10.57 59.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.326 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' ASP . 22.6 mt -96.04 28.69 3.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 111.012 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -144.67 -47.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.825 0.345 . . . . 3.6400000000000001 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.06 8.45 29.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 3.9399999999999999 111.265 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.472 ' NE ' HG21 ' A' ' 27' ' ' THR . 2.2 ttm-85 63.09 138.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.764 0.316 . . . . 6.8899999999999997 111.051 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.437 ' HB2' ' HD2' ' B' ' 67' ' ' PRO . 87.2 Cg_endo -83.94 175.75 7.38 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.633 2.222 . . . . 0.01 112.531 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 92.5 Cg_endo -86.83 137.58 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.833 2.355 . . . . 0.66000000000000003 112.227 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 33' ' ' TYR . 40.2 Cg_endo -66.99 162.81 36.42 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.442 2.095 . . . . 0.01 112.232 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.452 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.3 Cg_endo -61.32 -177.65 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.482 2.121 . . . . 0.01 112.273 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.98 -64.85 1.55 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.752 -0.737 . . . . 0.65000000000000002 112.322 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.31 -167.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.067 0.461 . . . . 4.1699999999999999 111.788 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.84 73.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.785 -0.643 . . . . 6.9500000000000002 110.732 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.156 -0.926 . . . . 5.7400000000000002 111.181 -179.899 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.799 0.333 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.58 102.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.424 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.8 mtt -80.09 156.04 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.592 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 53.2 m95 -139.67 117.69 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 111.732 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mt-10 -67.34 169.41 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.707 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -160.8 136.19 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.072 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.62 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 3.0 ttmt -127.7 122.36 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.291 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -55.98 -48.91 74.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.62 -177.08 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.892 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.01 38.27 4.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -110.19 167.92 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.985 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.07 0.44 89.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.138 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.48 -26.16 8.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.645 0.259 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.62 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.67 150.85 0.22 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.595 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.9 mt-10 -59.12 139.93 56.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 107.99 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 74.2 m-85 -126.45 -163.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 91.48 29.89 11.55 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.351 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 75.8 Cg_endo -83.37 26.08 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.882 1.721 . . . . 0.0 111.812 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -96.34 167.51 11.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.842 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 p -69.13 147.02 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.16 -34.04 1.71 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.216 0.532 . . . . 0.0 110.235 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -56.51 20.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.8 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.0 tp60 -58.08 -32.37 68.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.46 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mmm -72.71 -43.09 63.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -38.31 74.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.597 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.762 HG21 ' CZ ' ' B' ' 65' ' ' ARG . 65.5 m -64.81 -60.03 3.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.7 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.7 m0 -55.23 -43.23 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 111.016 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' MET . 77.6 t -65.85 -29.44 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -94.89 -29.71 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.34 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.0 tm-20 -57.61 -44.43 85.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.995 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.39 -3.05 5.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD ' ' B' ' 68' ' ' PRO . 16.1 m-85 -54.43 -32.04 56.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -111.04 78.82 1.76 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -20.15 47.62 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.176 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -116.95 -6.81 11.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.448 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.17 160.23 34.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.28 161.12 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 111.231 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -71.79 81.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.048 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.74 149.12 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 111.93 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -173.71 140.5 0.77 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.804 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 17.9 mttt -57.06 128.17 35.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 3' ' ' MET . 14.8 mt -45.73 -35.76 4.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.404 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -120.0 119.11 31.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.778 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.64 140.18 63.94 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.941 -1.275 . . . . 0.0 112.193 -0.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.73 123.45 4.23 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 0.0 112.422 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.31 99.3 1.25 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.612 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.49 18.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -66.36 74.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.681 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m-85 -44.19 166.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.437 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -140.85 127.6 20.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -57.72 131.72 51.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 p -53.03 -29.11 27.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -79.4 -2.5 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -118.05 3.92 12.08 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.516 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 19.8 mt -101.31 151.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.814 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.48 89.56 3.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.23 -16.28 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.502 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -71.92 -19.98 61.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.512 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.58 29.68 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 111.172 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.448 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 49.9 m-85 -139.59 -46.33 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.077 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.804 0.335 . . . . 3.6400000000000001 111.161 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.18 134.37 31.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 3.9399999999999999 111.006 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.762 ' CZ ' HG21 ' A' ' 27' ' ' THR . 3.7 tpp180 -163.07 141.57 6.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 6.8899999999999997 110.718 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.2 Cg_endo -78.22 174.36 12.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.543 2.162 . . . . 0.01 112.578 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -88.72 111.01 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.064 2.509 . . . . 0.66000000000000003 112.57 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 Cg_exo -56.94 167.51 3.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.41 2.073 . . . . 0.01 112.092 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 20.7 Cg_endo -64.87 179.54 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.267 1.978 . . . . 0.01 112.29 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.01 -78.08 2.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.779 -0.724 . . . . 0.65000000000000002 112.468 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.73 ' CE1' HG12 ' B' ' 73' ' ' VAL . 0.1 OUTLIER 45.91 -166.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.951 0.405 . . . . 4.1699999999999999 111.594 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.84 73.48 0.29 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 6.9500000000000002 110.609 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' B' ' 71' ' ' HIS . 6.1 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.202 -0.904 . . . . 5.7400000000000002 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.3 t0 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 t -67.46 110.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.214 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.538 ' CB ' HD12 ' A' ' 43' ' ' LEU . 15.7 mtp -87.34 145.78 26.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.795 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.775 ' O ' HD21 ' A' ' 43' ' ' LEU . 42.4 m95 -132.53 -172.07 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -147.45 163.16 37.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.022 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -151.98 136.89 17.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.976 0.417 . . . . 0.0 111.176 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.672 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -129.69 128.83 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 31.7 m95 -62.9 -57.38 10.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.74 134.3 50.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' CE1' ' A' ' 39' ' ' TYR . 6.7 m-20 -80.28 58.35 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -116.54 -177.67 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.98 1.83 71.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.16 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -116.8 -28.33 6.37 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.576 0.227 . . . . 0.0 111.146 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.672 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -45.12 144.18 1.37 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 111.44 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.01 -177.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.607 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.404 HD22 ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -143.61 84.44 1.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.201 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 45.0 m-85 -106.85 -175.24 2.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.961 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.26 -16.87 41.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.895 -0.947 . . . . 0.0 115.297 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.5 Cg_exo -40.29 -26.19 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 120.428 2.114 . . . . 0.0 112.985 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.2 m-85 -43.14 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.366 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -66.91 146.57 54.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 5.5 p -47.75 -30.53 3.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.14 0.495 . . . . 0.0 110.221 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.65 92.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.537 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.479 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.0 tp60 -71.23 -30.45 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.5 mmm -73.23 -47.06 46.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.201 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -57.08 -39.63 75.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -62.07 -59.76 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.684 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.479 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.1 m0 -57.2 -44.54 83.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.802 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 25' ' ' MET . 97.0 t -66.99 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.947 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -83.94 -41.65 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.26 -27.84 49.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.77 6.93 30.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.8 m-85 -54.09 -25.95 24.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.283 . . . . 0.0 111.081 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -117.56 80.85 13.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.793 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.69 -19.47 65.28 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.663 2.242 . . . . 0.0 112.531 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.51 -3.76 14.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.43 162.45 29.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.972 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 7.4 m -137.34 161.53 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.955 0.407 . . . . 0.0 111.458 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.01 90.21 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.421 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.622 ' CB ' HD12 ' A' ' 56' ' ' ILE . 1.8 m -88.04 142.23 27.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.81 139.79 11.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 1.5 mtmt -73.42 142.64 46.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.848 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.775 HD21 ' O ' ' A' ' 4' ' ' TRP . 5.6 mt -73.0 -65.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.98 131.25 24.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.4 143.64 76.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.274 0.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.89 137.18 19.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.519 2.146 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.31 -101.1 0.3 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.517 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 179.2 -145.79 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 42.07 70.94 0.24 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.218 0.532 . . . . 0.0 111.593 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -45.06 167.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.24 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -149.05 126.59 11.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -63.04 130.71 45.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -52.06 -28.2 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -7.8 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.97 7.29 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.479 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 51' ' ' TYR . 31.9 mt -104.28 153.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 111.141 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 56' ' ' ILE . 16.1 t70 -118.11 117.53 29.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.667 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -94.46 30.35 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.63 -26.01 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -97.67 29.39 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 42' ' ' LYS . 49.4 m-85 -133.49 -48.23 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.842 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.877 0.37 . . . . 3.6400000000000001 111.16 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -127.76 100.07 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 3.9399999999999999 110.909 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.99 157.75 73.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 6.8899999999999997 110.907 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 174.23 12.04 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 0.01 112.499 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -88.98 136.17 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.016 2.477 . . . . 0.66000000000000003 112.374 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 75.5 Cg_endo -77.4 169.21 21.55 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.42 2.08 . . . . 0.01 112.199 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.89 179.35 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.485 2.123 . . . . 0.01 112.179 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.91 -65.09 1.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.681 -0.771 . . . . 0.65000000000000002 112.388 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 43.33 -165.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.98 0.419 . . . . 4.1699999999999999 111.863 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 177.5 96.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.92 -0.582 . . . . 6.9500000000000002 110.788 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.275 -0.869 . . . . 5.7400000000000002 111.197 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.334 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.07 114.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.461 ' HB2' HD12 ' A' ' 43' ' ' LEU . 2.1 mtt -85.21 142.88 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.772 ' O ' HD21 ' A' ' 43' ' ' LEU . 49.6 m95 -129.78 -170.92 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 2.0 mt-10 -145.37 170.13 16.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.58 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' TYR . 1.3 p90 -168.22 130.54 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 3.2 pttt -126.09 128.7 47.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.205 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 72.4 m95 -63.82 -58.09 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HB3' HG23 ' A' ' 11' ' ' THR . 5.3 mt-10 -86.68 139.25 30.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.119 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -103.05 37.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.681 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.6 p -76.37 -164.25 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.0 3.66 75.09 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 -62.6 0.14 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.694 0.283 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.74 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.027 0.441 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 5.1 mm-40 -89.25 136.31 33.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.151 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.12 102.7 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.451 . . . . 0.0 111.439 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 6' ' ' TYR . 46.4 m-85 -131.11 179.74 5.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.963 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 107.35 -17.01 37.64 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.341 -0.933 . . . . 0.0 115.326 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.3 Cg_exo -40.38 -25.56 0.18 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 CA-C-N 120.235 2.018 . . . . 0.0 113.099 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.0 m-85 -43.01 166.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.328 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -66.89 145.9 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 12.1 t -47.04 -30.2 2.55 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.157 0.503 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.48 88.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.647 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 30.0 tp60 -69.72 -30.71 68.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.581 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.8 mmm -72.96 -46.81 50.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.303 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -59.39 -35.31 73.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.368 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.616 HG21 ' NE ' ' B' ' 65' ' ' ARG . 18.4 m -65.49 -61.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.8 m0 -54.7 -42.83 71.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 25' ' ' MET . 96.8 t -68.52 -33.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.928 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.9 p -84.62 -38.68 19.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.107 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -27.24 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 7.04 32.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.776 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.9 m-85 -54.87 -39.47 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -102.51 94.81 5.34 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 -24.73 30.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.553 2.169 . . . . 0.0 112.555 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.34 15.28 14.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.138 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.54 -176.23 35.67 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.018 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 2.6 m -152.11 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.875 0.369 . . . . 0.0 111.116 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -77.99 87.06 4.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.227 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 57.5 m -91.89 152.57 20.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 111.945 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 9.3 ttp85 -160.72 142.8 12.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.113 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 4.8 mtmt -68.41 146.4 53.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD21 ' O ' ' A' ' 4' ' ' TRP . 3.1 mt -80.09 -63.47 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -113.72 127.71 26.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.801 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.58 142.25 74.2 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.274 -0.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.71 131.49 15.99 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.536 2.158 . . . . 0.0 112.362 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.14 -102.0 0.41 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.559 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.57 -152.62 12.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 47.41 69.33 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.324 0.583 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 2.0 m-85 -44.87 161.65 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.133 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.64 126.86 21.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.927 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.3 134.54 45.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t -57.98 -37.12 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.26 -12.52 56.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.281 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 7.24 27.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 57' ' ' ASP . 51.4 mt -108.97 153.83 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.055 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' CB ' HD12 ' A' ' 60' ' ' LEU . 12.2 t0 -113.35 84.97 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -60.08 -20.98 60.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.256 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.22 -10.11 59.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.574 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 ' CB ' ' A' ' 57' ' ' ASP . 27.3 mt -96.41 28.7 3.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 111.194 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 39.9 m-85 -137.71 -47.42 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.978 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.95 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.794 0.33 . . . . 3.6400000000000001 111.143 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -63.45 -78.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 3.9399999999999999 110.977 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.616 ' NE ' HG21 ' A' ' 27' ' ' THR . 50.5 ttm-85 -142.97 140.13 17.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 6.8899999999999997 110.937 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.92 172.6 8.67 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.826 2.351 . . . . 0.01 112.802 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -91.03 153.15 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.104 2.536 . . . . 0.66000000000000003 112.308 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 81.0 Cg_endo -78.31 155.02 28.66 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.56 2.173 . . . . 0.01 112.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 28.0 Cg_endo -62.16 178.13 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.504 2.136 . . . . 0.01 112.199 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 8' ' ' TRP . . . 81.37 -70.99 2.99 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.685 -0.769 . . . . 0.65000000000000002 112.417 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 43.7 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.991 0.424 . . . . 4.1699999999999999 111.752 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 175.24 108.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.954 -0.566 . . . . 6.9500000000000002 110.796 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.277 -0.868 . . . . 5.7400000000000002 111.128 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.96 122.92 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.1 mmm -81.12 159.43 24.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.577 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 65.7 m95 -147.61 116.8 6.89 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.489 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 5.1 pt-20 -80.8 136.08 36.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.561 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -127.38 137.33 52.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.184 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 39.9 ttmt -126.05 128.49 47.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -59.1 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.065 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.02 140.57 47.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.96 58.44 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.795 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -81.41 -171.59 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.1 65.84 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.893 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -146.68 -59.82 0.29 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.706 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . 47.85 -176.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.093 0.473 . . . . 0.0 111.563 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 9.5 mm-40 -96.2 135.66 37.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 85.07 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 30.2 m-85 -109.29 -171.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.668 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.63 -9.87 41.39 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.057 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.8 Cg_exo -42.18 -26.48 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.431 2.116 . . . . 0.0 112.314 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.05 167.44 0.05 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.851 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -77.9 153.73 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -47.71 -29.58 3.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.073 0.463 . . . . 0.0 110.052 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.89 -57.56 11.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.625 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.3 tp60 -62.37 -37.47 85.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mmm -64.51 -49.85 69.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.659 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -54.12 -36.68 63.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' GLU . 88.2 m -61.11 -59.75 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.632 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -58.13 -46.08 86.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' MET . 94.0 t -57.86 -30.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 t -96.81 -29.29 13.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 14.1 tp10 -55.21 -30.22 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -0.66 26.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -58.83 -32.4 69.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -106.88 75.29 0.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.78 -21.69 69.44 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.86 6.51 15.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.207 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 159.81 10.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.094 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.88 161.5 41.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.836 0.35 . . . . 0.0 111.225 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -75.62 82.11 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.106 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 2.1 m -87.9 151.04 23.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.787 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 8.5 ptm180 179.02 151.76 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.434 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -59.32 135.9 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.872 0.367 . . . . 0.0 110.512 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.6 mt -55.53 -39.69 70.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.27 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.6 124.49 34.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.81 156.49 98.94 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.21 0.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.89 113.3 3.72 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.546 2.164 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.56 96.48 0.52 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.5 -155.14 6.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.847 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -66.61 74.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.939 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.7 m-85 -42.69 158.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.425 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CB ' HD11 ' A' ' 56' ' ' ILE . 3.3 m-85 -142.66 127.3 18.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.712 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -55.84 130.01 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -53.85 -28.3 35.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -2.06 46.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.229 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 4.87 11.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.532 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.466 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 40.1 mt -107.19 153.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 36.6 t0 -104.92 107.85 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -89.54 52.58 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.664 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -145.69 -37.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.299 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.24 28.01 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 24.2 m-85 -127.8 -40.48 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.009 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.914 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.787 0.327 . . . . 3.6400000000000001 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -85.35 -60.09 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.9399999999999999 110.905 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' B' ' 66' ' ' PRO . 0.0 OUTLIER -156.82 137.15 8.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 6.8899999999999997 110.668 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' B' ' 65' ' ' ARG . 92.6 Cg_endo -81.38 175.63 9.44 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.689 2.259 . . . . 0.01 112.562 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 91.0 Cg_endo -88.11 142.73 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.891 2.394 . . . . 0.66000000000000003 112.443 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.29 158.67 40.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.589 2.193 . . . . 0.01 112.246 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' PRO . . . . . 0.436 ' HG2' ' CG ' ' A' ' 17' ' ' TYR . 33.5 Cg_endo -65.85 178.38 2.35 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.383 2.055 . . . . 0.01 112.357 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.02 -74.24 1.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.816 -0.707 . . . . 0.65000000000000002 112.616 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 44.84 -166.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.925 0.393 . . . . 4.1699999999999999 111.825 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.32 134.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 6.9500000000000002 110.799 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.468 HG23 ' OXT' ' B' ' 73' ' ' VAL . 5.5 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.202 -0.904 . . . . 5.7400000000000002 111.104 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.23 108.88 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 mtt -74.65 163.86 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 64.8 m95 -145.49 115.8 7.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.697 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.554 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 8.6 pt-20 -76.2 146.17 39.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 1.5 p90 -133.99 134.82 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.71 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 17.9 ttmm -127.47 126.96 43.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.332 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -56.7 -49.58 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.7 -170.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -132.48 38.68 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.681 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -110.2 179.95 3.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.9 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.44 5.35 85.19 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.127 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.18 -31.63 5.6 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.602 0.239 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.85 152.38 0.17 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.397 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -55.67 -176.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.731 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -159.13 82.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 28.3 m-85 -113.88 -165.91 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.825 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 105.92 -9.45 43.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.357 -0.925 . . . . 0.0 115.036 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 99.7 Cg_exo -42.17 -26.68 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 120.408 2.104 . . . . 0.0 112.362 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.72 161.07 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 p -73.05 152.37 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 15.5 t -47.27 -29.68 2.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.209 0.528 . . . . 0.0 110.259 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.0 64.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.747 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -67.2 -35.4 79.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.634 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.426 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.9 mmm -70.72 -46.87 62.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.277 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -54.42 -37.3 64.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.497 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.0 m -63.8 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -51.31 -41.81 60.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.893 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 25' ' ' MET . 93.6 t -71.08 -31.07 43.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.832 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.75 23.73 13.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.8 tp10 -112.42 -33.87 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.61 -26.57 0.75 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' B' ' 68' ' ' PRO . 32.8 m-85 -64.15 168.04 5.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 55.0 68.02 2.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.753 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -24.36 76.5 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.637 2.225 . . . . 0.0 112.29 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -116.9 -5.93 11.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.45 158.13 30.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.021 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.55 161.25 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 0.0 111.217 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -68.51 83.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.151 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 3.4 m -91.66 146.38 23.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.724 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -179.06 147.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.538 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.62 131.11 49.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.412 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt -49.38 -33.27 13.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.086 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -120.41 127.52 26.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 98.8 Cg_endo -78.77 139.29 53.45 Favored 'Cis proline' 0 C--N 1.349 0.558 0 C-N-CA 123.596 -1.419 . . . . 0.0 112.328 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 32.4 Cg_exo -59.37 125.3 17.6 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.465 2.11 . . . . 0.0 112.268 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.65 92.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.585 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.12 -151.43 5.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.643 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -67.77 73.62 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -45.27 166.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.058 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -162.15 134.12 5.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.966 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.64 137.92 57.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.5 p -53.79 -30.68 45.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.976 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -78.81 -3.91 46.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.33 4.07 13.41 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.626 0.251 . . . . 0.0 111.459 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.554 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 30.1 mt -106.46 153.25 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.3 t0 -116.49 82.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -57.5 -24.04 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -74.91 -14.72 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 57' ' ' ASP . 56.8 mt -96.44 29.02 3.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.99 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -139.39 -47.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.954 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.868 0.366 . . . . 3.6400000000000001 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -113.12 38.93 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 3.9399999999999999 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HD2' ' CD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -156.97 135.78 7.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.399 . . . . 6.8899999999999997 110.927 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' B' ' 67' ' ' PRO . 92.1 Cg_endo -87.18 176.54 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.065 2.51 . . . . 0.01 112.392 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 83.4 Cg_endo -87.02 125.36 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.8 2.333 . . . . 0.66000000000000003 112.256 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 33' ' ' TYR . 43.9 Cg_endo -68.02 165.03 29.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.43 2.087 . . . . 0.01 112.35 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.76 -179.37 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.222 . . . . 0.01 112.385 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.56 -65.73 1.06 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.867 -0.682 . . . . 0.65000000000000002 112.476 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 43.01 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.932 0.396 . . . . 4.1699999999999999 111.81 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 178.46 124.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 6.9500000000000002 110.764 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.259 -0.877 . . . . 5.7400000000000002 111.16 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.824 0.345 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.45 ' HB3' HD11 ' A' ' 43' ' ' LEU . 24.3 mtt -78.12 160.79 27.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.558 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 59.4 m95 -144.23 116.63 8.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.572 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.482 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.9 mt-10 -68.21 165.34 18.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 1.3 p90 -154.07 132.8 12.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.7 125.84 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -56.49 -46.62 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 6.7 mt-10 . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.0 0.428 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -109.91 107.84 17.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.018 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 55.3 m-85 -130.84 -163.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.581 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.43 28.74 18.79 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.011 -0.614 . . . . 0.0 114.356 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 93.4 Cg_endo -82.16 25.76 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.907 1.738 . . . . 0.0 111.924 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -99.34 166.26 11.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.894 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.3 p -69.15 150.01 48.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.819 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.7 -30.28 2.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.134 0.493 . . . . 0.0 110.148 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.14 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.541 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 31.2 tp60 -65.99 -36.64 83.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.705 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.4 mmm -67.1 -44.29 80.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.536 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.84 -38.61 75.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLU . 84.9 m -60.65 -57.77 11.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.2 m0 -62.2 -45.26 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' MET . 58.5 t -65.73 -34.83 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.285 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -88.61 -35.05 17.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' THR . 3.4 mm-40 -55.67 -30.09 60.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.099 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.3 2.6 24.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 0.3 OUTLIER -55.09 -34.56 63.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.847 0.356 . . . . 0.0 110.819 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -108.51 81.06 1.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.42 -17.16 49.04 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.701 2.268 . . . . 0.0 112.514 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.26 -8.76 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.294 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 158.94 35.14 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.005 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.97 160.95 42.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.993 0.425 . . . . 0.0 111.452 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -70.11 85.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.413 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.7 m -83.32 143.88 30.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.469 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -170.4 137.41 1.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -59.55 132.54 54.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.588 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.0 mt . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.392 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 4.0 m-85 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.54 137.6 19.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.05 136.85 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.802 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -54.88 -30.78 58.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -8.34 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -107.81 2.73 23.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.558 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.7 mt -109.06 153.11 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -118.45 87.02 2.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -60.4 -24.04 64.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -62.61 -21.85 65.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 37.1 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.607 0.169 . . . . 0.01 111.848 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.474 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.1 Cg_endo -61.42 -179.44 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.355 2.037 . . . . 0.01 112.171 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 C-N-CA 120.707 -0.759 . . . . 0.65 112.453 179.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.832 0.349 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.7 mtt -78.75 153.33 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.527 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 68.7 m95 -140.73 115.13 9.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.956 0.407 . . . . 0.0 111.691 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -66.4 170.81 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.487 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -161.87 135.09 6.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -129.68 129.0 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.055 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -62.87 -57.39 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.17 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.4 mp0 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.948 0.404 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -110.02 94.91 5.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 67.0 m-85 -114.3 -166.1 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.459 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 93.32 27.59 13.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.993 -0.622 . . . . 0.0 114.466 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.1 Cg_endo -82.56 27.46 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.719 1.76 . . . . 0.0 111.753 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.5 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -98.7 167.52 10.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.98 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.7 p -70.15 149.81 47.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.91 -30.54 2.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.21 0.528 . . . . 0.0 110.148 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.65 86.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.76 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.5 tp60 -71.44 -31.7 67.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.839 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 mmm -75.16 -49.85 18.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.35 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.52 -33.08 69.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.399 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLU . 92.4 m -68.53 -51.5 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.476 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.4 m0 -63.2 -40.69 98.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' MET . 95.1 t -70.81 -30.98 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.253 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 p -95.11 -31.37 13.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.589 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.2 mm-40 -56.21 -46.16 79.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 110.982 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.63 -25.55 0.44 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -54.88 160.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.796 0.331 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 62.9 62.38 1.86 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.574 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.89 -23.79 17.2 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.582 2.188 . . . . 0.0 112.596 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.69 -4.51 10.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.468 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.65 160.31 34.1 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.883 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.96 160.36 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.964 0.412 . . . . 0.0 111.419 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.27 83.97 0.55 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.512 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -84.33 155.27 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.908 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 5.3 ptm180 -178.28 138.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -62.13 125.39 23.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.983 0.42 . . . . 0.0 110.547 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 14.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.683 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 134.91 19.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.779 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -55.25 133.07 49.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.6 p -53.3 -31.48 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.33 -7.82 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.029 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 1.83 22.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.677 0.275 . . . . 0.0 111.362 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.8 mt -108.08 152.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.793 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -117.96 84.75 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -58.88 -22.18 58.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -62.05 -25.9 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.162 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.464 -0.249 0 CA-C-O 120.673 0.197 . . . . 0.01 112.408 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 16.3 Cg_endo -59.69 -178.06 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.595 2.197 . . . . 0.01 112.363 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.507 0 CA-C-N 115.728 -0.669 . . . . 0.65 112.618 179.7 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 120.762 0.315 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.504 ' HB3' HD11 ' A' ' 43' ' ' LEU . 3.4 mtt -81.52 158.15 24.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.528 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 61.3 m95 -145.13 117.0 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 111.787 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 1.8 mt-10 -66.46 171.94 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.316 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -168.56 130.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HE2' ' CD2' ' A' ' 39' ' ' TYR . 11.1 pttt -128.87 127.51 41.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.367 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.25 -55.14 38.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 8.7 mt-10 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.07 89.69 3.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.243 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' B' ' 69' ' ' PRO . 75.6 m-85 -111.31 -164.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.083 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.629 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.83 23.99 34.02 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.813 -0.708 . . . . 0.0 114.29 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 85.5 Cg_endo -80.01 28.72 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 119.788 1.794 . . . . 0.0 112.031 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -102.93 169.19 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.8 p -72.27 150.86 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.834 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -48.12 -28.99 3.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 110.098 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.67 84.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.469 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 39.8 tp60 -74.79 -33.58 62.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.9 mmm -73.04 -44.48 60.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.475 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 51.9 tp60 -59.91 -40.51 89.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' GLU . 18.5 m -60.92 -52.2 66.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.469 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.8 m0 -62.83 -43.64 98.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' MET . 98.5 t -67.61 -33.25 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.184 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.5 t -89.06 -40.06 13.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.059 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 27' ' ' THR . 11.3 tm-20 -51.48 -28.93 14.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.08 4.31 29.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.832 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -35.82 65.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.327 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -105.35 78.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.535 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.06 -16.82 57.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.641 2.227 . . . . 0.0 112.401 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -113.97 -12.15 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.337 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.52 160.73 36.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -136.84 160.99 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -79.65 87.56 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.184 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 20.5 m -93.08 159.84 15.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.349 0.595 . . . . 0.0 112.134 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -178.85 141.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.305 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -51.69 134.24 30.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 111.338 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.7 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.148 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.473 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.0 m-85 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.691 0.281 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.45 129.64 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.028 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.12 124.53 15.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.41 -34.54 35.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -11.2 60.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.65 2.86 20.49 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.655 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.569 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 20.8 mt -101.41 153.41 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 110.771 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 56' ' ' ILE . 6.1 t0 -115.99 83.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.785 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 81.0 m-85 -56.81 -22.82 39.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -21.26 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.287 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 -179.956 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.558 0.149 . . . . 0.01 112.188 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 Cg_endo -65.14 -179.21 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.475 2.116 . . . . 0.01 112.264 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 C-N-CA 120.793 -0.718 . . . . 0.65 112.387 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.844 0.354 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 41.2 mtt -80.89 160.0 24.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.664 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 54.8 m95 -144.79 115.41 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.683 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 3.4 pt-20 -71.39 149.8 45.63 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 3.6 p90 -137.13 140.78 42.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.453 . . . . 0.0 111.564 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -131.21 123.41 28.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.832 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -62.48 -57.73 10.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.234 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.2 -179.474 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 89.01 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 54.3 m-85 -107.73 -161.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.95 25.4 29.44 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.224 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 96.8 Cg_endo -77.97 15.0 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 CA-C-N 119.635 1.718 . . . . 0.0 111.647 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -88.18 165.71 14.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.776 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 p -70.85 148.55 47.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -30.14 2.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.38 88.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.458 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.0 tp60 -73.37 -34.0 65.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.566 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.72 ' O ' HG23 ' A' ' 29' ' ' VAL . 36.3 mmm -71.61 -42.68 67.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.43 -43.95 92.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 31' ' ' GLU . 31.7 m -58.0 -53.52 57.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.87 -42.85 99.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.948 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 25' ' ' MET . 87.5 t -66.68 -33.99 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.444 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -30.63 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.3 mm-40 -56.34 -23.06 34.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.21 6.04 42.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.595 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD2' ' HD3' ' B' ' 68' ' ' PRO . 4.4 m-30 -61.81 -28.65 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.626 0.251 . . . . 0.0 111.229 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -114.1 80.75 5.76 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.836 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 33' ' ' TYR . 50.9 Cg_exo -52.85 -27.98 37.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.495 2.13 . . . . 0.0 112.427 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.13 15.13 15.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.074 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 71.36 -164.38 53.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.048 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 37' ' ' GLY . 2.6 m -162.03 161.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.908 0.385 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.446 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -71.09 85.66 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.773 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -93.72 152.22 19.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.808 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -178.75 150.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -58.98 136.05 57.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 21.7 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HD2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -159.68 134.02 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -58.13 133.82 55.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 38' ' ' VAL . 18.0 p -54.14 -28.89 42.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 0.8 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 2.11 10.63 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.326 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.664 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 33.1 mt -99.58 153.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -107.63 79.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -58.25 -24.29 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.05 -26.85 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.048 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.401 ' HD3' ' CD2' ' A' ' 33' ' ' TYR . 53.1 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 CA-C-O 120.746 0.227 . . . . 0.01 112.436 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.454 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 18.0 Cg_endo -62.1 -179.57 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.606 2.204 . . . . 0.01 112.312 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 C-N-CA 120.843 -0.694 . . . . 0.65 112.59 179.773 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.768 0.318 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 52.8 mtt -79.74 160.54 26.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.489 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.539 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 63.1 m95 -144.92 115.65 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 111.853 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.731 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.24 165.95 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -157.05 133.39 9.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.199 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 50' ' ' PHE . 10.8 pttt -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.376 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -60.58 -56.74 17.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.774 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.731 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -125.83 96.89 4.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.343 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 52.2 m-85 -111.02 -163.49 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.082 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.637 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.82 24.2 33.39 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.23 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 91.1 Cg_endo -79.02 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 CA-C-N 119.714 1.757 . . . . 0.0 111.859 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -101.85 166.33 10.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.4 p -66.44 147.97 52.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.464 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -46.75 -30.67 2.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.82 88.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -70.93 -34.17 71.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.613 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 58.6 mmm -73.96 -43.87 56.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.363 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.23 -36.36 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 55.7 m -66.34 -50.04 64.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.8 m0 -65.74 -44.22 86.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' MET . 87.8 t -65.71 -31.26 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.3 t -91.89 -33.45 14.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.051 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 4.1 mm-40 -57.19 -29.48 63.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.06 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.69 2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -55.29 -27.38 46.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -116.3 81.66 10.95 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.785 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.09 -27.0 53.14 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.548 2.165 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.54 12.19 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.102 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.03 -169.54 52.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.034 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.2 m -159.33 160.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -73.3 90.9 1.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.888 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -90.44 156.37 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.216 0.531 . . . . 0.0 111.95 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -175.2 142.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.752 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -64.17 127.79 32.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 15.5 mt . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 41' ' ' ARG . 2.7 m-85 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.889 0.376 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -156.1 134.87 11.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.25 138.01 57.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.9 p -53.88 -30.86 47.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -77.97 -3.86 44.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -115.3 2.89 14.11 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.539 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 46.7 mt -106.91 152.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.837 0.351 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.58 ' HB3' HD12 ' A' ' 60' ' ' LEU . 7.9 t0 -113.3 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -65.14 -24.3 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.15 -9.34 58.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 57' ' ' ASP . 40.5 mt . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.46 ' HG3' ' CD2' ' A' ' 28' ' ' TRP . 35.8 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.684 0.202 . . . . 0.01 112.118 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 14.2 Cg_endo -59.36 -178.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 0.01 112.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 C-N-CA 120.873 -0.68 . . . . 0.65 112.513 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.873 0.368 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.0 mtt -126.32 162.59 25.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.573 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 60.4 m95 -145.61 114.35 6.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.848 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.57 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.94 158.82 35.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.082 179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -145.87 136.58 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.51 122.88 36.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.15 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -53.65 -47.03 70.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.918 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.907 0.384 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -146.25 98.66 3.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.013 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 67.1 m-85 -115.77 -163.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.555 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.598 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 87.43 28.35 24.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.049 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.4 Cg_endo -81.24 22.12 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 CA-C-N 119.595 1.698 . . . . 0.0 111.64 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -94.18 165.41 12.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.567 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.1 p -68.51 146.87 52.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.51 -31.29 1.72 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.182 0.515 . . . . 0.0 110.237 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.58 70.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.474 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.43 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 36.2 tp60 -66.83 -36.8 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.7 mmm -68.27 -51.49 44.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 35.8 tp60 -54.19 -32.82 56.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.471 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 37.1 m -64.4 -52.36 58.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.568 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.43 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.2 m0 -64.55 -42.43 95.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 34' ' ' PHE . 98.4 t -64.57 -31.86 55.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.183 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 p -96.85 -31.27 12.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.454 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 16.6 mm-40 -54.37 -33.37 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.262 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.91 -26.25 1.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.484 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -56.09 164.2 1.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 60.4 61.86 3.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.518 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.72 -32.49 36.63 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.674 2.25 . . . . 0.0 112.531 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -115.2 12.63 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.251 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.74 159.81 24.85 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.111 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.83 161.97 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.125 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.81 80.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.27 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.6 m -82.77 145.14 29.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.717 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -169.27 135.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.082 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 4' ' ' TRP . 18.5 mtmt -60.39 136.23 57.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 3' ' ' MET . 10.7 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.774 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.708 0.289 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.92 132.08 9.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.15 134.54 56.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 p -55.14 -25.96 35.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 4.82 29.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.36 5.34 5.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.563 0.22 . . . . 0.0 111.554 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 24.1 mt -103.13 153.21 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.9 t0 -109.4 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 66.7 m-85 -70.21 -12.95 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.07 -14.58 46.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.475 HD12 ' CB ' ' A' ' 57' ' ' ASP . 81.0 mt . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.869 0.366 . . . . 0.0 111.196 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 CA-C-O 120.575 0.156 . . . . 0.01 112.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.483 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.3 Cg_endo -58.69 -174.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.447 2.098 . . . . 0.01 112.391 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 115.627 -0.715 . . . . 0.65 112.58 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.778 0.323 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.409 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.5 mtt -76.49 157.52 32.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.531 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 67.5 m95 -142.76 117.08 9.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.968 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -69.64 166.66 18.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.232 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -159.75 130.56 5.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.081 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -120.17 120.91 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.16 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 34' ' ' PHE . 85.1 m95 -56.94 -52.62 64.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 2.8 pm0 . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 121.002 0.43 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.59 107.87 16.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.4 m-85 -133.97 -164.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.553 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 95.52 18.25 33.57 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.872 -0.68 . . . . 0.0 114.337 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 78.3 Cg_endo -77.02 51.59 3.5 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.958 1.879 . . . . 0.0 111.544 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -127.08 166.67 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.52 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -70.55 148.35 48.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -46.57 -30.1 2.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.087 0.47 . . . . 0.0 110.181 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.03 30.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.398 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 42.3 tp60 -61.29 -34.67 75.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 29' ' ' VAL . 39.4 mmm -70.06 -41.25 74.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.445 ' HG2' ' CB ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -58.07 -40.17 80.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.561 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 31' ' ' GLU . 99.2 m -62.55 -60.71 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.446 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 12.4 m0 -55.99 -46.33 78.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' MET . 81.4 t -60.56 -29.61 45.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 m -99.05 -25.65 14.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.356 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.0 tp10 -56.82 -33.36 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.47 -5.39 13.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.735 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.15 -34.8 66.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 110.794 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -107.48 73.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.477 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.18 -19.94 62.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.596 2.197 . . . . 0.0 112.42 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.29 -12.44 11.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.193 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.79 159.4 28.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.809 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.87 160.98 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 79.15 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -78.22 150.34 33.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.542 -179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.6 ttm-85 -179.57 126.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.41 137.85 10.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.5 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.285 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 4.3 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.72 0.295 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.59 131.46 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -55.26 128.33 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.024 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -54.65 -32.23 58.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.82 -4.74 45.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -114.71 3.64 14.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.576 0.227 . . . . 0.0 111.569 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.531 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 58.6 mt -103.3 153.89 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.298 . . . . 0.0 110.97 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 56' ' ' ILE . 7.0 t0 -100.71 111.95 24.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CB ' ' HG2' ' A' ' 26' ' ' GLN . 88.6 m-85 -95.7 20.36 9.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.984 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -108.45 -23.46 11.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.95 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.232 0.199 0 CA-C-O 120.642 0.184 . . . . 0.01 112.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 28.9 Cg_endo -65.26 -178.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.451 2.1 . . . . 0.01 112.482 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 C-N-CA 120.866 -0.683 . . . . 0.65 112.536 179.835 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 43' ' ' LEU . 18.3 mtt -79.67 163.41 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.565 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.446 ' CZ2' ' HE2' ' A' ' 42' ' ' LYS . 54.4 m95 -148.02 117.13 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.712 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -70.14 163.81 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.0 p90 -152.22 137.23 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 0.0 110.997 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 10.9 ttmt -126.05 128.13 46.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -58.92 -51.72 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.773 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 17.0 mm-40 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.981 0.42 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.85 113.03 24.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 72.4 m-85 -133.22 -162.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.419 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.66 28.67 18.36 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.999 -0.62 . . . . 0.0 114.293 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.9 Cg_endo -80.77 23.62 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 119.668 1.734 . . . . 0.0 111.624 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -94.28 165.15 12.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.746 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 p -70.32 148.07 48.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -45.56 -30.88 1.6 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.212 0.529 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.11 -48.29 80.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.531 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 41.3 tp60 -68.89 -34.28 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.628 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 mmm -69.07 -46.29 68.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.279 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.675 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.1 m -59.02 -54.88 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.625 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.48 ' CD1' ' HG3' ' B' ' 68' ' ' PRO . 7.0 m0 -59.81 -40.96 90.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' MET . 95.8 t -73.19 -30.57 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.796 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 p -95.43 -31.58 13.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.8 tp10 -57.76 -47.99 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.24 -26.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.773 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -53.37 162.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER 63.48 55.6 1.87 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.31 -22.85 28.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.196 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -114.56 -14.04 12.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.32 158.34 23.99 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.948 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 53' ' ' SER . 13.9 m -130.56 159.93 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -74.49 88.08 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.22 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.2 m -80.94 158.03 25.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.178 0.513 . . . . 0.0 111.754 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HG3' ' CG ' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -179.72 145.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.714 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 18.2 mtmt -73.14 123.12 22.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.253 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.7 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.503 ' CD2' ' CD2' ' A' ' 39' ' ' TYR . 1.5 m-85 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -156.36 136.17 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -59.16 136.2 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 38' ' ' VAL . 6.5 t -53.27 -31.22 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -6.35 53.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.112 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -1.4 19.7 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 40' ' ' CYS . 39.8 mt -104.96 150.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.634 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -117.89 83.99 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -59.4 -25.56 64.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.5 -22.42 43.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 28' ' ' TRP . 32.5 Cg_exo . . . . . 0 C--O 1.232 0.205 0 CA-C-O 120.618 0.174 . . . . 0.01 112.3 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.6 Cg_endo -59.33 -177.71 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.507 2.138 . . . . 0.01 112.399 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.65 112.6 179.671 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.638 0.256 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 33.5 mtt -81.83 156.66 24.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.52 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 52.5 m95 -143.6 115.93 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.352 . . . . 0.0 111.845 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 5.4 pt-20 -71.87 162.79 28.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 6.0 p90 -152.63 135.43 15.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.42 128.7 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.05 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -62.04 -54.91 34.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.69 147.61 35.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.212 0.529 . . . . 0.0 111.54 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 70.3 m-85 -155.38 -160.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.77 29.66 17.68 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.864 -0.684 . . . . 0.0 114.284 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 90.4 Cg_endo -79.05 17.79 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 119.588 1.694 . . . . 0.0 111.464 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -91.19 166.24 13.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.716 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.9 p -68.46 148.52 50.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.991 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.4 p -47.26 -30.08 2.83 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.206 0.526 . . . . 0.0 110.284 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.37 80.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.2 tp60 -71.11 -33.05 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.9 mmm -72.77 -46.13 54.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.64 -38.0 71.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.395 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' GLU . 38.8 m -63.36 -60.52 3.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.49 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.459 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.1 m0 -53.8 -40.75 66.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.973 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 25' ' ' MET . 77.5 t -69.4 -33.53 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -89.68 -32.15 17.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.2 tp10 -56.46 -44.12 80.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -0.97 6.93 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.825 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -53.95 -33.4 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -105.39 82.15 0.73 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.54 -29.16 83.95 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.589 2.193 . . . . 0.0 112.243 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -115.53 14.75 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.594 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.52 -166.8 54.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.114 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.0 m -160.83 161.78 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 0.0 111.054 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.3 82.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.0 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.5 m -87.01 150.84 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.904 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -179.85 143.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.262 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HG2' ' CZ2' ' A' ' 4' ' ' TRP . 10.9 mttt -55.86 131.59 47.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 24.3 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.068 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.451 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 2.5 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.888 0.375 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -151.03 130.4 12.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.69 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -54.95 129.59 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.926 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.4 p -53.45 -32.27 49.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -78.71 -3.35 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -117.56 4.24 12.4 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.518 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.546 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 18.3 mt -101.15 153.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.693 ' HB3' HD12 ' A' ' 60' ' ' LEU . 9.0 t0 -109.48 80.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.001 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -58.14 -22.41 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -75.77 -6.74 52.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 57' ' ' ASP . 25.8 mt . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 111.062 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.596 0.165 . . . . 0.01 111.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.504 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.2 Cg_endo -60.52 -176.59 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.378 2.052 . . . . 0.01 112.271 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 CA-C-N 115.63 -0.714 . . . . 0.65 112.504 179.792 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.779 0.323 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.434 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . 5.6 mmm -79.64 152.11 30.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 73.9 m95 -144.65 114.84 7.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 111.736 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -70.3 170.58 11.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.353 179.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.87 135.38 8.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.28 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -127.4 129.43 47.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.037 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -58.43 -48.49 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.165 -179.696 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -140.73 92.34 2.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.717 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 53.9 m-85 -113.47 -166.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 92.38 28.55 12.75 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.527 -0.596 . . . . 0.0 114.317 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.3 Cg_endo -83.49 25.93 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 CA-C-N 119.788 1.794 . . . . 0.0 111.788 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -99.42 171.03 8.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -71.93 147.47 46.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.929 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -46.66 -30.64 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.285 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.04 -46.9 85.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.559 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.2 tp60 -70.33 -32.72 70.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.623 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.9 mmm -73.75 -47.98 35.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.305 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -56.92 -34.1 67.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.567 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLU . 8.4 m -71.05 -53.21 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.84 -42.05 98.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' MET . 73.8 t -65.38 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.9 m -95.6 -31.33 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.7 mm-40 -55.14 -32.09 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.133 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.16 -0.03 20.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CD2' ' HD2' ' B' ' 68' ' ' PRO . 53.9 m-85 -56.44 -34.47 66.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -109.39 76.38 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.5 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.2 -19.03 65.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.634 2.223 . . . . 0.0 112.408 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -115.85 2.23 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.66 159.33 13.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.982 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.23 160.64 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.957 0.408 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 87.53 3.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.353 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.69 156.33 19.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 0.0 111.807 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -175.29 127.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.082 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 12.6 mtmt -50.27 135.26 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.281 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 3.3 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.764 0.316 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.27 129.4 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.76 133.6 56.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -34.97 64.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -68.18 -12.12 60.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.186 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.26 11.98 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.559 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 47.2 mt -109.2 155.34 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.933 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' HB3' HD12 ' A' ' 60' ' ' LEU . 6.7 t0 -113.37 82.24 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -57.51 -22.49 44.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.96 -10.57 59.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.326 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' ASP . 22.6 mt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 111.012 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 33' ' ' TYR . 40.2 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.704 0.21 . . . . 0.01 112.232 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.452 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.3 Cg_endo -61.32 -177.65 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.482 2.121 . . . . 0.01 112.273 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 C-N-CA 120.752 -0.737 . . . . 0.65 112.322 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.74 0.305 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.424 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.8 mtt -80.09 156.04 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.592 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 53.2 m95 -139.67 117.69 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 111.732 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mt-10 -67.34 169.41 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.707 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -160.8 136.19 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.072 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -127.7 122.36 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.291 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -55.98 -48.91 74.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.892 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.9 mt-10 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 107.99 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 74.2 m-85 -126.45 -163.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 91.48 29.89 11.55 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.351 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 75.8 Cg_endo -83.37 26.08 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.882 1.721 . . . . 0.0 111.812 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -96.34 167.51 11.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.842 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 p -69.13 147.02 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -44.16 -34.04 1.71 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.216 0.532 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -56.51 20.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.8 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.0 tp60 -58.08 -32.37 68.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.46 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mmm -72.71 -43.09 63.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -57.58 -38.31 74.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 65.5 m -64.81 -60.03 3.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.7 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.7 m0 -55.23 -43.23 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 111.016 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' MET . 77.6 t -65.85 -29.44 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -94.89 -29.71 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.34 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.0 tm-20 -57.61 -44.43 85.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.995 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.39 -3.05 5.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD ' ' B' ' 68' ' ' PRO . 16.1 m-85 -54.43 -32.04 56.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -111.04 78.82 1.76 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -20.15 47.62 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.176 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -116.95 -6.81 11.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.448 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.17 160.23 34.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.28 161.12 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 111.231 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -71.79 81.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.048 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.74 149.12 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 111.93 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -173.71 140.5 0.77 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.804 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 17.9 mttt -57.06 128.17 35.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 3' ' ' MET . 14.8 mt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.404 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m-85 . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -140.85 127.6 20.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -57.72 131.72 51.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 p -53.03 -29.11 27.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -79.4 -2.5 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -118.05 3.92 12.08 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.516 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 19.8 mt -101.31 151.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.814 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.48 89.56 3.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.23 -16.28 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.502 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -71.92 -19.98 61.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.512 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 111.172 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 Cg_exo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.677 0.199 . . . . 0.01 112.092 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 20.7 Cg_endo -64.87 179.54 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.267 1.978 . . . . 0.01 112.29 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.779 -0.724 . . . . 0.65 112.468 179.839 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.848 0.356 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.538 ' CB ' HD12 ' A' ' 43' ' ' LEU . 15.7 mtp -87.34 145.78 26.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.795 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.775 ' O ' HD21 ' A' ' 43' ' ' LEU . 42.4 m95 -132.53 -172.07 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -147.45 163.16 37.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.022 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -151.98 136.89 17.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.976 0.417 . . . . 0.0 111.176 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HE3' HD22 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -129.69 128.83 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 31.7 m95 -62.9 -57.38 10.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.866 0.365 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.404 HD22 ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -143.61 84.44 1.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.201 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 45.0 m-85 -106.85 -175.24 2.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.961 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.26 -16.87 41.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.895 -0.947 . . . . 0.0 115.297 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.5 Cg_exo -40.29 -26.19 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 120.428 2.114 . . . . 0.0 112.985 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.2 m-85 -43.14 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.366 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -66.91 146.57 54.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 5.5 p -47.75 -30.53 3.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.14 0.495 . . . . 0.0 110.221 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.65 92.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.537 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.479 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.0 tp60 -71.23 -30.45 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.5 mmm -73.23 -47.06 46.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.201 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -57.08 -39.63 75.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -62.07 -59.76 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.684 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.479 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.1 m0 -57.2 -44.54 83.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.802 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 25' ' ' MET . 97.0 t -66.99 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.947 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -83.94 -41.65 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.26 -27.84 49.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.77 6.93 30.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.8 m-85 -54.09 -25.95 24.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.283 . . . . 0.0 111.081 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.486 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -117.56 80.85 13.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.793 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.69 -19.47 65.28 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.663 2.242 . . . . 0.0 112.531 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.51 -3.76 14.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.43 162.45 29.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.972 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 7.4 m -137.34 161.53 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.955 0.407 . . . . 0.0 111.458 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.01 90.21 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.421 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.622 ' CB ' HD12 ' A' ' 56' ' ' ILE . 1.8 m -88.04 142.23 27.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.81 139.79 11.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 1.5 mtmt -73.42 142.64 46.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.848 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.775 HD21 ' O ' ' A' ' 4' ' ' TRP . 5.6 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.797 0.332 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -149.05 126.59 11.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -63.04 130.71 45.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -52.06 -28.2 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -7.8 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.97 7.29 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.479 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 51' ' ' TYR . 31.9 mt -104.28 153.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 111.141 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 56' ' ' ILE . 16.1 t70 -118.11 117.53 29.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.667 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -94.46 30.35 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.63 -26.01 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.972 -179.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 75.5 Cg_endo . . . . . 0 N--CA 1.464 -0.206 0 CA-C-O 120.635 0.181 . . . . 0.01 112.199 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.89 179.35 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.485 2.123 . . . . 0.01 112.179 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 C-N-CA 120.681 -0.771 . . . . 0.65 112.388 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.76 0.314 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.461 ' HB2' HD12 ' A' ' 43' ' ' LEU . 2.1 mtt -85.21 142.88 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.772 ' O ' HD21 ' A' ' 43' ' ' LEU . 49.6 m95 -129.78 -170.92 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 2.0 mt-10 -145.37 170.13 16.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.58 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' TYR . 1.3 p90 -168.22 130.54 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 3.2 pttt -126.09 128.7 47.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.205 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 72.4 m95 -63.82 -58.09 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.119 -179.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 5.1 mm-40 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.805 0.336 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.12 102.7 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.451 . . . . 0.0 111.439 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 6' ' ' TYR . 46.4 m-85 -131.11 179.74 5.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.963 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 107.35 -17.01 37.64 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.341 -0.933 . . . . 0.0 115.326 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.3 Cg_exo -40.38 -25.56 0.18 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 CA-C-N 120.235 2.018 . . . . 0.0 113.099 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.0 m-85 -43.01 166.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.328 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -66.89 145.9 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 12.1 t -47.04 -30.2 2.55 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.157 0.503 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.48 88.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.647 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 30.0 tp60 -69.72 -30.71 68.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.581 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.8 mmm -72.96 -46.81 50.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.303 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -59.39 -35.31 73.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.368 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -65.49 -61.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.8 m0 -54.7 -42.83 71.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 25' ' ' MET . 96.8 t -68.52 -33.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.928 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.9 p -84.62 -38.68 19.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.107 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -27.24 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 7.04 32.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.776 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.9 m-85 -54.87 -39.47 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -102.51 94.81 5.34 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 -24.73 30.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.553 2.169 . . . . 0.0 112.555 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.34 15.28 14.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.138 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.54 -176.23 35.67 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.018 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 2.6 m -152.11 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.875 0.369 . . . . 0.0 111.116 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -77.99 87.06 4.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.227 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 57.5 m -91.89 152.57 20.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 111.945 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 9.3 ttp85 -160.72 142.8 12.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.113 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 4.8 mtmt -68.41 146.4 53.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD21 ' O ' ' A' ' 4' ' ' TRP . 3.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 2.0 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.64 126.86 21.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.927 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.3 134.54 45.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t -57.98 -37.12 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.26 -12.52 56.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.281 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 7.24 27.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 57' ' ' ASP . 51.4 mt -108.97 153.83 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.055 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.46 ' CB ' HD12 ' A' ' 60' ' ' LEU . 12.2 t0 -113.35 84.97 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -60.08 -20.98 60.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.256 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.22 -10.11 59.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.574 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 ' CB ' ' A' ' 57' ' ' ASP . 27.3 mt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 111.194 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 81.0 Cg_endo . . . . . 0 N--CA 1.463 -0.307 0 CA-C-O 120.703 0.209 . . . . 0.01 112.099 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 28.0 Cg_endo -62.16 178.13 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.504 2.136 . . . . 0.01 112.199 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 8' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.685 -0.769 . . . . 0.65 112.417 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.834 0.349 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.1 mmm -81.12 159.43 24.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.577 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 65.7 m95 -147.61 116.8 6.89 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.489 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 5.1 pt-20 -80.8 136.08 36.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.561 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -127.38 137.33 52.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.184 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -126.05 128.49 47.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.412 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -59.1 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.065 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 9.5 mm-40 . . . . . 0 C--O 1.231 0.12 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 85.07 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 30.2 m-85 -109.29 -171.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.668 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.63 -9.87 41.39 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.057 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.8 Cg_exo -42.18 -26.48 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.431 2.116 . . . . 0.0 112.314 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.05 167.44 0.05 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.851 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -77.9 153.73 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -47.71 -29.58 3.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.073 0.463 . . . . 0.0 110.052 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.89 -57.56 11.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.625 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.3 tp60 -62.37 -37.47 85.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mmm -64.51 -49.85 69.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.659 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -54.12 -36.68 63.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' GLU . 88.2 m -61.11 -59.75 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.632 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -58.13 -46.08 86.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' MET . 94.0 t -57.86 -30.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 t -96.81 -29.29 13.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 14.1 tp10 -55.21 -30.22 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -0.66 26.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -58.83 -32.4 69.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -106.88 75.29 0.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.78 -21.69 69.44 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.86 6.51 15.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.207 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 159.81 10.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.094 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.88 161.5 41.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.836 0.35 . . . . 0.0 111.225 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -75.62 82.11 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.106 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 2.1 m -87.9 151.04 23.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.787 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 8.5 ptm180 179.02 151.76 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.434 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -59.32 135.9 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.872 0.367 . . . . 0.0 110.512 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.6 mt . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.27 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.7 m-85 . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.807 0.337 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CB ' HD11 ' A' ' 56' ' ' ILE . 3.3 m-85 -142.66 127.3 18.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.712 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -55.84 130.01 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -53.85 -28.3 35.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -2.06 46.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.229 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 4.87 11.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.532 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.466 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 40.1 mt -107.19 153.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -104.92 107.85 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -89.54 52.58 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.664 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -145.69 -37.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.299 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.464 -0.213 0 CA-C-O 120.617 0.174 . . . . 0.01 112.246 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . 0.436 ' HG2' ' CG ' ' A' ' 17' ' ' TYR . 33.5 Cg_endo -65.85 178.38 2.35 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.383 2.055 . . . . 0.01 112.357 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.816 -0.707 . . . . 0.65 112.616 179.853 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 mtt -74.65 163.86 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 64.8 m95 -145.49 115.8 7.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.697 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.554 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 8.6 pt-20 -76.2 146.17 39.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 1.5 p90 -133.99 134.82 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HE2' ' CD2' ' A' ' 16' ' ' LEU . 17.9 ttmm -127.47 126.96 43.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.332 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -56.7 -49.58 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.815 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.871 0.367 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -159.13 82.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 28.3 m-85 -113.88 -165.91 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.825 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 105.92 -9.45 43.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.357 -0.925 . . . . 0.0 115.036 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 99.7 Cg_exo -42.17 -26.68 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 120.408 2.104 . . . . 0.0 112.362 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.72 161.07 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 p -73.05 152.37 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 15.5 t -47.27 -29.68 2.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.209 0.528 . . . . 0.0 110.259 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.0 64.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.747 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -67.2 -35.4 79.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.634 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.426 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.9 mmm -70.72 -46.87 62.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.277 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -54.42 -37.3 64.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.497 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.0 m -63.8 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -51.31 -41.81 60.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.893 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 25' ' ' MET . 93.6 t -71.08 -31.07 43.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.832 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.75 23.73 13.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.8 tp10 -112.42 -33.87 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.61 -26.57 0.75 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' B' ' 68' ' ' PRO . 32.8 m-85 -64.15 168.04 5.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 55.0 68.02 2.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.753 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -24.36 76.5 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.637 2.225 . . . . 0.0 112.29 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -116.9 -5.93 11.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.45 158.13 30.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.021 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.55 161.25 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 0.0 111.217 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -68.51 83.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.151 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 3.4 m -91.66 146.38 23.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.724 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -179.06 147.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.538 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.62 131.11 49.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.412 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.086 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.804 0.335 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -162.15 134.12 5.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.966 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.64 137.92 57.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.5 p -53.79 -30.68 45.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.976 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -78.81 -3.91 46.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.33 4.07 13.41 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.626 0.251 . . . . 0.0 111.459 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.554 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 30.1 mt -106.46 153.25 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.3 t0 -116.49 82.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -57.5 -24.04 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -74.91 -14.72 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 57' ' ' ASP . 56.8 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.99 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 33' ' ' TYR . 43.9 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.769 0.237 . . . . 0.01 112.35 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.76 -179.37 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.222 . . . . 0.01 112.385 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.867 -0.682 . . . . 0.65 112.476 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.1 p30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.849 0.357 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -154.77 108.25 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.45 ' HB3' HD11 ' A' ' 43' ' ' LEU . 24.3 mtt -78.12 160.79 27.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.558 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 59.4 m95 -144.23 116.63 8.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.572 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.482 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.9 mt-10 -68.21 165.34 18.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.413 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 1.3 p90 -154.07 132.8 12.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HE2' ' HB3' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -124.7 125.84 44.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -56.49 -46.62 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.79 -177.15 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.43 38.77 3.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 p -109.41 165.96 11.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.79 -3.77 90.35 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.183 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.26 -25.51 10.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.549 0.214 . . . . 0.0 111.012 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.561 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . . . -43.01 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.732 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 6.7 mt-10 -67.05 136.95 56.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -109.91 107.84 17.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.018 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 55.3 m-85 -130.84 -163.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.581 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.43 28.74 18.79 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.011 -0.614 . . . . 0.0 114.356 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 93.4 Cg_endo -82.16 25.76 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.907 1.738 . . . . 0.0 111.924 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -99.34 166.26 11.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.894 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.3 p -69.15 150.01 48.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.819 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.7 -30.28 2.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.134 0.493 . . . . 0.0 110.148 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.09 -50.14 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.541 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 31.2 tp60 -65.99 -36.64 83.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.705 ' O ' HG23 ' A' ' 29' ' ' VAL . 51.4 mmm -67.1 -44.29 80.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.536 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.84 -38.61 75.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 31' ' ' GLU . 84.9 m -60.65 -57.77 11.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.806 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.2 m0 -62.2 -45.26 94.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' MET . 58.5 t -65.73 -34.83 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.285 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -88.61 -35.05 17.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.281 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' THR . 3.4 mm-40 -55.67 -30.09 60.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.099 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.3 2.6 24.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.795 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.45 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 0.3 OUTLIER -55.09 -34.56 63.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.847 0.356 . . . . 0.0 110.819 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -108.51 81.06 1.29 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.42 -17.16 49.04 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.701 2.268 . . . . 0.0 112.514 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.26 -8.76 12.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.294 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.64 158.94 35.14 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.005 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -132.97 160.95 42.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.993 0.425 . . . . 0.0 111.452 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -70.11 85.01 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.413 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.7 m -83.32 143.88 30.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.469 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -170.4 137.41 1.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -59.55 132.54 54.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.037 0.446 . . . . 0.0 110.588 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.0 mt -50.58 -53.83 27.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.392 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -101.13 126.07 36.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.1 161.46 90.75 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.629 -1.404 . . . . 0.0 112.428 0.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.62 117.74 3.73 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.68 2.253 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.9 99.43 1.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.652 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.29 -175.23 27.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.742 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.7 mt-30 -67.0 75.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.939 0.4 . . . . 0.0 110.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 41' ' ' ARG . 4.0 m-85 -42.15 163.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.65 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -150.54 137.6 19.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -57.05 136.85 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.802 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.8 p -54.88 -30.78 58.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.958 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -8.34 55.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -107.81 2.73 23.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.558 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.7 mt -109.06 153.11 10.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -118.45 87.02 2.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -60.4 -24.04 64.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.077 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -62.61 -21.85 65.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.266 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.2 mt -97.1 29.33 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -142.78 -46.1 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.9 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.338 . . . . 3.64 111.244 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -62.43 177.44 0.51 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 3.94 110.861 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 155.47 21.32 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.955 0.407 . . . . 6.89 111.079 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -77.64 167.37 24.23 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.881 2.387 . . . . 0.01 112.417 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.44 132.79 28.25 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.714 2.276 . . . . 0.66 112.015 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 37.1 Cg_endo -65.69 155.66 67.94 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.234 1.956 . . . . 0.01 111.848 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.474 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.1 Cg_endo -61.42 -179.44 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.355 2.037 . . . . 0.01 112.171 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 76.79 -80.08 1.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.707 -0.759 . . . . 0.65 112.453 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 41.98 -163.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.916 0.389 . . . . 4.17 111.831 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 176.05 106.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.03 -0.532 . . . . 6.95 110.87 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.572 ' OXT' HG23 ' B' ' 73' ' ' VAL . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.209 -0.9 . . . . 5.74 111.151 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.84 108.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.7 mtt -78.75 153.33 30.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.527 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 68.7 m95 -140.73 115.13 9.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.956 0.407 . . . . 0.0 111.691 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -66.4 170.81 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.487 179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -161.87 135.09 6.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.813 ' HD2' ' HB3' ' A' ' 14' ' ' ALA . 30.4 ttpt -129.68 129.0 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.055 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -62.87 -57.39 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.17 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HB3' HG23 ' A' ' 11' ' ' THR . 1.4 mm-40 -81.98 -176.16 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.98 39.0 4.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.7 p -105.57 171.92 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.82 -9.38 71.45 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.148 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -109.65 -19.92 13.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.491 0.186 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.813 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . . . -42.21 159.11 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 111.491 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.4 mp0 -62.0 135.88 57.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.495 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -110.02 94.91 5.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.089 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 67.0 m-85 -114.3 -166.1 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.459 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 93.32 27.59 13.07 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.993 -0.622 . . . . 0.0 114.466 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.1 Cg_endo -82.56 27.46 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.719 1.76 . . . . 0.0 111.753 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.5 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -98.7 167.52 10.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.98 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.7 p -70.15 149.81 47.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.91 -30.54 2.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.21 0.528 . . . . 0.0 110.148 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.65 86.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.76 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.5 tp60 -71.44 -31.7 67.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.839 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.486 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 mmm -75.16 -49.85 18.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.35 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.52 -33.08 69.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.399 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 31' ' ' GLU . 92.4 m -68.53 -51.5 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.476 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.4 m0 -63.2 -40.69 98.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 25' ' ' MET . 95.1 t -70.81 -30.98 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.253 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 p -95.11 -31.37 13.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.589 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.2 mm-40 -56.21 -46.16 79.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 110.982 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.63 -25.55 0.44 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -54.88 160.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.796 0.331 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 62.9 62.38 1.86 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.574 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.89 -23.79 17.2 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.582 2.188 . . . . 0.0 112.596 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.69 -4.51 10.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.468 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.65 160.31 34.1 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.883 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.96 160.36 41.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.964 0.412 . . . . 0.0 111.419 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.27 83.97 0.55 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.512 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -84.33 155.27 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.908 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 5.3 ptm180 -178.28 138.27 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -62.13 125.39 23.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.983 0.42 . . . . 0.0 110.547 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 14.2 mt -46.25 -61.48 1.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.289 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.21 137.29 19.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 97.7 Cg_endo -79.45 153.34 88.1 Favored 'Cis proline' 0 C--N 1.348 0.528 0 C-N-CA 123.515 -1.452 . . . . 0.0 112.411 0.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 51.5 Cg_exo -54.15 156.28 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.65 85.46 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.312 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.51 159.12 20.01 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.813 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -67.38 77.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.7 0.286 . . . . 0.0 110.642 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -31.87 144.43 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.683 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 134.91 19.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.779 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -55.25 133.07 49.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.6 p -53.3 -31.48 44.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.01 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -75.33 -7.82 55.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.029 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 1.83 22.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.677 0.275 . . . . 0.0 111.362 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 36.8 mt -108.08 152.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.793 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -117.96 84.75 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -58.88 -22.18 58.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -62.05 -25.9 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 mt -97.22 29.36 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 20.0 m-85 -138.27 -46.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.904 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.865 0.364 . . . . 3.64 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -62.4 -58.18 8.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.94 110.919 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.405 ' HB2' ' HD2' ' B' ' 66' ' ' PRO . 0.1 OUTLIER -68.83 157.63 88.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 6.89 110.91 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' B' ' 65' ' ' ARG . 57.6 Cg_endo -71.65 174.82 10.45 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.736 2.291 . . . . 0.01 112.608 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -87.95 151.73 7.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.987 2.458 . . . . 0.66 112.452 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.06 154.36 37.55 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.614 2.209 . . . . 0.01 112.408 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 16.3 Cg_endo -59.69 -178.06 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.595 2.197 . . . . 0.01 112.363 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 77.96 -73.22 2.16 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.728 -0.669 . . . . 0.65 112.618 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 45.02 -167.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 4.17 111.7 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.09 135.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.886 -0.597 . . . . 6.95 110.823 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.205 -0.902 . . . . 5.74 111.172 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.786 0.327 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 123.71 20.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.504 ' HB3' HD11 ' A' ' 43' ' ' LEU . 3.4 mtt -81.52 158.15 24.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.528 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 61.3 m95 -145.13 117.0 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.418 . . . . 0.0 111.787 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 1.8 mt-10 -66.46 171.94 4.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.316 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -168.56 130.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.363 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HE2' ' CD2' ' A' ' 39' ' ' TYR . 11.1 pttt -128.87 127.51 41.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.367 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.25 -55.14 38.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -69.44 146.01 52.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.763 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -97.88 40.12 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.692 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.524 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.9 p -100.83 -171.61 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.59 -9.29 41.19 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.634 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -128.79 -3.5 5.25 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' A' ' 9' ' ' GLU . . . -51.18 178.09 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.848 0.356 . . . . 0.0 111.357 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 8.7 mt-10 -55.14 140.9 36.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.769 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.07 89.69 3.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.243 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' B' ' 69' ' ' PRO . 75.6 m-85 -111.31 -164.49 0.92 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.083 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.629 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.83 23.99 34.02 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.813 -0.708 . . . . 0.0 114.29 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 85.5 Cg_endo -80.01 28.72 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 CA-C-N 119.788 1.794 . . . . 0.0 112.031 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -102.93 169.19 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.881 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 37.8 p -72.27 150.86 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.834 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.6 t -48.12 -28.99 3.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 110.098 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.67 84.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.562 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.469 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 39.8 tp60 -74.79 -33.58 62.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.752 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.9 mmm -73.04 -44.48 60.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.475 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 51.9 tp60 -59.91 -40.51 89.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' GLU . 18.5 m -60.92 -52.2 66.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.469 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.8 m0 -62.83 -43.64 98.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 25' ' ' MET . 98.5 t -67.61 -33.25 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.184 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.5 t -89.06 -40.06 13.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.059 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 27' ' ' THR . 11.3 tm-20 -51.48 -28.93 14.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.078 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.08 4.31 29.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.832 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -35.82 65.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.788 0.327 . . . . 0.0 110.955 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -105.35 78.67 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.535 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.06 -16.82 57.11 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.641 2.227 . . . . 0.0 112.401 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -113.97 -12.15 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.337 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.52 160.73 36.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 m -136.84 160.99 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.819 0.342 . . . . 0.0 111.262 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.437 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -79.65 87.56 5.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.184 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 20.5 m -93.08 159.84 15.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.349 0.595 . . . . 0.0 112.134 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -178.85 141.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.305 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -51.69 134.24 30.4 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 111.338 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.7 mt -59.92 -32.81 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.148 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 6.7 t70 -117.06 114.2 39.09 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.965 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 64.5 Cg_endo -73.19 149.48 94.22 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.594 -1.419 . . . . 0.0 112.42 -0.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.23 123.04 3.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.674 2.249 . . . . 0.0 112.565 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.36 96.2 0.44 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.505 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.45 -147.8 5.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.845 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.11 74.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.045 0.45 . . . . 0.0 110.791 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.473 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.0 m-85 -44.27 159.88 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.153 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.45 129.64 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.028 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.12 124.53 15.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.41 -34.54 35.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -11.2 60.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.281 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.65 2.86 20.49 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.655 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.569 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 20.8 mt -101.41 153.41 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 110.771 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 56' ' ' ILE . 6.1 t0 -115.99 83.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.785 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.407 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 81.0 m-85 -56.81 -22.82 39.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.218 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -21.26 66.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.287 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.9 mt -96.92 29.24 3.14 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.09 -62.71 0.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.949 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.913 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.831 0.348 . . . . 3.64 111.107 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -135.13 62.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 3.94 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.36 151.99 63.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 6.89 110.972 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.73 174.48 12.54 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.794 2.33 . . . . 0.01 112.442 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -88.59 135.24 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.959 2.439 . . . . 0.66 112.408 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.11 156.6 55.5 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.466 2.111 . . . . 0.01 112.188 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 Cg_endo -65.14 -179.21 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.475 2.116 . . . . 0.01 112.264 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 70.45 -77.38 0.48 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.793 -0.718 . . . . 0.65 112.387 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.34 -165.26 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.955 0.407 . . . . 4.17 111.916 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 174.73 92.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 6.95 110.842 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.301 -0.857 . . . . 5.74 111.17 -179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.88 0.371 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.35 118.68 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 41.2 mtt -80.89 160.0 24.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.522 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.664 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 54.8 m95 -144.79 115.41 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.683 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 3.4 pt-20 -71.39 149.8 45.63 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.379 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 3.6 p90 -137.13 140.78 42.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.453 . . . . 0.0 111.564 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.768 ' HD2' ' HB3' ' A' ' 14' ' ' ALA . 28.0 ttpt -131.21 123.41 28.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.832 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -62.48 -57.73 10.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 0.0 111.234 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -100.16 126.07 46.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.2 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -77.56 60.34 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.709 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 p -111.55 -178.58 3.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.907 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.68 -11.67 61.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.254 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -112.27 -18.59 12.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.544 0.211 . . . . 0.0 111.108 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.768 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . . . -45.23 145.59 1.08 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.786 0.327 . . . . 0.0 111.252 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -58.4 179.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.995 0.426 . . . . 0.0 110.695 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 89.01 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 54.3 m-85 -107.73 -161.91 0.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.95 25.4 29.44 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.224 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 96.8 Cg_endo -77.97 15.0 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 CA-C-N 119.635 1.718 . . . . 0.0 111.647 178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.457 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -88.18 165.71 14.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.776 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 p -70.85 148.55 47.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -30.14 2.42 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.177 0.513 . . . . 0.0 110.242 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.38 88.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.458 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.424 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.0 tp60 -73.37 -34.0 65.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.566 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.72 ' O ' HG23 ' A' ' 29' ' ' VAL . 36.3 mmm -71.61 -42.68 67.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.327 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.43 -43.95 92.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.42 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 31' ' ' GLU . 31.7 m -58.0 -53.52 57.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.813 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.87 -42.85 99.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.948 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 25' ' ' MET . 87.5 t -66.68 -33.99 67.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.444 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -30.63 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.797 0.332 . . . . 0.0 110.982 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 27' ' ' THR . 8.3 mm-40 -56.34 -23.06 34.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.21 6.04 42.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.595 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' CD2' ' HD3' ' B' ' 68' ' ' PRO . 4.4 m-30 -61.81 -28.65 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.626 0.251 . . . . 0.0 111.229 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -114.1 80.75 5.76 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.836 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 33' ' ' TYR . 50.9 Cg_exo -52.85 -27.98 37.0 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.495 2.13 . . . . 0.0 112.427 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -117.13 15.13 15.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.074 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 71.36 -164.38 53.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.048 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 37' ' ' GLY . 2.6 m -162.03 161.38 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.908 0.385 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.446 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -71.09 85.66 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.773 179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -93.72 152.22 19.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.808 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -178.75 150.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.361 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -58.98 136.05 57.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.043 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 21.7 mt -57.39 -47.67 81.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -118.42 120.61 31.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.69 136.95 47.12 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.208 -0.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.41 141.12 19.88 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.501 2.134 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 91.53 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -138.76 2.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.577 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.71 72.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.973 0.416 . . . . 0.0 110.892 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HD2' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -47.45 160.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.108 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -159.68 134.02 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -58.13 133.82 55.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 38' ' ' VAL . 18.0 p -54.14 -28.89 42.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 0.8 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.265 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 2.11 10.63 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.326 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.664 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 33.1 mt -99.58 153.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 110.837 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -107.63 79.32 1.28 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.946 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' O ' HG22 ' A' ' 62' ' ' THR . 86.1 m-85 -58.25 -24.29 58.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.097 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.05 -26.85 63.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.6 28.76 3.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.048 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.28 -52.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 58' ' ' PHE . 5.0 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.829 0.347 . . . . 3.64 111.24 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -137.6 112.21 8.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 3.94 110.905 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.07 156.17 72.12 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.423 . . . . 6.89 110.85 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.02 174.94 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.861 2.374 . . . . 0.01 112.631 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.74 140.75 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.858 2.372 . . . . 0.66 112.244 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.401 ' HD3' ' CD2' ' A' ' 33' ' ' TYR . 53.1 Cg_endo -69.88 162.67 41.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.484 2.123 . . . . 0.01 112.436 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.454 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 18.0 Cg_endo -62.1 -179.57 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.606 2.204 . . . . 0.01 112.312 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.2 -118.94 5.06 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.843 -0.694 . . . . 0.65 112.59 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.502 ' C ' ' CD2' ' B' ' 71' ' ' HIS . 0.0 OUTLIER 66.31 120.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 4.17 110.258 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.586 ' O ' HG13 ' B' ' 73' ' ' VAL . 0.0 OUTLIER -131.04 146.29 52.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 6.95 110.797 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.586 HG13 ' O ' ' B' ' 72' ' ' ARG . 3.2 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.252 -0.88 . . . . 5.74 111.089 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.749 0.309 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -68.63 116.12 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 52.8 mtt -79.74 160.54 26.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.489 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.539 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 63.1 m95 -144.92 115.65 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 111.853 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.731 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.24 165.95 22.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.327 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -157.05 133.39 9.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.199 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HE2' ' CZ ' ' A' ' 50' ' ' PHE . 10.8 pttt -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.376 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -60.58 -56.74 17.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.774 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.48 154.89 41.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -98.12 39.74 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.05 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 14' ' ' ALA . 3.0 p -112.7 160.42 17.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.73 -3.04 86.36 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.317 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.86 -25.62 8.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.65 0.262 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB2' ' OG1' ' A' ' 11' ' ' THR . . . -45.76 163.04 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.38 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -49.24 145.08 4.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.087 0.47 . . . . 0.0 110.903 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.731 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -125.83 96.89 4.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.343 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' B' ' 69' ' ' PRO . 52.2 m-85 -111.02 -163.49 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.082 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.637 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.82 24.2 33.39 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.23 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 91.1 Cg_endo -79.02 28.68 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 CA-C-N 119.714 1.757 . . . . 0.0 111.859 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -101.85 166.33 10.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.714 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.4 p -66.44 147.97 52.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.464 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -46.75 -30.67 2.52 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.82 88.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.689 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -70.93 -34.17 71.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.613 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.528 ' O ' HG23 ' A' ' 29' ' ' VAL . 58.6 mmm -73.96 -43.87 56.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.363 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.23 -36.36 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.54 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 55.7 m -66.34 -50.04 64.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.8 m0 -65.74 -44.22 86.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 25' ' ' MET . 87.8 t -65.71 -31.26 53.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.3 t -91.89 -33.45 14.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.051 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 4.1 mm-40 -57.19 -29.48 63.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.06 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.69 2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -55.29 -27.38 46.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -116.3 81.66 10.95 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.785 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.09 -27.0 53.14 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.548 2.165 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.54 12.19 16.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.102 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.03 -169.54 52.81 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.034 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.2 m -159.33 160.99 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.897 0.38 . . . . 0.0 111.051 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -73.3 90.9 1.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.888 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -90.44 156.37 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.216 0.531 . . . . 0.0 111.95 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -175.2 142.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.752 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -64.17 127.79 32.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 15.5 mt -47.35 -48.86 25.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 20.7 t0 -123.2 120.31 27.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.918 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 6.2 Cg_exo -78.59 143.34 71.84 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.076 -0.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -85.72 130.14 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.604 2.203 . . . . 0.0 112.601 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.75 99.84 1.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.731 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.26 -155.31 9.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 1.2 mt-30 -66.42 75.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.68 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CD2' ' HG3' ' A' ' 41' ' ' ARG . 2.7 m-85 -42.8 158.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.585 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 49' ' ' GLN . 25.4 m-85 -156.1 134.87 11.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.25 138.01 57.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.757 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.9 p -53.88 -30.86 47.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -77.97 -3.86 44.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -115.3 2.89 14.11 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.539 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 46.7 mt -106.91 152.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.837 0.351 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.58 ' HB3' HD12 ' A' ' 60' ' ' LEU . 7.9 t0 -113.3 90.61 3.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.965 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -65.14 -24.3 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.15 -9.34 58.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.276 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 57' ' ' ASP . 40.5 mt -97.14 29.34 3.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 110.983 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -140.19 -51.71 0.49 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.936 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.822 0.344 . . . . 3.64 111.181 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -166.28 -41.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 3.94 111.051 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' B' ' 66' ' ' PRO . 0.0 OUTLIER -50.83 140.09 20.76 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.308 -0.405 . . . . 6.89 110.829 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.6 Cg_endo -76.87 173.03 15.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.538 2.159 . . . . 0.01 112.694 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' B' ' 68' ' ' PRO . 91.7 Cg_endo -89.85 128.24 1.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.178 2.585 . . . . 0.66 112.569 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.46 ' HG3' ' CD2' ' A' ' 28' ' ' TRP . 35.8 Cg_exo -59.43 166.71 7.32 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.412 2.075 . . . . 0.01 112.118 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 14.2 Cg_endo -59.36 -178.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 0.01 112.255 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 78.31 -80.42 1.41 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.873 -0.68 . . . . 0.65 112.513 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.81 -167.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.424 . . . . 4.17 111.76 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.81 88.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 6.95 110.862 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 73' ' ' VAL . 6.9 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.279 -0.867 . . . . 5.74 111.144 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.81 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.441 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.0 mtt -126.32 162.59 25.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.573 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 60.4 m95 -145.61 114.35 6.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.848 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.57 ' CD ' HD11 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -71.94 158.82 35.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.082 179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -145.87 136.58 24.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 111.0 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.742 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 5.4 ttmt -126.51 122.88 36.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.15 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -53.65 -47.03 70.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' A' ' 11' ' ' THR . 4.5 mt-10 -104.45 -176.63 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 39' ' ' TYR . 8.3 m-20 -129.36 38.81 3.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.673 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.3 p -103.84 174.11 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.55 6.02 81.6 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.088 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -117.59 -31.73 5.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.572 0.225 . . . . 0.0 111.005 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.66 142.94 1.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.432 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -56.9 -176.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.961 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 ' CD ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -146.25 98.66 3.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.013 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 67.1 m-85 -115.77 -163.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.555 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.598 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 87.43 28.35 24.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.049 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.4 Cg_endo -81.24 22.12 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 CA-C-N 119.595 1.698 . . . . 0.0 111.64 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -94.18 165.41 12.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.567 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.1 p -68.51 146.87 52.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.705 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.51 -31.29 1.72 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.182 0.515 . . . . 0.0 110.237 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -50.58 70.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.474 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.43 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 36.2 tp60 -66.83 -36.8 83.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 33.7 mmm -68.27 -51.49 44.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' OE1' ' CD1' ' A' ' 58' ' ' PHE . 35.8 tp60 -54.19 -32.82 56.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.471 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 37.1 m -64.4 -52.36 58.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.568 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.43 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.2 m0 -64.55 -42.43 95.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.938 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 34' ' ' PHE . 98.4 t -64.57 -31.86 55.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.183 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 p -96.85 -31.27 12.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.454 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' THR . 16.6 mm-40 -54.37 -33.37 58.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.262 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.91 -26.25 1.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.484 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -56.09 164.2 1.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 60.4 61.86 3.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.518 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -50.72 -32.49 36.63 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.674 2.25 . . . . 0.0 112.531 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -115.2 12.63 16.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.251 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.74 159.81 24.85 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.111 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.83 161.97 36.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.125 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -70.81 80.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.27 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.6 m -82.77 145.14 29.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.717 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -169.27 135.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.082 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 4' ' ' TRP . 18.5 mtmt -60.39 136.23 57.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 3' ' ' MET . 10.7 mt -60.24 -67.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.774 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -120.42 138.71 27.66 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.746 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.89 149.28 87.38 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.478 -0.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.61 153.99 34.74 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.626 2.218 . . . . 0.0 112.352 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.5 -92.9 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.541 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.05 -155.96 22.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.47 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.21 67.89 0.81 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.402 0.62 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.57 179.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.24 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -156.92 132.08 9.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.846 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.15 134.54 56.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.781 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 p -55.14 -25.96 35.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 4.82 29.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.414 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.36 5.34 5.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.563 0.22 . . . . 0.0 111.554 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 24.1 mt -103.13 153.21 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.9 t0 -109.4 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' CD1' ' OE1' ' A' ' 26' ' ' GLN . 66.7 m-85 -70.21 -12.95 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -85.07 -14.58 46.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.488 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.475 HD12 ' CB ' ' A' ' 57' ' ' ASP . 81.0 mt -96.09 28.75 3.04 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.869 0.366 . . . . 0.0 111.196 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -140.88 -47.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.912 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.74 0.305 . . . . 3.64 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -127.06 -169.33 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 3.94 110.971 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' B' ' 65' ' ' ARG . 0.0 OUTLIER 63.38 137.37 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 6.89 110.905 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -86.58 173.25 6.42 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.854 2.369 . . . . 0.01 112.674 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -90.83 150.66 4.03 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.266 2.644 . . . . 0.66 112.324 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.27 156.87 46.23 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.497 2.131 . . . . 0.01 112.218 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.483 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.3 Cg_endo -58.69 -174.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.447 2.098 . . . . 0.01 112.391 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 70.96 -65.31 0.89 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.627 -0.715 . . . . 0.65 112.58 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.2 -164.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.402 . . . . 4.17 111.813 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.73 119.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 6.95 110.849 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.268 -0.872 . . . . 5.74 111.086 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.733 0.302 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.05 108.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.177 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.409 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.5 mtt -76.49 157.52 32.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.501 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.531 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 67.5 m95 -142.76 117.08 9.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.968 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -69.64 166.66 18.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.232 179.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -159.75 130.56 5.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.081 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.712 ' CD ' ' HB3' ' A' ' 14' ' ' ALA . 18.4 ttpt -120.17 120.91 37.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.16 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 34' ' ' PHE . 85.1 m95 -56.94 -52.62 64.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.022 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' HB3' HG23 ' A' ' 11' ' ' THR . 5.7 mm-40 -83.03 -177.54 6.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.431 ' ND2' ' CD1' ' A' ' 39' ' ' TYR . 14.2 m120 -129.61 37.48 3.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.499 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.8 p -91.21 -167.01 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.69 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.49 -12.9 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.43 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -139.43 11.06 2.53 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . . . -47.76 167.51 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.654 0.264 . . . . 0.0 111.19 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 2.8 pm0 -49.75 134.41 20.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.912 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.59 107.87 16.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 52.4 m-85 -133.97 -164.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.553 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.661 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 95.52 18.25 33.57 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.872 -0.68 . . . . 0.0 114.337 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 78.3 Cg_endo -77.02 51.59 3.5 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.958 1.879 . . . . 0.0 111.544 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -127.08 166.67 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.52 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -70.55 148.35 48.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -46.57 -30.1 2.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.087 0.47 . . . . 0.0 110.181 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.03 30.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.398 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 42.3 tp60 -61.29 -34.67 75.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 29' ' ' VAL . 39.4 mmm -70.06 -41.25 74.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.182 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.445 ' HG2' ' CB ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -58.07 -40.17 80.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.561 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 31' ' ' GLU . 99.2 m -62.55 -60.71 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.446 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 12.4 m0 -55.99 -46.33 78.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 25' ' ' MET . 81.4 t -60.56 -29.61 45.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.23 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.2 m -99.05 -25.65 14.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.356 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 27' ' ' THR . 6.0 tp10 -56.82 -33.36 66.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 111.097 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.47 -5.39 13.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.735 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.15 -34.8 66.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.902 0.382 . . . . 0.0 110.794 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -107.48 73.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.477 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.18 -19.94 62.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.596 2.197 . . . . 0.0 112.42 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.29 -12.44 11.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.193 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.79 159.4 28.64 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.809 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.87 160.98 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.966 0.412 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.431 ' CD1' ' ND2' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -70.87 79.15 0.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.431 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -78.22 150.34 33.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.542 -179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.6 ttm-85 -179.57 126.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.41 137.85 10.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 111.075 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 3' ' ' MET . 16.5 mt -57.46 -36.93 72.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.285 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 9.6 t70 -118.46 116.38 35.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.072 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 72.8 Cg_endo -76.17 144.9 80.93 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.22 -0.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.58 115.07 2.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.536 2.157 . . . . 0.0 112.49 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.32 100.42 1.91 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.691 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.07 -153.67 8.53 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -67.76 74.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 4.3 m-85 -41.73 160.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.417 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.59 131.46 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -55.26 128.33 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.024 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 p -54.65 -32.23 58.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -76.82 -4.74 45.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -114.71 3.64 14.79 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.576 0.227 . . . . 0.0 111.569 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.531 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 58.6 mt -103.3 153.89 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.298 . . . . 0.0 110.97 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.414 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 7.0 t0 -100.71 111.95 24.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' CB ' ' HG2' ' A' ' 26' ' ' GLN . 88.6 m-85 -95.7 20.36 9.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.984 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -108.45 -23.46 11.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.29 29.35 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.95 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 57' ' ' ASP . 25.8 m-85 -135.2 -48.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.884 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.749 0.309 . . . . 3.64 111.157 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -94.26 51.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 3.94 110.827 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -90.81 136.77 27.39 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 6.89 110.82 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.25 174.83 8.84 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.748 2.299 . . . . 0.01 112.523 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.82 123.1 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.079 2.519 . . . . 0.66 112.271 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.91 168.57 20.05 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.412 2.075 . . . . 0.01 112.296 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 28.9 Cg_endo -65.26 -178.89 0.93 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.451 2.1 . . . . 0.01 112.482 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.522 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 72.37 -67.17 1.24 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.866 -0.683 . . . . 0.65 112.536 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 42.65 -163.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.932 0.396 . . . . 4.17 111.763 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.18 98.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.066 -0.515 . . . . 6.95 110.964 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.236 -0.888 . . . . 5.74 111.121 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.887 0.375 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.06 110.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 43' ' ' LEU . 18.3 mtt -79.67 163.41 24.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.565 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.446 ' CZ2' ' HE2' ' A' ' 42' ' ' LYS . 54.4 m95 -148.02 117.13 6.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.712 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -70.14 163.81 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.0 p90 -152.22 137.23 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.351 . . . . 0.0 110.997 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.738 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 10.9 ttmt -126.05 128.13 46.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -58.92 -51.72 68.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.116 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 5.9 mm-40 -90.48 162.08 15.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -101.05 38.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -104.44 -173.08 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.27 -6.72 36.07 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.252 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -112.09 -20.89 11.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.49 0.186 . . . . 0.0 111.224 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -44.2 163.05 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.733 0.301 . . . . 0.0 111.608 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 17.0 mm-40 -60.82 139.05 58.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.85 113.03 24.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 72.4 m-85 -133.22 -162.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.419 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 89.66 28.67 18.36 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.999 -0.62 . . . . 0.0 114.293 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.9 Cg_endo -80.77 23.62 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 119.668 1.734 . . . . 0.0 111.624 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -94.28 165.15 12.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.746 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 p -70.32 148.07 48.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.779 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 t -45.56 -30.88 1.6 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.212 0.529 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.11 -48.29 80.81 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.531 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 41.3 tp60 -68.89 -34.28 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.628 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.444 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 mmm -69.07 -46.29 68.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.279 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -42.3 73.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.675 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.559 HG22 ' HD3' ' B' ' 65' ' ' ARG . 91.1 m -59.02 -54.88 42.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.625 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.48 ' CD1' ' HG3' ' B' ' 68' ' ' PRO . 7.0 m0 -59.81 -40.96 90.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 25' ' ' MET . 95.8 t -73.19 -30.57 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.796 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 p -95.43 -31.58 13.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.8 tp10 -57.76 -47.99 80.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.24 -26.37 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.773 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -53.37 162.44 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.7 OUTLIER 63.48 55.6 1.87 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.31 -22.85 28.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.231 . . . . 0.0 112.196 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -114.56 -14.04 12.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.32 158.34 23.99 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.948 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 53' ' ' SER . 13.9 m -130.56 159.93 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.928 0.394 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD2' ' CD2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -74.49 88.08 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.22 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.2 m -80.94 158.03 25.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.178 0.513 . . . . 0.0 111.754 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HG3' ' CG ' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -179.72 145.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.714 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 18.2 mtmt -73.14 123.12 22.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.253 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.7 mt -42.64 -52.06 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 45' ' ' PRO . 7.0 t70 -118.84 125.75 27.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 44' ' ' ASP . 87.8 Cg_endo -80.72 152.47 82.22 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 123.627 -1.405 . . . . 0.0 112.391 -0.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.37 139.64 13.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.76 2.307 . . . . 0.0 112.497 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.5 97.11 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.518 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' ' NH1' ' A' ' 41' ' ' ARG . . . -158.77 -169.46 22.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.866 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -67.06 75.84 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.503 ' CD2' ' CD2' ' A' ' 39' ' ' TYR . 1.5 m-85 -38.92 156.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -156.36 136.17 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -59.16 136.2 57.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.525 ' HB2' HG23 ' A' ' 38' ' ' VAL . 6.5 t -53.27 -31.22 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -6.35 53.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.112 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 -1.4 19.7 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.309 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 40' ' ' CYS . 39.8 mt -104.96 150.65 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.634 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -117.89 83.99 2.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -59.4 -25.56 64.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.5 -22.42 43.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.207 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mt -96.52 29.09 3.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -139.52 -51.1 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.907 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.783 0.325 . . . . 3.64 111.156 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -100.7 91.11 4.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 3.94 110.678 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.559 ' HD3' HG22 ' A' ' 27' ' ' THR . 17.5 ttp-105 -62.93 133.93 95.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 6.89 110.934 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.98 175.13 5.12 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.004 2.469 . . . . 0.01 112.889 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' B' ' 68' ' ' PRO . 91.2 Cg_endo -88.68 123.85 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.12 2.547 . . . . 0.66 112.619 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 28' ' ' TRP . 32.5 Cg_exo -58.33 142.55 97.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.535 2.157 . . . . 0.01 112.3 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 13.6 Cg_endo -59.33 -177.71 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.507 2.138 . . . . 0.01 112.399 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 80.84 -79.29 1.8 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.65 112.6 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.49 -167.09 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.861 0.362 . . . . 4.17 111.672 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.81 98.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 6.95 110.851 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.243 -0.884 . . . . 5.74 111.104 179.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.89 0.376 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.35 117.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.187 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 33.5 mtt -81.83 156.66 24.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.52 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 52.5 m95 -143.6 115.93 8.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.352 . . . . 0.0 111.845 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 5.4 pt-20 -71.87 162.79 28.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 6.0 p90 -152.63 135.43 15.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.688 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -123.42 128.7 50.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -62.04 -54.91 34.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.32 167.05 17.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -106.13 38.83 1.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.68 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -105.77 -172.59 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.965 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.85 -11.7 27.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.153 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -106.66 -21.09 13.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.575 0.226 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.75 147.5 0.45 Allowed 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.765 0.317 . . . . 0.0 111.58 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -60.13 135.6 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.171 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.69 147.61 35.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.212 0.529 . . . . 0.0 111.54 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 70.3 m-85 -155.38 -160.79 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 88.77 29.66 17.68 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.864 -0.684 . . . . 0.0 114.284 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 90.4 Cg_endo -79.05 17.79 1.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-N 119.588 1.694 . . . . 0.0 111.464 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -91.19 166.24 13.05 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.716 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.9 p -68.46 148.52 50.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.991 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.4 p -47.26 -30.08 2.83 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.206 0.526 . . . . 0.0 110.284 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -47.37 80.77 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.459 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 35.2 tp60 -71.11 -33.05 69.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.9 mmm -72.77 -46.13 54.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.183 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -56.64 -38.0 71.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.395 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.547 HG21 ' CZ ' ' B' ' 65' ' ' ARG . 38.8 m -63.36 -60.52 3.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.49 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.459 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 7.1 m0 -53.8 -40.75 66.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.973 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 25' ' ' MET . 77.5 t -69.4 -33.53 57.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.243 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -89.68 -32.15 17.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.2 tp10 -56.46 -44.12 80.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 111.107 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -0.97 6.93 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.825 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -53.95 -33.4 56.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.912 0.387 . . . . 0.0 110.817 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -105.39 82.15 0.73 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.521 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.54 -29.16 83.95 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.589 2.193 . . . . 0.0 112.243 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -115.53 14.75 16.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.594 ' O ' HG13 ' A' ' 38' ' ' VAL . . . 73.52 -166.8 54.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.114 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 37' ' ' GLY . 3.0 m -160.83 161.78 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.892 0.377 . . . . 0.0 111.054 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.451 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.3 82.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.0 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HB3' HD12 ' A' ' 56' ' ' ILE . 1.5 m -87.01 150.84 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.904 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -179.85 143.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.262 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HE2' ' CE1' ' A' ' 61' ' ' TYR . 10.9 mttt -55.86 131.59 47.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 110.871 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' CD1' ' HB2' ' A' ' 3' ' ' MET . 24.3 mt -49.21 -31.27 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -120.45 119.62 30.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.832 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.66 143.03 74.77 Favored 'Cis proline' 0 C--N 1.35 0.623 0 C-N-CA 123.68 -1.383 . . . . 0.0 112.29 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.21 119.85 5.14 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.511 2.14 . . . . 0.0 112.44 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.76 96.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.22 -148.63 5.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.633 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -67.47 73.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.783 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' CB ' ' CD2' ' A' ' 39' ' ' TYR . 2.5 m-85 -45.58 166.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.433 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -151.03 130.4 12.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.69 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -54.95 129.59 38.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.926 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB3' HG23 ' A' ' 38' ' ' VAL . 9.4 p -53.45 -32.27 49.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -78.71 -3.35 43.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -117.56 4.24 12.4 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.518 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.546 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 18.3 mt -101.15 153.58 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.693 ' HB3' HD12 ' A' ' 60' ' ' LEU . 9.0 t0 -109.48 80.6 1.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.001 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -58.14 -22.41 50.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -75.77 -6.74 52.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.481 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 57' ' ' ASP . 25.8 mt -96.48 28.54 3.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 111.062 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.424 ' CE1' ' HE2' ' A' ' 42' ' ' LYS . 98.9 m-85 -146.89 -47.53 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.941 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.772 0.32 . . . . 3.64 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -60.27 -69.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 3.94 110.849 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.547 ' CZ ' HG21 ' A' ' 27' ' ' THR . 16.8 tpp180 -62.41 139.97 96.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 6.89 110.64 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.3 Cg_endo -78.41 172.68 14.91 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.563 2.175 . . . . 0.01 112.64 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -90.97 117.81 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.157 2.571 . . . . 0.66 112.48 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.46 164.49 32.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.01 111.916 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.504 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 16.2 Cg_endo -60.52 -176.59 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.378 2.052 . . . . 0.01 112.271 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.521 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 70.51 -70.02 0.69 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.63 -0.714 . . . . 0.65 112.504 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.14 -164.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.92 0.391 . . . . 4.17 111.811 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.403 ' N ' ' CD2' ' B' ' 71' ' ' HIS . 0.9 OUTLIER -174.4 124.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.532 . . . . 6.95 110.956 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.201 -0.904 . . . . 5.74 111.166 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.869 0.366 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 119.95 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.127 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.434 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . 5.6 mmm -79.64 152.11 30.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.559 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 73.9 m95 -144.65 114.84 7.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 111.736 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -70.3 170.58 11.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.353 179.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.87 135.38 8.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.002 0.429 . . . . 0.0 111.28 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.798 ' HD2' ' HB3' ' A' ' 14' ' ' ALA . 5.4 ttpm? -127.4 129.43 47.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.037 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -58.43 -48.49 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB3' HG23 ' A' ' 11' ' ' THR . 70.5 mm-40 -129.04 131.53 47.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.165 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 10.8 t-20 -74.03 62.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 9' ' ' GLU . 5.1 p -117.5 169.72 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.33 -0.87 89.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.221 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -114.41 -30.14 6.66 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.59 0.233 . . . . 0.0 110.968 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.798 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . . . -45.66 151.62 0.4 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.91 0.385 . . . . 0.0 111.53 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -71.44 -177.73 1.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -140.73 92.34 2.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.717 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 53.9 m-85 -113.47 -166.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 92.38 28.55 12.75 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.527 -0.596 . . . . 0.0 114.317 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 86.3 Cg_endo -83.49 25.93 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 CA-C-N 119.788 1.794 . . . . 0.0 111.788 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -99.42 171.03 8.22 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -71.93 147.47 46.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.929 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -46.66 -30.64 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.181 0.515 . . . . 0.0 110.285 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.04 -46.9 85.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.559 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.2 tp60 -70.33 -32.72 70.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.623 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.9 mmm -73.75 -47.98 35.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.305 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -56.92 -34.1 67.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.567 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 31' ' ' GLU . 8.4 m -71.05 -53.21 15.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.9 m0 -61.84 -42.05 98.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.729 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' MET . 73.8 t -65.38 -30.17 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.921 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.9 m -95.6 -31.33 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.7 mm-40 -55.14 -32.09 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.133 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.16 -0.03 20.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CD2' ' HD2' ' B' ' 68' ' ' PRO . 53.9 m-85 -56.44 -34.47 66.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -109.39 76.38 0.83 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.5 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.2 -19.03 65.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.634 2.223 . . . . 0.0 112.408 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -115.85 2.23 13.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.66 159.33 13.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.982 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.23 160.64 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.957 0.408 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -76.51 87.53 3.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.353 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.69 156.33 19.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.28 0.562 . . . . 0.0 111.807 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -175.29 127.19 0.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.082 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 41' ' ' ARG . 12.6 mtmt -50.27 135.26 21.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.281 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt -59.4 -63.16 1.4 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -114.28 137.46 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.814 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.43 132.6 27.79 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.857 -1.309 . . . . 0.0 112.18 0.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.74 102.42 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.489 2.126 . . . . 0.0 112.275 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 -81.25 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.533 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 -145.71 7.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.363 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.14 69.0 0.46 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.17 0.51 . . . . 0.0 111.382 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 3.3 m-85 -58.62 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.27 129.4 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.76 133.6 56.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.19 -34.97 64.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -68.18 -12.12 60.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.186 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.26 11.98 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.559 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 47.2 mt -109.2 155.34 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.933 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' HB3' HD12 ' A' ' 60' ' ' LEU . 6.7 t0 -113.37 82.24 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -57.51 -22.49 44.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.96 -10.57 59.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.326 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 57' ' ' ASP . 22.6 mt -96.04 28.69 3.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 111.012 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -144.67 -47.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.825 0.345 . . . . 3.64 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.06 8.45 29.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 3.94 111.265 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.472 ' NE ' HG21 ' A' ' 27' ' ' THR . 2.2 ttm-85 63.09 138.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.764 0.316 . . . . 6.89 111.051 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.437 ' HB2' ' HD2' ' B' ' 67' ' ' PRO . 87.2 Cg_endo -83.94 175.75 7.38 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.633 2.222 . . . . 0.01 112.531 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 92.5 Cg_endo -86.83 137.58 4.75 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.833 2.355 . . . . 0.66 112.227 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 33' ' ' TYR . 40.2 Cg_endo -66.99 162.81 36.42 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.442 2.095 . . . . 0.01 112.232 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.452 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 18.3 Cg_endo -61.32 -177.65 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.482 2.121 . . . . 0.01 112.273 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 72.98 -64.85 1.55 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.752 -0.737 . . . . 0.65 112.322 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.482 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.31 -167.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.067 0.461 . . . . 4.17 111.788 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.84 73.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.785 -0.643 . . . . 6.95 110.732 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.156 -0.926 . . . . 5.74 111.181 -179.899 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.799 0.333 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.58 102.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.424 ' HB3' HD11 ' A' ' 43' ' ' LEU . 45.8 mtt -80.09 156.04 27.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.592 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 53.2 m95 -139.67 117.69 11.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.928 0.394 . . . . 0.0 111.732 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mt-10 -67.34 169.41 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.707 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -160.8 136.19 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.072 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.62 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 3.0 ttmt -127.7 122.36 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.291 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -55.98 -48.91 74.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.978 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.62 -177.08 4.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.892 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.01 38.27 4.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.775 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -110.19 167.92 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.985 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.07 0.44 89.77 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.138 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.48 -26.16 8.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.645 0.259 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.62 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.67 150.85 0.22 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.595 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 2.9 mt-10 -59.12 139.93 56.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 110.761 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.14 107.99 18.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' CG ' ' HB2' ' B' ' 69' ' ' PRO . 74.2 m-85 -126.45 -163.99 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.603 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 91.48 29.89 11.55 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 121.033 -0.603 . . . . 0.0 114.351 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 75.8 Cg_endo -83.37 26.08 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 121.882 1.721 . . . . 0.0 111.812 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' CE1' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -96.34 167.51 11.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.842 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.8 p -69.13 147.02 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.804 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -44.16 -34.04 1.71 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.216 0.532 . . . . 0.0 110.235 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -56.51 20.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.8 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.0 tp60 -58.08 -32.37 68.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.46 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.6 mmm -72.71 -43.09 63.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 22' ' ' SER . 0.7 OUTLIER -57.58 -38.31 74.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.597 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.762 HG21 ' CZ ' ' B' ' 65' ' ' ARG . 65.5 m -64.81 -60.03 3.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.7 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 9.7 m0 -55.23 -43.23 74.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.975 0.417 . . . . 0.0 111.016 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' MET . 77.6 t -65.85 -29.44 46.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -94.89 -29.71 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.34 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.0 tm-20 -57.61 -44.43 85.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.995 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.39 -3.05 5.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.905 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE2' ' CD ' ' B' ' 68' ' ' PRO . 16.1 m-85 -54.43 -32.04 56.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -111.04 78.82 1.76 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.56 -20.15 47.62 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.565 2.176 . . . . 0.0 112.56 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -116.95 -6.81 11.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.448 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.17 160.23 34.47 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.915 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.5 m -132.28 161.12 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 111.231 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.444 ' CD2' ' CB ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -71.79 81.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.048 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 1.3 m -87.74 149.12 24.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 111.93 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' HB3' ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -173.71 140.5 0.77 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.804 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 4' ' ' TRP . 17.9 mttt -57.06 128.17 35.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 3' ' ' MET . 14.8 mt -45.73 -35.76 4.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.404 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -120.0 119.11 31.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.778 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.64 140.18 63.94 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.941 -1.275 . . . . 0.0 112.193 -0.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.73 123.45 4.23 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.585 2.19 . . . . 0.0 112.422 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.31 99.3 1.25 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.612 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.51 -157.49 18.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -66.36 74.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.971 0.415 . . . . 0.0 110.681 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 41' ' ' ARG . 6.2 m-85 -44.19 166.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.437 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -140.85 127.6 20.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -57.72 131.72 51.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 p -53.03 -29.11 27.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.091 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -79.4 -2.5 42.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.313 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -118.05 3.92 12.08 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.516 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 19.8 mt -101.31 151.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.746 0.308 . . . . 0.0 110.814 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -110.48 89.56 3.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.23 -16.28 63.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.502 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -71.92 -19.98 61.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.512 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -97.58 29.68 3.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 0.0 111.172 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.448 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 49.9 m-85 -139.59 -46.33 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.077 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.804 0.335 . . . . 3.64 111.161 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.18 134.37 31.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 3.94 111.006 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.762 ' CZ ' HG21 ' A' ' 27' ' ' THR . 3.7 tpp180 -163.07 141.57 6.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 6.89 110.718 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' B' ' 65' ' ' ARG . 73.2 Cg_endo -78.22 174.36 12.55 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.543 2.162 . . . . 0.01 112.578 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -88.72 111.01 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.064 2.509 . . . . 0.66 112.57 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 38.3 Cg_exo -56.94 167.51 3.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.41 2.073 . . . . 0.01 112.092 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.494 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . 20.7 Cg_endo -64.87 179.54 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.267 1.978 . . . . 0.01 112.29 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 82.01 -78.08 2.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.779 -0.724 . . . . 0.65 112.468 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.526 ' NE2' HG12 ' B' ' 73' ' ' VAL . 0.3 OUTLIER 45.91 -166.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.951 0.405 . . . . 4.17 111.594 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.444 ' N ' ' CD2' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -163.84 73.48 0.29 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 6.95 110.609 178.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 73' ' ' VAL . 6.1 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.202 -0.904 . . . . 5.74 111.049 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.3 t0 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 t -67.46 110.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.214 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.538 ' CB ' HD12 ' A' ' 43' ' ' LEU . 15.7 mtp -87.34 145.78 26.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.795 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.775 ' O ' HD21 ' A' ' 43' ' ' LEU . 42.4 m95 -132.53 -172.07 2.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -147.45 163.16 37.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.022 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -151.98 136.89 17.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.976 0.417 . . . . 0.0 111.176 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.672 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -129.69 128.83 43.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 31.7 m95 -62.9 -57.38 10.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.74 134.3 50.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' ND2' ' CE1' ' A' ' 39' ' ' TYR . 6.7 m-20 -80.28 58.35 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -116.54 -177.67 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.98 1.83 71.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.16 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -116.8 -28.33 6.37 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.576 0.227 . . . . 0.0 111.146 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.672 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -45.12 144.18 1.37 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 111.44 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.01 -177.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.607 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.404 HD22 ' HE3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -143.61 84.44 1.8 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.201 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 45.0 m-85 -106.85 -175.24 2.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.961 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.26 -16.87 41.42 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.895 -0.947 . . . . 0.0 115.297 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.5 Cg_exo -40.29 -26.19 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 120.428 2.114 . . . . 0.0 112.985 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.2 m-85 -43.14 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.366 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -66.91 146.57 54.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 4' ' ' TRP . 5.5 p -47.75 -30.53 3.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.14 0.495 . . . . 0.0 110.221 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.65 92.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.537 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.479 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 33.0 tp60 -71.23 -30.45 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.552 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 29' ' ' VAL . 52.5 mmm -73.23 -47.06 46.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.201 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -57.08 -39.63 75.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -62.07 -59.76 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.684 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.479 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 11.1 m0 -57.2 -44.54 83.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.802 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 25' ' ' MET . 97.0 t -66.99 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.947 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -83.94 -41.65 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.26 -27.84 49.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.145 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.77 6.93 30.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.869 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.8 m-85 -54.09 -25.95 24.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.283 . . . . 0.0 111.081 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -117.56 80.85 13.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.793 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.69 -19.47 65.28 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.663 2.242 . . . . 0.0 112.531 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -112.51 -3.76 14.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.474 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.43 162.45 29.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.972 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 7.4 m -137.34 161.53 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.955 0.407 . . . . 0.0 111.458 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -73.01 90.21 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.421 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.622 ' CB ' HD12 ' A' ' 56' ' ' ILE . 1.8 m -88.04 142.23 27.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.81 139.79 11.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.112 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 1.5 mtmt -73.42 142.64 46.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.848 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.775 HD21 ' O ' ' A' ' 4' ' ' TRP . 5.6 mt -73.0 -65.83 0.75 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.848 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.98 131.25 24.42 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.4 143.64 76.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.274 0.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.89 137.18 19.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.519 2.146 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.31 -101.1 0.3 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.517 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 179.2 -145.79 6.84 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.448 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 42.07 70.94 0.24 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.218 0.532 . . . . 0.0 111.593 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -45.06 167.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.24 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -149.05 126.59 11.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -63.04 130.71 45.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -52.06 -28.2 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.069 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.49 -7.8 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.311 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.97 7.29 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.479 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 51' ' ' TYR . 31.9 mt -104.28 153.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 111.141 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 56' ' ' ILE . 16.1 t70 -118.11 117.53 29.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.667 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -94.46 30.35 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.63 -26.01 9.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 mt -97.67 29.39 3.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 42' ' ' LYS . 49.4 m-85 -133.49 -48.23 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.842 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.877 0.37 . . . . 3.64 111.16 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -127.76 100.07 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 3.94 110.909 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.99 157.75 73.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 6.89 110.907 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 174.23 12.04 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 0.01 112.499 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -88.98 136.17 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.016 2.477 . . . . 0.66 112.374 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 75.5 Cg_endo -77.4 169.21 21.55 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.42 2.08 . . . . 0.01 112.199 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.89 179.35 1.43 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.485 2.123 . . . . 0.01 112.179 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.496 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 73.91 -65.09 1.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.681 -0.771 . . . . 0.65 112.388 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.33 -165.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.98 0.419 . . . . 4.17 111.863 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 177.5 96.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.92 -0.582 . . . . 6.95 110.788 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.275 -0.869 . . . . 5.74 111.197 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.334 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.07 114.02 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.183 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.461 ' HB2' HD12 ' A' ' 43' ' ' LEU . 2.1 mtt -85.21 142.88 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.772 ' O ' HD21 ' A' ' 43' ' ' LEU . 49.6 m95 -129.78 -170.92 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 2.0 mt-10 -145.37 170.13 16.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.58 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 17' ' ' TYR . 1.3 p90 -168.22 130.54 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.09 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 50' ' ' PHE . 3.2 pttt -126.09 128.7 47.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.205 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.442 ' CE3' HG12 ' A' ' 38' ' ' VAL . 72.4 m95 -63.82 -58.09 7.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HB3' HG23 ' A' ' 11' ' ' THR . 5.3 mt-10 -86.68 139.25 30.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.119 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -103.05 37.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.681 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 9' ' ' GLU . 1.6 p -76.37 -164.25 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.0 3.66 75.09 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.109 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 -62.6 0.14 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 120.694 0.283 . . . . 0.0 110.407 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 47.74 -175.6 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.027 0.441 . . . . 0.0 111.601 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 5.1 mm-40 -89.25 136.31 33.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.151 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.12 102.7 11.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.048 0.451 . . . . 0.0 111.439 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 6' ' ' TYR . 46.4 m-85 -131.11 179.74 5.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.963 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 107.35 -17.01 37.64 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.341 -0.933 . . . . 0.0 115.326 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 72.3 Cg_exo -40.38 -25.56 0.18 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 CA-C-N 120.235 2.018 . . . . 0.0 113.099 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' GLY . 2.0 m-85 -43.01 166.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.328 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -66.89 145.9 54.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 12.1 t -47.04 -30.2 2.55 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.157 0.503 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.25 -44.48 88.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.647 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 30.0 tp60 -69.72 -30.71 68.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.581 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.665 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.8 mmm -72.96 -46.81 50.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.303 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -59.39 -35.31 73.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.368 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.616 HG21 ' NE ' ' B' ' 65' ' ' ARG . 18.4 m -65.49 -61.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.771 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.8 m0 -54.7 -42.83 71.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.746 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 25' ' ' MET . 96.8 t -68.52 -33.28 59.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.928 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.9 p -84.62 -38.68 19.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.107 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.06 -27.24 52.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.021 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.39 7.04 32.96 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.776 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE1' ' HD2' ' B' ' 68' ' ' PRO . 2.9 m-85 -54.87 -39.47 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.809 0.338 . . . . 0.0 111.146 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -102.51 94.81 5.34 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.58 -24.73 30.18 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.553 2.169 . . . . 0.0 112.555 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.34 15.28 14.81 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.138 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.54 -176.23 35.67 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.018 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' CE3' ' A' ' 8' ' ' TRP . 2.6 m -152.11 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.875 0.369 . . . . 0.0 111.116 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -77.99 87.06 4.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.227 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 57.5 m -91.89 152.57 20.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.11 0.481 . . . . 0.0 111.945 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 9.3 ttp85 -160.72 142.8 12.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.113 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HG3' ' CH2' ' A' ' 4' ' ' TRP . 4.8 mtmt -68.41 146.4 53.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD21 ' O ' ' A' ' 4' ' ' TRP . 3.1 mt -80.09 -63.47 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -113.72 127.71 26.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.801 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.58 142.25 74.2 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.274 -0.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.71 131.49 15.99 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.536 2.158 . . . . 0.0 112.362 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.14 -102.0 0.41 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.559 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.57 -152.62 12.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 47.41 69.33 0.52 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.324 0.583 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 41' ' ' ARG . 2.0 m-85 -44.87 161.65 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.133 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.64 126.86 21.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.927 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.3 134.54 45.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t -57.98 -37.12 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.069 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.26 -12.52 56.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.281 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 7.24 27.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.572 0.225 . . . . 0.0 111.505 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 57' ' ' ASP . 51.4 mt -108.97 153.83 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.92 0.391 . . . . 0.0 111.055 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.46 ' CB ' HD12 ' A' ' 60' ' ' LEU . 12.2 t0 -113.35 84.97 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.857 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -60.08 -20.98 60.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.256 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -81.22 -10.11 59.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.574 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 ' CB ' ' A' ' 57' ' ' ASP . 27.3 mt -96.41 28.7 3.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 111.194 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CE2' ' CZ2' ' A' ' 4' ' ' TRP . 39.9 m-85 -137.71 -47.42 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.978 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.95 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.794 0.33 . . . . 3.64 111.143 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -63.45 -78.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 3.94 110.977 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.616 ' NE ' HG21 ' A' ' 27' ' ' THR . 50.5 ttm-85 -142.97 140.13 17.66 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 6.89 110.937 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.92 172.6 8.67 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.826 2.351 . . . . 0.01 112.802 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -91.03 153.15 3.87 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.104 2.536 . . . . 0.66 112.308 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' A' ' 33' ' ' TYR . 81.0 Cg_endo -78.31 155.02 28.66 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.56 2.173 . . . . 0.01 112.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.421 ' HG2' ' HB3' ' A' ' 17' ' ' TYR . 28.0 Cg_endo -62.16 178.13 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.504 2.136 . . . . 0.01 112.199 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.51 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 81.37 -70.99 2.99 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.685 -0.769 . . . . 0.65 112.417 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.51 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.7 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.991 0.424 . . . . 4.17 111.752 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 175.24 108.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.954 -0.566 . . . . 6.95 110.796 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.277 -0.868 . . . . 5.74 111.128 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.844 0.354 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.96 122.92 11.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 43' ' ' LEU . 4.1 mmm -81.12 159.43 24.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.577 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 65.7 m95 -147.61 116.8 6.89 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.489 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 5.1 pt-20 -80.8 136.08 36.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.561 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 3.2 p90 -127.38 137.33 52.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.184 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.604 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 39.9 ttmt -126.05 128.49 47.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -59.1 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.065 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -133.02 140.57 47.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.96 58.44 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.795 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -81.41 -171.59 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.671 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.1 65.84 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.893 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -146.68 -59.82 0.29 Allowed 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 110.706 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . 47.85 -176.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.093 0.473 . . . . 0.0 111.563 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 9.5 mm-40 -96.2 135.66 37.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.127 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 85.07 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.929 0.395 . . . . 0.0 111.539 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 30.2 m-85 -109.29 -171.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.668 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 106.63 -9.87 41.39 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.057 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 97.8 Cg_exo -42.18 -26.48 0.53 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.431 2.116 . . . . 0.0 112.314 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.05 167.44 0.05 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.851 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.9 p -77.9 153.73 32.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -47.71 -29.58 3.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.073 0.463 . . . . 0.0 110.052 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.89 -57.56 11.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.625 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 40.3 tp60 -62.37 -37.47 85.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mmm -64.51 -49.85 69.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.659 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -54.12 -36.68 63.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' GLU . 88.2 m -61.11 -59.75 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.632 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -58.13 -46.08 86.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 25' ' ' MET . 94.0 t -57.86 -30.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 t -96.81 -29.29 13.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 14.1 tp10 -55.21 -30.22 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.56 -0.66 26.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.795 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -58.83 -32.4 69.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -106.88 75.29 0.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.618 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.78 -21.69 69.44 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.623 2.215 . . . . 0.0 112.304 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.86 6.51 15.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.207 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.88 159.81 10.27 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.094 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.88 161.5 41.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.836 0.35 . . . . 0.0 111.225 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -75.62 82.11 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.106 179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 2.1 m -87.9 151.04 23.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.787 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 8.5 ptm180 179.02 151.76 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.434 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -59.32 135.9 57.8 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.872 0.367 . . . . 0.0 110.512 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 3' ' ' MET . 11.6 mt -55.53 -39.69 70.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.27 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.6 124.49 34.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.81 156.49 98.94 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.21 0.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.89 113.3 3.72 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.546 2.164 . . . . 0.0 112.502 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.56 96.48 0.52 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.5 -155.14 6.95 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.847 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -66.61 74.84 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.939 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 41' ' ' ARG . 2.7 m-85 -42.69 158.1 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.425 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' CB ' HD11 ' A' ' 56' ' ' ILE . 3.3 m-85 -142.66 127.3 18.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.712 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -55.84 130.01 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -53.85 -28.3 35.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -2.06 46.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.229 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.76 4.87 11.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.532 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.466 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 40.1 mt -107.19 153.03 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.024 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 36.6 t0 -104.92 107.85 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -89.54 52.58 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.664 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -145.69 -37.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.299 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.24 28.01 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 24.2 m-85 -127.8 -40.48 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.009 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.914 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.787 0.327 . . . . 3.64 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -85.35 -60.09 2.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.94 110.905 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' B' ' 66' ' ' PRO . 0.0 OUTLIER -156.82 137.15 8.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 6.89 110.668 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' B' ' 65' ' ' ARG . 92.6 Cg_endo -81.38 175.63 9.44 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.689 2.259 . . . . 0.01 112.562 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 91.0 Cg_endo -88.11 142.73 5.53 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.891 2.394 . . . . 0.66 112.443 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.29 158.67 40.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.589 2.193 . . . . 0.01 112.246 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . 0.436 ' HG2' ' CG ' ' A' ' 17' ' ' TYR . 33.5 Cg_endo -65.85 178.38 2.35 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.383 2.055 . . . . 0.01 112.357 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.502 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 77.02 -74.24 1.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.816 -0.707 . . . . 0.65 112.616 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.502 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 44.84 -166.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.925 0.393 . . . . 4.17 111.825 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.32 134.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 6.95 110.799 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.468 ' OXT' HG23 ' B' ' 73' ' ' VAL . 5.5 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.202 -0.904 . . . . 5.74 111.104 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.855 0.359 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.23 108.88 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.4 mtt -74.65 163.86 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.554 ' CZ3' HD13 ' A' ' 56' ' ' ILE . 64.8 m95 -145.49 115.8 7.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.697 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.554 ' HA ' ' HA3' ' A' ' 18' ' ' GLY . 8.6 pt-20 -76.2 146.17 39.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 17' ' ' TYR . 1.5 p90 -133.99 134.82 42.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.71 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 17.9 ttmm -127.47 126.96 43.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.332 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -56.7 -49.58 74.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.7 -170.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.815 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -132.48 38.68 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.681 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -110.2 179.95 3.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.9 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.44 5.35 85.19 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.127 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.18 -31.63 5.6 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.602 0.239 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . . . -43.85 152.38 0.17 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.397 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -55.67 -176.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.731 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' CD2' ' HE2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -159.13 82.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.437 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 28.3 m-85 -113.88 -165.91 1.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.825 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' N ' ' CD ' ' A' ' 19' ' ' PRO . . . 105.92 -9.45 43.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.357 -0.925 . . . . 0.0 115.036 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 18' ' ' GLY . 99.7 Cg_exo -42.17 -26.68 0.55 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 CA-C-N 120.408 2.104 . . . . 0.0 112.362 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.72 161.07 0.05 OUTLIER 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.072 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 p -73.05 152.37 41.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 15.5 t -47.27 -29.68 2.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.209 0.528 . . . . 0.0 110.259 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.08 -52.0 64.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.747 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 28' ' ' TRP . 37.4 tp60 -67.2 -35.4 79.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.634 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.426 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.9 mmm -70.72 -46.87 62.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.277 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -54.42 -37.3 64.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.497 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 31' ' ' GLU . 91.0 m -63.8 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.419 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.464 ' CZ3' ' HG3' ' A' ' 24' ' ' GLN . 8.4 m0 -51.31 -41.81 60.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.893 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 25' ' ' MET . 93.6 t -71.08 -31.07 43.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.832 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.75 23.73 13.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.8 tp10 -112.42 -33.87 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 110.84 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.61 -26.57 0.75 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CE2' ' HD2' ' B' ' 68' ' ' PRO . 32.8 m-85 -64.15 168.04 5.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER 55.0 68.02 2.83 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.753 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.09 -24.36 76.5 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.637 2.225 . . . . 0.0 112.29 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -116.9 -5.93 11.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.45 158.13 30.72 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.021 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 m -129.55 161.25 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 0.0 111.217 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CD2' ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -68.51 83.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.151 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' GLU . 3.4 m -91.66 146.38 23.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.724 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.447 ' HG2' ' CE1' ' A' ' 50' ' ' PHE . 3.0 ptm180 -179.06 147.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.538 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.62 131.11 49.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.412 . . . . 0.0 110.811 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 19' ' ' PRO . 12.9 mt -49.38 -33.27 13.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.086 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -120.41 127.52 26.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 98.8 Cg_endo -78.77 139.29 53.45 Favored 'Cis proline' 0 C--N 1.349 0.558 0 C-N-CA 123.596 -1.419 . . . . 0.0 112.328 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 45' ' ' PRO . 32.4 Cg_exo -59.37 125.3 17.6 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.465 2.11 . . . . 0.0 112.268 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.65 92.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.585 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.12 -151.43 5.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.643 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -67.77 73.62 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.933 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CG ' ' CD2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -45.27 166.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.058 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -162.15 134.12 5.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.966 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.64 137.92 57.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.5 p -53.79 -30.68 45.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.976 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -78.81 -3.91 46.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.33 4.07 13.41 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.626 0.251 . . . . 0.0 111.459 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.554 HD13 ' CZ3' ' A' ' 4' ' ' TRP . 30.1 mt -106.46 153.25 7.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' CB ' HD12 ' A' ' 60' ' ' LEU . 8.3 t0 -116.49 82.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -57.5 -24.04 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.059 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -74.91 -14.72 60.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.359 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.604 HD12 ' CB ' ' A' ' 57' ' ' ASP . 56.8 mt -96.44 29.02 3.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.99 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -139.39 -47.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.954 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.868 0.366 . . . . 3.64 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -113.12 38.93 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 3.94 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HD2' ' CD1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -156.97 135.78 7.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.399 . . . . 6.89 110.927 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' B' ' 67' ' ' PRO . 92.1 Cg_endo -87.18 176.54 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.065 2.51 . . . . 0.01 112.392 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' B' ' 66' ' ' PRO . 83.4 Cg_endo -87.02 125.36 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.8 2.333 . . . . 0.66 112.256 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.42 ' HD2' ' CE2' ' A' ' 33' ' ' TYR . 43.9 Cg_endo -68.02 165.03 29.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.43 2.087 . . . . 0.01 112.35 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.76 -179.37 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.634 2.222 . . . . 0.01 112.385 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' B' ' 71' ' ' HIS . . . 71.56 -65.73 1.06 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.867 -0.682 . . . . 0.65 112.476 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' B' ' 70' ' ' GLY . 0.4 OUTLIER 43.01 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.932 0.396 . . . . 4.17 111.81 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 178.46 124.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.045 -0.525 . . . . 6.95 110.764 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.259 -0.877 . . . . 5.74 111.16 179.94 . . . . . . . . 0 0 . 1 stop_ save_